SVB Financial (SIVBQ) 10-Q7 Nov 222022 Q3 Quarterly reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2022	Oct. 31, 2022
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-39154
Entity Registrant Name	SVB FINANCIAL GROUP
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	91-1962278
Entity Address, Address Line One	3003 Tasman Drive
Entity Address, City or Town	Santa Clara
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95054-1191
City Area Code	408
Local Phone Number	654-7400
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		59,104,124
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Central Index Key	0000719739
Amendment Flag	false
Common Stock
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	SIVB
Security Exchange Name	NASDAQ
Series A Preferred Stock
Entity Information [Line Items]
Title of 12(b) Security	Depositary shares, each representing a 1/40th ownership interest in a share of 5.250% Fixed-Rate Non-Cumulative Perpetual Preferred Stock, Series A
Trading Symbol	SIVBP
Security Exchange Name	NASDAQ

Interim Consolidated Balance Sh

Interim Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Assets:
Cash and cash equivalents	$ 13,968	$ 14,586
Available-for-sale securities, at fair value (cost of $29,502 and $27,370, respectively)	26,711	27,221
Held-to-maturity securities, at amortized cost and net of allowance for credit losses of $6 and $7 (fair value of $77,370 and $97,227, respectively)	93,286	98,195
Non-marketable and other equity securities	2,595	2,543
Total investment securities	122,592	127,959
Loans, amortized cost	72,129	66,276
Allowance for credit losses: loans	(557)	(422)
Net loans	71,572	65,854
Premises and equipment, net of accumulated depreciation and amortization	346	270
Goodwill	375	375
Other intangible assets, net	142	160
Lease right-of-use assets	349	313
Accrued interest receivable and other assets	3,523	1,791
Total assets	212,867	211,308
Liabilities:
Noninterest-bearing demand deposits	93,988	125,851
Interest-bearing deposits	82,831	63,352
Total deposits	176,819	189,203
Short-term borrowings	13,552	71
Lease liabilities	429	388
Other liabilities	2,889	2,467
Long-term debt	3,368	2,570
Total liabilities	197,057	194,699
Commitments and contingencies (Note 11 and Note 14)
SVBFG stockholders’ equity:
Preferred stock, $0.001 par value, 20,000,000 shares authorized; 383,500 and 383,500 shares issued and outstanding, respectively	3,646	3,646
Common stock, $0.001 par value, 150,000,000 shares authorized; 59,104,124 and 58,748,469 shares issued and outstanding, respectively	0	0
Additional paid-in capital	5,272	5,157
Retained earnings	8,676	7,442
Accumulated other comprehensive income (loss)	(2,085)	(9)
Total SVBFG stockholders’ equity	15,509	16,236
Noncontrolling interests	301	373
Total equity	15,810	16,609
Total liabilities and total equity	$ 212,867	$ 211,308

Interim Consolidated Balance _2

Interim Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Available-for-sale, amortized cost	$ 29,502	$ 27,370
Held-to-maturity securities, allowance for credit losses	6	7
HTM securities	$ 77,370	$ 97,227
Preferred stock, par value, in usd per share	$ 0.001	$ 0.001
Preferred stock, shares authorized	20,000,000	20,000,000
Preferred stock, shares issued	383,500	383,500
Preferred stock, shares outstanding	383,500	383,500
Common stock, par value, in usd per share	$ 0.001	$ 0.001
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares, issued	59,104,124	58,748,469
Common stock, shares outstanding	59,104,124	58,748,469

Interim Consolidated Statements

Interim Consolidated Statements of Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Interest income:
Loans	$ 865	$ 519	$ 2,089	$ 1,422
Investment securities:
Taxable	545	332	1,618	807
Non-taxable	35	28	105	73
Federal funds sold, securities purchased under agreements to resell and other short-term investment securities	76	5	105	12
Total interest income	1,521	884	3,917	2,314
Interest expense:
Deposits	249	19	348	41
Borrowings	74	13	122	33
Total interest expense	323	32	470	74
Net interest income	1,198	852	3,447	2,240
Provision for credit losses	72	21	279	75
Net interest income after provision for credit losses	1,126	831	3,168	2,165
Noninterest income:
Gains (losses) on investment securities, net	(127)	189	(199)	661
Gains on equity warrant assets, net	40	147	120	491
Client investment fees	119	20	237	55
Wealth management and trust fees	19	22	63	22
Foreign exchange fees	74	65	216	189
Credit card fees	37	34	114	93
Deposit service charges	32	29	94	82
Lending related fees	20	21	65	55
Letters of credit and standby letters of credit fees	15	13	43	39
Investment banking revenue	75	90	293	335
Commissions	24	17	73	58
Other	31	25	119	97
Total noninterest income	359	672	1,238	2,177
Noninterest expense:
Compensation and benefits	563	548	1,649	1,418
Professional services	117	104	355	282
Premises and equipment	71	54	189	124
Net occupancy	25	25	74	60
Business development and travel	21	6	62	13
FDIC and state assessments	25	13	57	33
Merger-related charges	7	83	39	102
Other	63	46	188	136
Total noninterest expense	892	879	2,613	2,168
Income before income tax expense	593	624	1,793	2,174
Income tax expense	175	149	489	509
Net income before noncontrolling interests and dividends	418	475	1,304	1,665
Net (income) loss attributable to noncontrolling interests	51	(88)	53	(226)
Preferred stock dividends	(40)	(22)	(123)	(40)
Net income available to common stockholders	$ 429	$ 365	$ 1,234	$ 1,399
Earnings per common share—basic (dollars per share)	$ 7.26	$ 6.33	$ 20.94	$ 25.54
Earnings per common share—diluted (dollars per share)	$ 7.21	$ 6.24	$ 20.73	$ 25.16

Interim Consolidated Statemen_2

Interim Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Comprehensive Income [Abstract]
Net income before noncontrolling interests	$ 418	$ 475	$ 1,304	$ 1,665
Change in foreign currency cumulative translation gains and losses:
Foreign currency translation gains (losses), net of hedges	(39)	(6)	(81)	(4)
Related tax benefit (expense)	11	2	23	1
Change in unrealized gains and losses on AFS securities:
Unrealized holding gains (losses)	(1,187)	(30)	(2,734)	(584)
Related tax benefit (expense)	336	8	774	163
Reclassification adjustment for (gains) losses included in net income	0	0	(48)	0
Related tax benefit (expense)	0	0	14	0
Cumulative-effect adjustment for unrealized losses on securities transferred from AFS to HTM	0	(54)	0	(132)
Related tax benefit (expense)	0	15	0	36
Amortization of unrealized holding net gains (losses) on securities transferred from AFS to HTM	3	0	10	(5)
Related tax benefit (expense)	(1)	0	(3)	1
Change in unrealized gains and losses on cash flow hedges:
Reclassification adjustment for gains included in net income	(14)	(16)	(43)	(47)
Related tax benefit (expense)	4	4	12	13
Other comprehensive income (loss), net of tax	(887)	(77)	(2,076)	(558)
Comprehensive income (loss)	(469)	398	(772)	1,107
Comprehensive (income) loss attributable to noncontrolling interests	51	(88)	53	(226)
Comprehensive income (loss) attributable to SVBFG	$ (418)	$ 310	$ (719)	$ 881

Interim Consolidated Statemen_3

Interim Consolidated Statements of Stockholders' Equity - USD ($) $ in Millions	Total	Noncumulative Preferred Stock	Preferred Stock	Preferred Stock Noncumulative Preferred Stock	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Total SVBFG Stockholders’ Equity	Total SVBFG Stockholders’ Equity Noncumulative Preferred Stock	Noncontrolling Interests
Balance (in shares) at Dec. 31, 2020					51,888,463
Balance, beginning of period, net of tax at Dec. 31, 2020	$ 8,433		$ 340		$ 0	$ 1,585	$ 5,672	$ 623	$ 8,220		$ 213
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued under employee benefit plans, net of restricted stock cancellations (in shares)					374,039
Common stock issued under employee benefit plans, net of restricted stock cancellations	(1)				$ 0	(1)			(1)
Issuance of stock (in shares)					4,527,000
Issuance of stock	2,363	$ 1,724		$ 1,724	$ 0	2,363			2,363	$ 1,724
Issuance of common stock for the acquisition of Boston Private (in shares)					1,887,981
Issuance of common stock for the acquisition of Boston Private	1,060					1,060			1,060
Net income	1,665						1,439		1,439		226
Capital calls and distributions, net	(70)										(70)
Other comprehensive income (loss), net of tax	(558)							(558)	(558)
Share-based compensation, net	93					93			93
Dividends on preferred stock	(40)						(40)		(40)
Balance (in shares) at Sep. 30, 2021					58,677,483
Balance, end of period, net of tax at Sep. 30, 2021	14,669		2,064		$ 0	5,100	7,071	65	14,300		369
Balance (in shares) at Jun. 30, 2021					54,530,307
Balance, beginning of period, net of tax at Jun. 30, 2021	11,967		2,064		$ 0	2,755	6,706	142	11,667		300
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued under employee benefit plans, net of restricted stock cancellations (in shares)					32,195
Common stock issued under employee benefit plans, net of restricted stock cancellations	2					2			2
Issuance of stock (in shares)					2,227,000
Issuance of stock	1,245				$ 0	1,245			1,245
Issuance of common stock for the acquisition of Boston Private (in shares)					1,887,981
Issuance of common stock for the acquisition of Boston Private	1,060				$ 0	1,060			1,060
Net income	475						387		387		88
Capital calls and distributions, net	(19)										(19)
Other comprehensive income (loss), net of tax	(77)							(77)	(77)
Share-based compensation, net	38					38			38
Dividends on preferred stock	(22)						(22)		(22)
Balance (in shares) at Sep. 30, 2021					58,677,483
Balance, end of period, net of tax at Sep. 30, 2021	14,669		2,064		$ 0	5,100	7,071	65	14,300		369
Balance (in shares) at Dec. 31, 2021					58,748,469
Balance, beginning of period, net of tax at Dec. 31, 2021	16,609		3,646		$ 0	5,157	7,442	(9)	16,236		373
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued under employee benefit plans, net of restricted stock cancellations (in shares)					355,655
Common stock issued under employee benefit plans, net of restricted stock cancellations	(31)				$ 0	(31)			(31)
Net income	1,304						1,357		1,357		(53)
Capital calls and distributions, net	(19)										(19)
Other comprehensive income (loss), net of tax	(2,076)							(2,076)	(2,076)
Share-based compensation, net	146					146			146
Dividends on preferred stock	(123)						(123)		(123)
Balance (in shares) at Sep. 30, 2022					59,104,124
Balance, end of period, net of tax at Sep. 30, 2022	15,810		3,646		$ 0	5,272	8,676	(2,085)	15,509		301
Balance (in shares) at Jun. 30, 2022					59,081,326
Balance, beginning of period, net of tax at Jun. 30, 2022	16,276		3,646		$ 0	5,223	8,247	(1,198)	15,918		358
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued under employee benefit plans, net of restricted stock cancellations (in shares)					22,798
Common stock issued under employee benefit plans, net of restricted stock cancellations	(2)					(2)			(2)
Net income	418						469		469		(51)
Capital calls and distributions, net	(6)										(6)
Other comprehensive income (loss), net of tax	(887)							(887)	(887)
Share-based compensation, net	51					51			51
Dividends on preferred stock	(40)						(40)		(40)
Balance (in shares) at Sep. 30, 2022					59,104,124
Balance, end of period, net of tax at Sep. 30, 2022	$ 15,810		$ 3,646		$ 0	$ 5,272	$ 8,676	$ (2,085)	$ 15,509		$ 301

Interim Consolidated Statemen_4

Interim Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net income before noncontrolling interests	$ 1,304,000	$ 1,665,000
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	279,000	75,000
Changes in fair values of equity warrant assets, net of proceeds from exercises	(38,000)	(36,000)
Changes in fair values of derivatives, net	345,000	18,000
Losses (Gains) on investment securities, net	199,000	(661,000)
Distributions of earnings from non-marketable and other equity securities	52,000	166,000
Depreciation and amortization	155,000	106,000
Amortization of premiums and discounts on investment securities, net	271,000	294,000
Amortization of share-based compensation	146,000	93,000
Amortization of deferred loan fees	(192,000)	(193,000)
Deferred income tax (benefit) expense	(173,000)	73,000
Excess tax benefit from exercise of stock options and vesting of restricted shares	(20,000)	(34,000)
Losses from the write-off of premises and equipment and right-of-use assets	0	38,000
Changes in other assets and liabilities:
Accrued interest receivable and payable, net	(72,000)	(117,000)
Accounts receivable and payable, net	(6,000)	5,000
Income tax receivable and payable, net	377,000	(141,000)
Accrued compensation	(296,000)	89,000
Other, net	(487,000)	(298,000)
Net cash provided by operating activities	1,844,000	1,142,000
Cash flows from investing activities:
Purchases of AFS securities	(12,407,000)	(5,395,000)
Sales proceeds	8,511,000	168,000
Proceeds from maturities and paydowns of AFS securities	1,174,000	3,892,000
Purchases of HTM securities	(4,961,000)	(65,048,000)
Proceeds from maturities and paydowns of HTM securities	9,605,000	8,993,000
Purchases of non-marketable and other equity securities	(292,000)	(310,000)
Proceeds from sales and distributions of capital of non-marketable and other securities	86,000	587,000
Net increase in loans	(5,759,000)	(9,006,000)
Purchases of premises and equipment	(141,000)	(77,000)
Cash Acquired from Acquisition	0	1,116,000
Net cash used for investing activities	(4,184,000)	(65,080,000)
Cash flows from financing activities:
Net (decrease) increase in deposits	(12,384,000)	60,216,000
Net increase in short-term borrowings	13,481,000	13,000
Proceeds from issuance of long-term debt	798,000	990,000
(Distributions to noncontrolling interests), net of contributions from noncontrolling interests	(19,000)	(70,000)
Net proceeds from the issuance of preferred stock	0	1,724,000
Payment of preferred stock dividend	(123,000)	(40,000)
Proceeds from issuance of common stock, ESPP and ESOP, net of restricted stock awards	(31,000)	2,362,000
Net cash provided by financing activities	1,722,000	65,195,000
Net (decrease) increase in cash and cash equivalents	(618,000)	1,257,000
Cash and cash equivalents at beginning of period	14,586,000	17,622,000
Cash and cash equivalents at end of period	13,968,000	18,879,000
Cash paid during the period for:
Interest	412,000	57,000
Income taxes, net of refunds	249,000	547,000
Noncash items during the period:
Changes in unrealized gains and losses on AFS securities, net of tax	(1,994,000)	(421,000)
Distributions of stock from investments	1,000	62,000
Transfers from AFS securities to HTM	$ 0	$ 8,953,000

Basis of Presentation

Basis of Presentation	9 Months Ended
Basis of Presentation	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation SVB Financial Group is a diversified financial services company, as well as a bank holding company and a financial holding company. SVB Financial was incorporated in the state of Delaware in March 1999. Through our various subsidiaries and divisions, we offer a diverse set of banking and financial products and services to support our clients of all sizes and stages throughout their life cycles. In these notes to our unaudited interim consolidated financial statements, when we refer to “SVB,” “SVB Financial Group,” “SVBFG," the “Company,” “we,” “our,” “us” or use similar words, we mean SVB Financial Group and all of its subsidiaries collectively, including Silicon Valley Bank (the “Bank”), unless the context requires otherwise. When we refer to “SVB Financial” or the “Parent” we are referring only to the parent company, SVB Financial Group (not including subsidiaries). The accompanying unaudited interim consolidated financial statements reflect all adjustments of a normal and recurring nature that are, in the opinion of management, necessary to fairly present our financial position, results of operations and cash flows in accordance with GAAP. Such unaudited interim consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q pursuant to the rules and regulations of the SEC. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of results to be expected for any future periods. These unaudited interim consolidated financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2021 (“2021 Form 10-K”). Use of Estimates and Assumptions The preparation of unaudited interim consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates may change as new information is obtained. Among the more significant estimates are those that relate to: 1) ACL for loans and for unfunded credit commitments, 2) valuation of non-marketable and other equity securities, 3) valuation of equity warrant assets, 4) goodwill, intangible assets and other purchase accounting related adjustments, and 5) income taxes. Principles of Consolidation and Presentation Our unaudited interim consolidated financial statements include the accounts of SVB Financial Group and consolidated entities. All significant intercompany accounts and transactions with consolidated entities have been eliminated. For a further description of our accounting policies regarding consolidation refer to Consolidated Financial Statements and Supplementary Data — Note 2 — “Summary of Significant Accounting Policies” under Part II, Item 8 of our 2021 Form 10-K. Reclassifications Certain prior period amounts have been reclassified to conform to current period presentation to account for the change in presentation of derivative asset and liability positions and the related cash collateral disclosed in the Summary of Significant Accounting Polices in Part 1, Item 1 of this report. These changes are included in our Consolidated Balance Sheets (unaudited) and Consolidated Statements of Cash Flows (unaudited) as well as the Cash and Cash Equivalents, Derivative Financial Instruments and Fair Value of Financial Instruments footnotes. Summary of Significant Accounting Policies During the third quarter of 2022, we changed our presentation of derivative asset and liability positions and the related cash collateral in the unaudited interim consolidated balance sheets. The balances are presented net by counterparty when a legally enforceable right of setoff exists under a master netting arrangement in accordance with ASC 815, Derivatives and Hedging . Previously, fair values of derivative positions were reported in the line items “Accrued interest receivable and other assets” and “Other liabilities” gross. The related cash collateral was reported in the line items "Cash and cash equivalents" and "Short-term borrowings". For impact on presentation, please refer to the balance sheet offsetting section of Note 8 – “Derivative Financial Instruments”. This change had no impact on our net income. We concluded that this presentation was preferable as it better reflects the credit risk of derivatives traded under master netting arrangements. This change represents a change in accounting principle under ASC 250, Accounting Changes and Error Corrections , with retrospective application to the earliest period presented. In the third quarter of 2022, we also adjusted the allowance models for the CRE and Other C&I loan portfolios to more precisely forecast lifetime loan losses for those portfolios. As a result, the allowance model for the CRE loan portfolio uses a reasonable and supportable forecast period that is less than, but approximately, three years; the Company continues to use a three-year reasonable and supportable forecast period for all other loan loss models. Subsequent to the forecast period period, the CRE and Other C&I models' reversion to average historical losses uses an approach that gradually trends towards the mean historical loss over the remaining contractual lives of loans, whereas all other loan models continue to use an autoregressive approach. The impact on overall reserves as a result of these changes was not material. This change represents a change in accounting estimate under ASC 250, Accounting Changes and Error Corrections , with prospective application.

Stockholders' Equity and EPS

Stockholders' Equity and EPS	9 Months Ended
Stockholders' Equity and EPS	Sep. 30, 2022
Equity and Earnings Per Share [Abstract]
Stockholders' Equity and EPS	Stockholders' Equity and EPS AOCI The following table summarizes the items reclassified out of AOCI into the Consolidated Statements of Income (unaudited) for the three and nine months ended September 30, 2022 and 2021: Three months ended September 30, Nine months ended September 30, (Dollars in millions) Income Statement Location 2022 2021 2022 2021 Reclassification adjustment for losses (gains) included in net income Gains (losses) on investment securities, net $ — $ — $ (48) $ — Related tax expense Income tax expense — — 14 — Reclassification adjustment for gains on cash flow hedges included in net income Net interest income (14) (16) (43) (47) Related tax expense Income tax expense 4 4 12 13 Total reclassification adjustment for gains included in net income, net of tax $ (10) $ (12) $ (65) $ (34) The table below summarizes the activity relating to net gains and losses on our cash flow hedges included in AOCI for the three and nine months ended September 30, 2022 and 2021. Over the next 12 months, we expect that approximately $46 million in AOCI at September 30, 2022, related to unrealized gains will be reclassified out of AOCI and recognized in net income. Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Balance, beginning of period, net of tax $ 62 $ 107 $ 83 $ 129 Net realized (gain) loss reclassified to net income, net of tax (10) (12) (31) (34) Balance, end of period, net of tax $ 52 $ 95 $ 52 $ 95 EPS Basic EPS is the amount of earnings available to each share of common stock outstanding during the reporting period. Diluted EPS is the amount of earnings available to each share of common stock outstanding during the reporting period adjusted to include the effect of potentially dilutive common shares. Potentially dilutive common shares include incremental shares issuable for stock options and restricted stock unit awards outstanding under our 2006 Equity Incentive Plan and our ESPP. Potentially dilutive common shares are excluded from the computation of dilutive EPS in periods in which the effect would be antidilutive. The following is a reconciliation of basic EPS to diluted EPS for the three and nine months ended September 30, 2022 and 2021: Three months ended September 30, Nine months ended September 30, (Dollars in millions except per share amounts, shares in thousands) 2022 2021 2022 2021 Numerator: Net income available to common stockholders $ 429 $ 365 $ 1,234 $ 1,399 Denominator: Weighted average common shares outstanding—basic 59,096 57,723 58,945 54,772 Weighted average effect of dilutive securities: Stock options and ESPP 165 268 206 278 Restricted stock units and awards 288 530 384 567 Weighted average common shares outstanding—diluted 59,549 58,521 59,535 55,617 Earnings per common share: Basic $ 7.26 $ 6.33 $ 20.94 $ 25.54 Diluted 7.21 6.24 20.73 25.16 The following table summarizes the weighted-average common shares excluded from the diluted EPS calculation due to the antidilutive effect for the three and nine months ended September 30, 2022 and 2021: Three months ended September 30, Nine months ended September 30, (Shares in thousands) 2022 2021 2022 2021 Stock options 142 56 105 31 Restricted stock units 477 — 99 — Total 619 56 204 31 Preferred Stock The following table summarizes our preferred stock at September 30, 2022: Series Description Amount outstanding (in millions) Carrying value Shares issued and outstanding Par Value Ownership interest per depositary share Liquidation preference per depositary share 2022 dividends paid per depositary share Series A 5.25% Fixed-Rate Non-Cumulative Perpetual Preferred Stock $ 350 $ 340 350,000 $ 0.001 1/40 th $ 25 $ 0.984375 Series B 4.100% Fixed-Rate Non-Cumulative Perpetual Preferred Stock 750 739 7,500 0.001 1/100 th 1,000 30.75 Series C 4.000% Fixed-Rate Non-Cumulative Perpetual Preferred Stock 1,000 985 10,000 0.001 1/100 th 1,000 30.00 Series D 4.250% Fixed-Rate Non-Cumulative Perpetual Preferred Stock 1,000 989 10,000 0.001 1/100 th 1,000 33.88 Series E 4.700% Fixed-Rate Non-Cumulative Perpetual Preferred Stock 600 593 6,000 0.001 1/100 th 1,000 37.47 Consolidated Statement of Changes in Equity The following table summarizes the changes in our consolidated equity for the three months ended September 30, 2022 and 2021: Preferred Common Stock Additional Retained Accumulated Total SVBFG Noncontrolling Interests Total (Dollars in millions, except share data) Shares Amount Balance at June 30, 2021 $ 2,064 54,530,307 $ — $ 2,755 $ 6,706 $ 142 $ 11,667 $ 300 $ 11,967 Common stock issued under employee benefit plans and ESOP, net of restricted stock cancellations — 32,195 — 2 — — 2 — 2 Issuance of Common Stock — 2,227,000 — 1,245 — — 1,245 — 1,245 Issuance of common stock for the acquisition of Boston Private — 1,887,981 — 1,060 1,060 1,060 Net income — — — — 387 — 387 88 475 Capital calls and distributions, net — — — — — — — (19) (19) Other comprehensive income (loss), net of tax — — — — — (77) (77) — (77) Share-based compensation, net — — — 38 — — 38 — 38 Dividends on preferred stock — — — — (22) — (22) — (22) Balance at September 30, 2021 $ 2,064 58,677,483 $ — $ 5,100 $ 7,071 $ 65 $ 14,300 $ 369 $ 14,669 Balance at June 30, 2022 $ 3,646 59,081,326 $ — $ 5,223 $ 8,247 $ (1,198) $ 15,918 $ 358 $ 16,276 Common stock issued under employee benefit plans and ESOP, net of restricted stock cancellations — 22,798 — (2) — — (2) — (2) Net income — — — — 469 — 469 (51) 418 Capital calls and distributions, net — — — — — — — (6) (6) Other comprehensive income (loss), net of tax — — — — — (887) (887) — (887) Share-based compensation, net — — — 51 — — 51 — 51 Dividends on preferred stock — — — — (40) — (40) — (40) Balance at September 30, 2022 $ 3,646 59,104,124 $ — $ 5,272 $ 8,676 $ (2,085) $ 15,509 $ 301 $ 15,810

Variable Interest Entities

Variable Interest Entities	9 Months Ended
Variable Interest Entities	Sep. 30, 2022
Investments In Variable Interest Entities [Abstract]
Variable Interest Entities	Variable Interest EntitiesOur involvement with VIEs includes our investments in venture capital and private equity funds, debt funds, private and public portfolio companies, qualified affordable housing projects, and subordinated debt instruments. The following table presents the carrying amounts and classification of variable interests in consolidated and unconsolidated VIEs as of September 30, 2022 and December 31, 2021: (Dollars in millions) Consolidated VIEs Unconsolidated VIEs Maximum Exposure to Loss in Unconsolidated VIEs September 30, 2022: Assets: Cash and cash equivalents $ 7 $ — $ — Non-marketable and other equity securities (1) 767 1,369 1,369 Accrued interest receivable and other assets (2) 35 6 — Total assets $ 809 $ 1,375 $ 1,369 Liabilities: Other liabilities (1) $ 23 $ 672 $ — Long term debt (2) — 91 — Total liabilities $ 23 $ 763 $ — December 31, 2021: Assets: Cash and cash equivalents $ 13 $ — $ — Non-marketable and other equity securities (1) 768 1,233 1,233 Accrued interest receivable and other assets (2) 31 6 — Total assets $ 812 $ 1,239 $ 1,233 Liabilities: Other liabilities (1) $ 18 $ 482 $ — Long term debt (2) — 90 — Total liabilities $ 18 $ 572 $ — (1) Included in our unconsolidated non-marketable and other equity securities portfolio at September 30, 2022 and December 31, 2021 are investments in qualified affordable housing projects of $1.2 billion and $954 million, respectively, and related other liabilities consisting of unfunded commitments of $672 million and $482 million, respectively. (2) Included in our unconsolidated accrued interest receivable and other assets are investments in statutory trusts for junior subordinated debt and included in long term debt previously issued by Boston Private and assumed in the acquisition of $6 million and $91 million at September 30, 2022 and $6 million and $90 million at December 31, 2021. Non-marketable and other equity securities Our non-marketable and other equity securities portfolio primarily represents investments in venture capital and private equity funds, SPD-SVB, debt funds, private and public portfolio companies and qualified affordable housing projects. Many of these are investments held by SVB Financial in third-party funds in which we do not have controlling or significant variable interests. These investments represent our unconsolidated VIEs in the table above. Our non-marketable and other equity securities portfolio also includes investments from SVB Capital. SVB Capital is the funds management business of SVB Financial Group, which focuses primarily on venture capital investments. The SVB Capital family of funds is comprised of direct venture funds that invest in companies and funds of funds that invest in other venture capital funds. We have a controlling and significant variable interest in four of these SVB Capital funds and consolidate these funds for financial reporting purposes. Most investments are generally nonredeemable, and distributions are expected to be received through the liquidation of the underlying investments throughout the life of the investment fund. Investments may only be sold or transferred subject to the notice and approval provisions of the underlying investment agreement. Subject to applicable regulatory requirements, including the Volcker Rule, we also make commitments to invest in venture capital and private equity funds. For additional details, see Note 11 — “Off-Balance Sheet Arrangements, Guarantees and Other Commitments.” The Bank also has variable interests in low income housing tax credit funds, in connection with fulfilling its responsibilities under the CRA, that are designed to generate a return primarily through the realization of federal tax credits. These investments are typically limited partnerships in which the general partner, other than the Bank, holds the power over significant activities of the VIE; therefore, these investments are not consolidated. For additional information on our investments in qualified affordable housing projects, see Note 5 — “Investment Securities.". As of September 30, 2022, our exposure to loss with respect to the consolidated VIEs is limited to our net assets of $786 million and our exposure to loss for our unconsolidated VIEs is equal to our investment in these assets of $1.4 billion. Junior subordinated debentures SVB Financial Group assumed two statutory trusts during the merger with Boston Private. These trusts were for the purpose of issuing trust preferred securities and investing the proceeds in junior subordinated debentures. These statutory trusts created by legacy Boston Private are not consolidated within the financial statements as the Company is not the primary beneficiary of the trusts; however, the total junior subordinated debentures payable to the preferred stockholders of statutory trusts are reported as long-term debt in the financial statements.

Cash and Cash Equivalents

Cash and Cash Equivalents	9 Months Ended
Cash and Cash Equivalents	Sep. 30, 2022
Cash and Cash Equivalents [Abstract]
Cash and Cash Equivalents	Cash and Cash Equivalents The following table details our cash and cash equivalents at September 30, 2022 and December 31, 2021: (Dollars in millions) September 30, 2022 December 31, 2021 Cash and due from banks $ 1,411 $ 2,168 Interest bearing deposits with the Federal Reserve Bank 7,550 5,686 Interest bearing deposits with other institutions 4,610 5,773 Securities purchased under agreements to resell (1) 397 607 Other short-term investment securities — 352 Total cash and cash equivalents $ 13,968 $ 14,586 (1) At September 30, 2022 and December 31, 2021, securities purchased und er agreements to resell were collateralized by U.S. Treasury securities and U.S. agency securities with aggregate fair value s of $402 million a n d $620 million, respectively. None of these securities were sold or repledged as of September 30, 2022 and December 31, 2021.

Investment Securities

Investment Securities	9 Months Ended
Investment Securities	Sep. 30, 2022
Investments, Debt and Equity Securities [Abstract]
Investment Securities	Investment Securities Our investment securities portfolio consists of: (i) an AFS securities portfolio and a HTM securities portfolio, both of which represent interest-earning investment securities, and (ii) a non-marketable and other equity securities portfolio, which primarily represents investments managed as part of our funds management business, investments in qualified affordable housing projects, as well as public equity securities held as a result of equity warrant assets exercised. AFS Securities The major components of our AFS investment securities portfolio at September 30, 2022 and December 31, 2021 are as follows: September 30, 2022 (Dollars in millions) Amortized Unrealized Unrealized Carrying AFS securities, at fair value: U.S. Treasury securities $ 18,041 $ — $ (1,196) $ 16,845 U.S. agency debentures 120 — (20) 100 Foreign government debt securities 1,062 — (149) 913 Residential MBS: Agency-issued MBS 7,883 — (1,200) 6,683 Agency-issued CMO—fixed rate 792 — (78) 714 Agency-issued CMBS 1,604 — (148) 1,456 Total AFS securities $ 29,502 $ — $ (2,791) $ 26,711 December 31, 2021 (Dollars in millions) Amortized Unrealized Unrealized Carrying AFS securities, at fair value: U.S. Treasury securities $ 15,799 $ 121 $ (70) $ 15,850 U.S. agency debentures 200 — (4) 196 Foreign government debt securities 61 — — 61 Residential MBS: Agency-issued MBS 8,786 13 (210) 8,589 Agency-issued CMO—fixed rate 988 3 (9) 982 Agency-issued CMBS 1,536 27 (20) 1,543 Total AFS securities $ 27,370 $ 164 $ (313) $ 27,221 The following table summarizes sale activity of AFS securities during the three and nine months ended September 30, 2022 and 2021 as recorded in the line item “Gains on investment securities, net," a component of noninterest income: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Sales proceeds $ — $ 168 $ 8,511 $ 168 Net realized gains and losses: Gross realized gains — — 146 — Gross realized losses — — (98) — Net realized gains (losses) $ — $ — $ 48 $ — The following tables summarize our AFS securities in an unrealized loss position for which an ACL has not been recorded and summarized into categories of AFS securities that were in an unrealized loss for position for less than 12 months, or 12 months or longer, as of September 30, 2022 and December 31, 2021: September 30, 2022 Less than 12 months 12 months or longer Total (Dollars in millions) Fair Value of Unrealized Fair Value of Unrealized Fair Value of Unrealized AFS securities: U.S. Treasury securities $ 13,359 $ (958) $ 3,487 $ (238) $ 16,846 $ (1,196) U.S. agency debentures 20 (1) 80 (19) 100 (20) Foreign government debt securities 913 (149) — — 913 (149) Residential MBS: Agency-issued MBS 2,236 (304) 4,448 (896) 6,684 (1,200) Agency-issued CMO —fixed rate 534 (55) 168 (23) 702 (78) Agency-issued CMBS 806 (59) 649 (89) 1,455 (148) Total AFS securities (1) $ 17,868 $ (1,526) $ 8,832 $ (1,265) $ 26,700 $ (2,791) (1) As of September 30, 2022, we identified a total of 804 investments that were in unrealized loss positions with 289 investments in an unrealized loss position for a period of time greater than 12 months. Based on our analysis of the securities in an unrealized loss position as of September 30, 2022, the decline in value is unrelated to credit loss and is related to changes in market interest rates since purchase, and therefore, changes in value for securities are included in other comprehensive income. Market valuations and credit loss analyses on assets in the AFS securities portfolio are reviewed and monitored on a quarterly basis. As of September 30, 2022, we do not intend to sell any of our securities in an unrealized loss position prior to recovery of our amortized cost basis, and it is more likely than not that we will not be required to sell any of our securities prior to recovery of our amortized cost basis. None of the investments in our AFS securities portfolio were past due as of September 30, 2022. December 31, 2021 Less than 12 months 12 months or longer Total (Dollars in millions) Fair Value of Unrealized Fair Value of Unrealized Fair Value of Unrealized AFS securities: U.S. Treasury securities $ 7,777 $ (70) $ — $ — $ 7,777 $ (70) U.S. agency debentures 196 (4) — — 196 (4) Residential MBS: Agency-issued MBS 8,280 (210) — — 8,280 (210) Agency-issued CMO—fixed rate 740 (9) — — 740 (9) Agency-issued CMBS 603 (11) 163 (9) 766 (20) Total AFS securities (1) $ 17,596 $ (304) $ 163 $ (9) $ 17,759 $ (313) (1) As of December 31, 2021, we identified a total of 475 investments that were in unrealized loss positions, of which 4 investments are in an unrealized loss position for a period of time greater than 12 months. None of the investments in our AFS securities portfolio were past due as of December 31, 2021. The following table summarizes the fixed income securities, carried at fair value, classified as AFS as of September 30, 2022 by the remaining contractual principal maturities. For U.S. Treasury securities, U.S. agency debentures and foreign government debt securities, the expected maturity is the actual contractual maturity of the notes. Expected maturities for MBS may differ significantly from their contractual maturities because mortgage borrowers have the right to prepay outstanding loan obligations with or without penalties. MBS classified as AFS typically have original contractual maturities from 10 to 30 years, whereas expected average lives of these securities tend to be significantly shorter and vary based upon structure and prepayments in lower interest rate environments. September 30, 2022 (Dollars in millions) Total One Year After One After Five After U.S. Treasury securities $ 16,845 $ 936 $ 15,133 $ 776 $ — U.S. agency debentures 100 — 34 66 — Foreign government debt securities 913 41 46 826 — Residential MBS: Agency-issued MBS 6,683 — — 45 6,638 Agency-issued CMO—fixed rate 714 — — — 714 Agency-issued CMBS 1,456 — 100 1,356 — Total $ 26,711 $ 977 $ 15,313 $ 3,069 $ 7,352 HTM Securities The components of our HTM investment securities portfolio at September 30, 2022 and December 31, 2021 are as follows: September 30, 2022 (Dollars in millions) Amortized Unrealized Unrealized Fair Value ACL HTM securities, at cost: U.S. agency debentures (1) $ 486 $ — $ (53) $ 433 $ — Residential MBS: Agency-issued MBS 59,200 — (10,017) 49,183 — Agency-issued CMO—fixed rate 10,741 — (1,813) 8,928 — Agency-issued CMO—variable rate 83 — (1) 82 — Agency-issued CMBS 14,644 — (2,304) 12,340 — Municipal bonds and notes 7,429 — (1,612) 5,817 1 Corporate bonds 709 — (122) 587 5 Total HTM securities $ 93,292 $ — $ (15,922) $ 77,370 $ 6 (1) Consists of pools of Small Business Investment Company debentures issued and guaranteed by the U.S. Small Business Administration, an independent agency of the United States. December 31, 2021 (Dollars in millions) Amortized Unrealized Unrealized Fair Value ACL HTM securities, at amortized cost: U.S. agency debentures (1) $ 609 $ 8 $ (2) $ 615 $ — Residential MBS: Agency-issued MBS 64,439 124 (887) 63,676 — Agency-issued CMO—fixed rate 10,226 9 (145) 10,090 — Agency-issued CMO—variable rate 100 1 — 101 — Agency-issued CMBS 14,959 39 (277) 14,721 — Municipal bonds and notes 7,157 185 (27) 7,315 1 Corporate bonds 712 2 (5) 709 6 Total HTM securities $ 98,202 $ 368 $ (1,343) $ 97,227 $ 7 (1) Consists of pools of Small Business Investment Company debentures issued and guaranteed by the U.S. Small Business Administration, an independent agency of the United States. Allowance for Credit Losses for HTM Securities For HTM securities, for the three months ended September 30, 2022, the ACL balance remained consistent at $6 million. For HTM securities, for the nine months ended September 30, 2022 the beginning ACL balance was $7 million, the reduction of credit losses was $1 million, and the ending ACL balance was $6 million. For HTM securities, for the three months ended September 30, 2021, the beginning ACL balance was $5 million, the provision for credit losses was $1 million and the ending ACL balance was $6 million. For HTM securities, for the nine months ended September 30, 2021 the beginning ACL balance was less than $1 million, the provision for credit losses was $6 million and the ending ACL balance was $6 million. AIR from HTM securities totaled $205 million at September 30, 2022 and $225 million at December 31, 2021 and is reported in "Accrued interest receivable and other assets" in our unaudited interim consolidated balance sheets. Credit Quality Indicators On a quarterly basis, management monitors the credit quality for HTM securities through the use of standard credit ratings. The following table summarizes our amortized cost of HTM securities aggregated by credit quality indicator at September 30, 2022 and December 31, 2021: (Dollars in millions) September 30, 2022 December 31, 2021 Municipal bonds and notes: Aaa $ 4,270 $ 3,774 Aa1 1,880 2,031 Aa2 1,081 1,154 Aa3 171 172 A1 27 26 Total municipal bonds and notes $ 7,429 $ 7,157 Corporate bonds: Aaa $ 39 $ 39 Aa2 42 42 Aa3 105 105 A1 282 251 A2 230 264 A3 11 11 Total corporate bonds $ 709 $ 712 September 30, 2022 Total One Year After One Year to After Five Years to After (Dollars in millions) Net Carry Value Fair Value Net Carry Value Fair Value Net Carry Value Fair Value Net Carry Value Fair Value Net Carry Value Fair Value U.S. agency debentures $ 486 $ 433 $ 1 $ 1 $ 118 $ 111 $ 367 $ 321 $ — $ — Residential MBS: Agency-issued MBS 59,200 49,183 1 1 2 2 1,148 1,063 58,049 48,117 Agency-issued CMO—fixed rate 10,741 8,928 — — 87 83 154 146 10,500 8,699 Agency-issued CMO—variable rate 83 82 — — — — — — 83 82 Agency-issued CMBS 14,644 12,340 45 44 159 146 968 802 13,472 11,348 Municipal bonds and notes 7,428 5,817 25 25 235 222 1,265 1,114 5,903 4,456 Corporate bonds 704 587 — — 115 102 589 485 — — Total $ 93,286 $ 77,370 $ 72 $ 71 $ 716 $ 666 $ 4,491 $ 3,931 $ 88,007 $ 72,702 Non-marketable and Other Equity Securities The major components of our non-marketable and other equity securities portfolio at September 30, 2022 and December 31, 2021 are as follows: (Dollars in millions) September 30, 2022 December 31, 2021 Non-marketable and other equity securities: Non-marketable securities (fair value accounting): Consolidated venture capital and private equity fund investments (1) $ 147 $ 130 Unconsolidated venture capital and private equity fund investments (2) 123 208 Other investments without a readily determinable fair value (3) 176 164 Other equity securities in public companies (fair value accounting) (4) 29 117 Non-marketable securities (equity method accounting) (5): Venture capital and private equity fund investments 639 671 Debt funds 4 5 Other investments 272 294 Investments in qualified affordable housing projects, net (6) 1,205 954 Total non-marketable and other equity securities $ 2,595 $ 2,543 (1) The following table shows the amounts of venture capital and private equity fund investments held by the following consolidated funds and our ownership percentage of each fund at September 30, 2022 and December 31, 2021 (fair value accounting): September 30, 2022 December 31, 2021 (Dollars in millions) Amount Ownership % Amount Ownership % Strategic Investors Fund, LP $ 2 12.6 % $ 2 12.6 % Capital Preferred Return Fund, LP 30 20.0 61 20.0 Growth Partners, LP 25 33.0 67 33.0 Redwood Evergreen Fund, LP 90 100.0 — — Total consolidated venture capital and private equity fund investments $ 147 $ 130 (2) The carrying value represents investments in 141 and 150 funds (primarily venture capital funds) at September 30, 2022 and December 31, 2021, respectively, where our ownership interest is typically less than 5% of the voting interests of each such fund and in which we do not have the ability to exercise significant influence over the partnerships operating activities and financial policies. We carry our unconsolidated venture capital and private equity fund investments at fair value based on the fund investments' net asset values per share as obtained from the general partners of the investments. For each fund investment, we adjust the net asset value per share for differences between our measurement date and the date of the fund investment’s net asset value by using the most recently available financial information from the investee general partner, for example June 30 th for our September 30 th consolidated financial statements, adjusted for any contributions paid, distributions received from the investment, and significant fund transactions or market events during the reporting period. (3) These investments include direct equity investments in private companies. The carrying value is based on the price at which the investment was acquired plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments. We consider a range of factors when adjusting the fair value of these investments, including, but not limited to, the term and nature of the investment, local market conditions, values for comparable securities, current and projected operating performance, exit strategies, financing transactions subsequent to the acquisition of the investment, and a discount for certain investments that have lock-up restrictions or other features that indicate a discount to fair value is warranted. The following table shows the changes to the carrying amount of other investments without a readily determinable fair value for the nine months ended September 30, 2022: (Dollars in millions) Nine months ended September 30, 2022 Cumulative Adjustments Measurement alternative: Carrying value at September 30, 2022 $ 176 Carrying value adjustments: Impairment $ — $ (1) Upward changes for observable prices — 52 Downward changes for observable prices (6) (11) (4) Investments classified as other equity securities (fair value accounting) represent shares held in public companies as a result of exercising public equity warrant assets and direct equity investments in public companies held by our consolidated funds. Changes in equity securities measured at fair value are recognized through net income. (5) The following table shows the carrying value and our ownership percentage of each investment at September 30, 2022 and December 31, 2021 (equity method accounting): September 30, 2022 December 31, 2021 (Dollars in millions) Amount Ownership % Amount Ownership % Venture capital and private equity fund investments: Strategic Investors Fund II, LP $ 2 8.6 % $ 3 8.6 % Strategic Investors Fund III, LP 13 5.9 25 5.9 Strategic Investors Fund IV, LP 23 5.0 36 5.0 Strategic Investors Fund V funds 59 Various 87 Various CP II, LP (i) 2 5.1 2 5.1 Other venture capital and private equity fund investments 540 Various 518 Various Total venture capital and private equity fund investments $ 639 $ 671 Debt funds: Gold Hill Capital 2008, LP (ii) $ 3 15.5 % $ 4 15.5 % Other debt funds 1 Various 1 Various Total debt funds $ 4 $ 5 Other investments: SPD Silicon Valley Bank Co., Ltd. $ 143 50.0 % $ 154 50.0 % Other investments 129 Various 140 Various Total other investments $ 272 $ 294 (i) Our ownership includes direct ownership interest of 1.3 percent and indirect ownership interest of 3.8 percent through our investments in Strategic Investors Fund II, LP. (ii) Our ownership includes direct ownership interest of 11.5 percent and an indirect interest in the fund through our investment in Gold Hill Capital 2008, LLC of 4.0 percent. (6) The following table presents the balances of our investments in qualified affordable housing projects and related unfunded commitments included as a component of “Other liabilities” on our consolidated balance sheets at September 30, 2022 and December 31, 2021: (Dollars in millions) September 30, 2022 December 31, 2021 Investments in qualified affordable housing projects, net $ 1,205 $ 954 Other liabilities 672 482 The following table presents other information relating to our investments in qualified affordable housing projects for the three and nine months ended September 30, 2022 and 2021: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Tax credits and other tax benefits recognized $ 30 $ 9 $ 80 $ 63 Amortization expense included in provision for income taxes (i) 17 17 52 48 (i) All investments are amortized using the proportional amortization method, and amortization expense is included in the provision for income taxes. The following table presents the net gains and losses on non-marketable and other equity securities for the three and nine months ended September 30, 2022 and 2021 as recorded in the line item “Gains on investment securities, net," a component of noninterest income: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Net (losses) gains on non-marketable and other equity securities: Non-marketable securities (fair value accounting): Consolidated venture capital and private equity fund investments $ (52) $ 36 $ (100) $ 72 Unconsolidated venture capital and private equity fund investments (61) 47 (80) 79 Other investments without a readily determinable fair value — (2) (3) 11 Other equity securities in public companies (fair value accounting) (8) (39) (52) 53 Non-marketable securities (equity method accounting): Venture capital and private equity fund investments (12) 144 (20) 438 Debt funds (1) — (1) 2 Other investments 7 3 9 6 Total net (losses) gains on non-marketable and other equity securities $ (127) $ 189 $ (247) $ 661 Less: realized net gains (losses) on sales of non-marketable and other equity securities 13 (17) (16) 110 Net (losses) gains on non-marketable and other equity securities still held $ (140) $ 206 $ (231) $ 551

Loans and Allowance for Credit

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments	9 Months Ended
	Sep. 30, 2022
Receivables [Abstract]
Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments	Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments We serve a variety of commercial clients in the private equity/venture capital, technology, life science/healthcare, premium wine and commercial real estate industries. Loans made to private equity/venture capital firm clients typically enable them to fund investments prior to their receipt of funds from capital calls and are reported under the Global Fund Banking class of financing receivable below. Our technology clients generally tend to be in the industries of hardware (such as semiconductors, communications, data, storage and electronics), software/internet (such as infrastructure software, applications, software services, digital content and advertising technology) and ERI. Our life science/healthcare clients primarily tend to be in the industries of biotechnology, medical devices, healthcare information technology and healthcare services. Loans to our technology and life science/healthcare clients are reported under the Investor Dependent, Cash Flow Dependent - SLBO and Innovation C&I classes of financing receivable below. We also make commercial and industrial loans, such as working capital lines and term loans for equipment and fixed assets, to clients that are not in the technology and life science/healthcare industries which are reported in the Other C&I class of financing receivable below. Loans to the premium wine industry focus on vineyards and wineries that produce grapes and wines of high quality. Commercial real estate loans are generally acquisition financing for commercial properties such as office buildings, retail properties, apartment buildings, and industrial/warehouse space, which moving forward, will predominantly support the innovation economy segments. In addition to commercial loans, we make consumer loans through SVB Private and provide real estate secured loans to eligible employees through our EHOP. We also provide community development loans made as part of our responsibilities under the CRA. The majority of these loans are included within the Other loan class below and are primarily secured by real estate. Additionally, beginning in April 2020, we accepted applications under the PPP administered by the SBA under the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act") and originated loans to qualified small businesses. PPP funds under the CARES Act were disbursed throughout 2020 and up to June 30, 2021. Loan Portfolio Segments and Classes of Financing Receivables The composition of loans at amortized cost basis broken out by class of financing receivable at September 30, 2022 and December 31, 2021 is presented in the following table: (Dollars in millions) September 30, 2022 December 31, 2021 Global fund banking $ 40,337 $ 37,958 Investor dependent: Early stage 1,911 1,593 Growth stage 4,398 3,951 Total investor dependent 6,309 5,544 Cash flow dependent - SLBO 1,845 1,798 Innovation C&I 8,321 6,673 Private bank 10,102 8,743 CRE 2,609 2,670 Premium wine 1,117 985 Other C&I 1,087 1,257 Other 374 317 PPP 28 331 Total loans (1) (2) (3) $ 72,129 $ 66,276 ACL (557) (422) Net loans $ 71,572 $ 65,854 (1) Total loans at amortized cost is net of unearned income, deferred fees and costs, and net unamortized premiums and discounts of $244 million and $250 million at September 30, 2022 and December 31, 2021, respectively. (2) Included within our total loan portfolio are credit card loans of $582 million and $583 million at September 30, 2022 and December 31, 2021, respectively. (3) Included within our total loan portfolio are construction loans of $454 million and $367 million at September 30, 2022 and December 31, 2021, respectively. Credit Quality Indicators For each individual client, we establish an internal credit risk rating for that loan, which is used for assessing and monitoring credit risk as well as performance of the loan and the overall portfolio. Our internal credit risk ratings are also used to summarize the risk of loss due to failure by an individual borrower to repay the loan. For our internal credit risk ratings, each individual loan is given a risk rating of 1 through 10. Loans risk-rated 1 through 4 are performing loans and translate to an internal rating of “Pass,” with loans risk-rated 1 being cash secured. Loans risk-rated 5 through 7 are performing loans; however, we consider them as demonstrating higher risk, which requires more frequent review of the individual exposures; these translate to an internal rating of “Criticized.” All of our nonaccrual loans are risk-rated 8 or 9 and are classified with the internal rating of "Nonperforming." Loans rated 10 are charged-off and are not included as part of our loan portfolio balance. We review our credit quality indicators on a quarterly basis for performance and appropriateness of risk ratings as part of our evaluation process for our ACL for loans. The following tables summarize the credit quality indicators, broken out by class of financing receivable and vintage year, as of September 30, 2022 and December 31, 2021: Term Loans by Origination Year September 30, 2022 (Dollars in millions) 2022 2021 2020 2019 2018 Prior Revolving Loans Revolving Loans Converted to Term Loans Unallocated (1) Total Global fund banking: Risk rating: Pass $ 512 $ 95 $ 63 $ 31 $ 1 $ 10 $ 39,616 $ — $ — $ 40,328 Criticized — — — — — — 9 — — 9 Nonperforming — — — — — — — — — — Total global fund banking $ 512 $ 95 $ 63 $ 31 $ 1 $ 10 $ 39,625 $ — $ — $ 40,337 Investor dependent: Early stage: Risk rating: Pass $ 727 $ 626 $ 73 $ 36 $ 2 $ 1 $ 191 $ — $ — $ 1,656 Criticized 67 122 27 7 — 2 26 — — 251 Nonperforming 1 1 — — — — 2 — — 4 Total early stage $ 795 $ 749 $ 100 $ 43 $ 2 $ 3 $ 219 $ — $ — $ 1,911 Term Loans by Origination Year September 30, 2022 (Dollars in millions) 2022 2021 2020 2019 2018 Prior Revolving Loans Revolving Loans Converted to Term Loans Unallocated (1) Total Growth stage: Risk rating: Pass $ 1,684 $ 1,456 $ 360 $ 72 $ 28 $ 6 $ 243 $ 5 $ — $ 3,854 Criticized 147 233 53 14 5 — 49 — — 501 Nonperforming 19 18 2 — — — 4 — — 43 Total growth stage $ 1,850 $ 1,707 $ 415 $ 86 $ 33 $ 6 $ 296 $ 5 $ — $ 4,398 Total investor dependent $ 2,645 $ 2,456 $ 515 $ 129 $ 35 $ 9 $ 515 $ 5 $ — $ 6,309 Cash flow dependent - SLBO: Risk rating: Pass $ 678 $ 609 $ 199 $ 203 $ 14 $ 39 $ 30 $ — $ — $ 1,772 Criticized 20 — 16 2 1 22 5 — — 66 Nonperforming — — — — 5 — 2 — — 7 Total cash flow dependent - SLBO $ 698 $ 609 $ 215 $ 205 $ 20 $ 61 $ 37 $ — $ — $ 1,845 Innovation C&I Risk rating: Pass $ 1,788 $ 1,734 $ 773 $ 166 $ 18 $ 54 $ 3,102 $ — $ — $ 7,635 Criticized 49 148 121 32 11 — 324 — — 685 Nonperforming — — — — — — 1 — — 1 Total innovation C&I $ 1,837 $ 1,882 $ 894 $ 198 $ 29 $ 54 $ 3,427 $ — $ — $ 8,321 Private bank: Risk rating: Pass $ 2,210 $ 2,817 $ 1,753 $ 948 $ 441 $ 1,054 $ 818 $ 5 $ — $ 10,046 Criticized — 16 — 2 — 15 10 — — 43 Nonperforming — — 1 2 1 8 1 — — 13 Total private bank $ 2,210 $ 2,833 $ 1,754 $ 952 $ 442 $ 1,077 $ 829 $ 5 $ — $ 10,102 CRE Risk rating: Pass $ 406 $ 292 $ 181 $ 240 $ 143 $ 894 $ 96 $ 5 $ — $ 2,257 Criticized 2 4 51 135 24 114 17 — — 347 Nonperforming — — — 5 — — — — — 5 Total CRE $ 408 $ 296 $ 232 $ 380 $ 167 $ 1,008 $ 113 $ 5 $ — $ 2,609 Premium wine: Risk rating: Pass $ 255 $ 213 $ 91 $ 137 $ 47 $ 144 $ 156 $ 34 $ — $ 1,077 Criticized 1 5 — 7 9 9 9 — — 40 Nonperforming — — — — — — — — — — Total premium wine $ 256 $ 218 $ 91 $ 144 $ 56 $ 153 $ 165 $ 34 $ — $ 1,117 Other C&I Risk rating: Pass $ 31 $ 149 $ 161 $ 70 $ 81 $ 304 $ 234 $ 10 $ — $ 1,040 Criticized 1 — 3 6 3 19 11 1 — 44 Nonperforming — — 1 — 1 1 — — — 3 Total other C&I $ 32 $ 149 $ 165 $ 76 $ 85 $ 324 $ 245 $ 11 $ — $ 1,087 Other: Risk rating: Pass $ 25 $ 151 $ 172 $ 30 $ — $ — $ 11 $ — $ (44) $ 345 Criticized — 3 17 9 — — — — — 29 Nonperforming — — — — — — — — — — Total other $ 25 $ 154 $ 189 $ 39 $ — $ — $ 11 $ — $ (44) $ 374 PPP: Risk rating: Pass $ — $ 16 $ 3 $ — $ — $ — $ — $ — $ — $ 19 Criticized — 3 6 — — — — — — 9 Nonperforming — — — — — — — — — — Total PPP $ — $ 19 $ 9 $ — $ — $ — $ — $ — $ — $ 28 Term Loans by Origination Year September 30, 2022 (Dollars in millions) 2022 2021 2020 2019 2018 Prior Revolving Loans Revolving Loans Converted to Term Loans Unallocated (1) Total Total loans $ 8,623 $ 8,711 $ 4,127 $ 2,154 $ 835 $ 2,696 $ 44,967 $ 60 $ (44) $ 72,129 (1) These amounts consist of fees and clearing items that have not yet been allocated at the loan level. Term Loans by Origination Year December 31, 2021 (Dollars in millions) 2021 2020 2019 2018 2017 Prior Revolving Loans Revolving Loans Converted to Term Loans Unallocated (1) Total Global fund banking: Risk rating: Pass $ 764 $ 115 $ 36 $ 6 $ 8 $ 4 $ 36,955 $ — $ — $ 37,888 Criticized 50 18 — — — 1 1 — — 70 Nonperforming — — — — — — — — — — Total global fund banking $ 814 $ 133 $ 36 $ 6 $ 8 $ 5 $ 36,956 $ — $ — $ 37,958 Investor dependent: Early stage: Risk rating: Pass $ 754 $ 287 $ 122 $ 26 $ 6 $ 1 $ 171 $ — $ — $ 1,367 Criticized 64 87 30 5 — — 29 — — 215 Nonperforming 2 5 3 — — — 1 — — 11 Total early stage $ 820 $ 379 $ 155 $ 31 $ 6 $ 1 $ 201 $ — $ — $ 1,593 Growth stage: Risk rating: Pass $ 2,072 $ 910 $ 265 $ 78 $ 14 $ 1 $ 286 $ 5 $ — $ 3,631 Criticized 159 85 27 6 3 — 34 — — 314 Nonperforming 2 — 1 2 — — 1 — — 6 Total growth stage $ 2,233 $ 995 $ 293 $ 86 $ 17 $ 1 $ 321 $ 5 $ — $ 3,951 Total investor dependent $ 3,053 $ 1,374 $ 448 $ 117 $ 23 $ 2 $ 522 $ 5 $ — $ 5,544 Cash flow dependent - SLBO: Risk rating: Pass $ 875 $ 384 $ 252 $ 72 $ 76 $ 2 $ 35 $ — $ — $ 1,696 Criticized — — 20 25 — 13 10 — — 68 Nonperforming — — 12 10 7 — 5 — — 34 Total cash flow dependent - SLBO $ 875 $ 384 $ 284 $ 107 $ 83 $ 15 $ 50 $ — $ — $ 1,798 Innovation C&I: Risk rating: Pass $ 2,230 $ 1,058 $ 288 $ 123 $ 58 $ — $ 2,411 $ — $ — $ 6,168 Criticized 64 130 62 12 — — 236 — — 504 Nonperforming — — — — — — 1 — — 1 Total Innovation C&I $ 2,294 $ 1,188 $ 350 $ 135 $ 58 $ — $ 2,648 $ — $ — $ 6,673 Private bank: Risk rating: Pass $ 2,952 $ 2,015 $ 1,122 $ 520 $ 432 $ 952 $ 705 $ 8 $ — $ 8,706 Criticized — — 2 — 2 9 3 — — 16 Nonperforming — — 2 9 — 8 2 — — 21 Total private bank $ 2,952 $ 2,015 $ 1,126 $ 529 $ 434 $ 969 $ 710 $ 8 $ — $ 8,743 CRE Risk rating: Pass $ 326 $ 215 $ 344 $ 155 $ 236 $ 868 $ 110 $ 2 $ — $ 2,256 Criticized 3 39 114 37 47 139 18 12 — 409 Nonperforming — — 5 — — — — — — 5 Total CRE $ 329 $ 254 $ 463 $ 192 $ 283 $ 1,007 $ 128 $ 14 $ — $ 2,670 Premium wine: Risk rating: Pass $ 217 $ 112 $ 156 $ 69 $ 71 $ 162 $ 125 $ 34 $ — $ 946 Criticized 1 7 11 9 — — 11 — — 39 Nonperforming — — — — — — — — — — Total Premium wine $ 218 $ 119 $ 167 $ 78 $ 71 $ 162 $ 136 $ 34 $ — $ 985 Other C&I Risk rating: Pass $ 181 $ 175 $ 82 $ 86 $ 28 $ 301 $ 350 $ 11 $ — $ 1,214 Criticized 5 6 6 7 2 — 8 5 — 39 Nonperforming — — — 2 — 1 1 — — 4 Total other C&I $ 186 $ 181 $ 88 $ 95 $ 30 $ 302 $ 359 $ 16 $ — $ 1,257 Other: Term Loans by Origination Year December 31, 2021 (Dollars in millions) 2021 2020 2019 2018 2017 Prior Revolving Loans Revolving Loans Converted to Term Loans Unallocated (1) Total Risk rating: Pass $ 61 $ 144 $ 82 $ 20 $ 14 $ — $ 7 $ — $ (21) $ 307 Criticized — 7 1 — 2 — — — — 10 Nonperforming — — — — — — — — — — Total other $ 61 $ 151 $ 83 $ 20 $ 16 $ — $ 7 $ — $ (21) $ 317 PPP: Risk rating: Pass $ 226 $ 72 $ — $ — $ — $ — $ — $ — $ — $ 298 Criticized 22 9 — — — — — — — 31 Nonperforming 2 — — — — — — — — 2 Total PPP $ 250 $ 81 $ — $ — $ — $ — $ — $ — $ — $ 331 Total loans $ 11,032 $ 5,880 $ 3,045 $ 1,279 $ 1,006 $ 2,462 $ 41,516 $ 77 $ (21) $ 66,276 Allowance for Credit Losses: Loans In the third quarter of 2022, the ACL for loans increased by $12 million, driven primarily by loan growth and the continued deterioration in projected economic conditions. The Moody's Analytics September 2022 forecast was utilized in our quantitative model for the ACL as of September 30, 2022. The forecast assumptions included a significantly worse housing price index growth rate than that of last quarter, as well as a lower gross domestic product growth rate. The forecast's starting unemployment rate was unchanged from prior quarter, but it is worse in future quarters than in previous projections. The overall impact of these assumptions was a worse forecast than that used at June 30, 2022. Additionally, we reduced the weighting applied to the Moody's downside economic scenario to reflect that the September forecasts more closely aligned with our expectations as of September 30, 2022, thereby no longer requiring a downside weighting as significant as in the previous quarter. To the extent we identified credit risk considerations that were not captured by the Moody's Analytics September 2022 forecast, we addressed the risk through management's adjustments to the scenario weightings. After adjusting the weightings accordingly, we determined the forecast to be representative of our outlook for the economy given the available information at current quarter end. We do not estimate expected credit losses on AIR on loans, as AIR is reversed or written off when the full collection of the AIR related to a loan becomes doubtful. AIR on loans totaled $294 million at September 30, 2022 and $171 million at December 31, 2021 and is reported in "Accrued interest receivable and other assets" in our unaudited interim consolidated balance sheets. The following tables summarize the activity relating to our ACL for loans for the three and nine months ended September 30, 2022 and 2021, broken out by portfolio segment: Three months ended September 30, 2022 Beginning Balance June 30, 2022 Charge-offs Recoveries Provision (Reduction) for Credit Loss for Loans Foreign Currency Translation Adjustments Ending Balance September 30, 2022 (Dollars in millions) Global fund banking $ 89 $ — $ 6 $ (4) $ — $ 91 Investor dependent 224 (20) 4 25 1 234 Cash flow dependent and innovation C&I 130 (5) — 11 — 136 Private bank 45 — — 2 — 47 CRE 34 — — (7) — 27 Other C&I 12 (1) 1 — — 12 Premium wine and other 11 — — 3 (4) 10 Total ACL $ 545 $ (26) $ 11 $ 30 $ (3) $ 557 Three months ended September 30, 2021 Beginning Balance June 30, 2021 Initial Charge-offs Recoveries Provision (Reduction) for Credit Loss for Loans Ending Balance September 30, 2021 (Dollars in millions) Global fund banking $ 66 $ — $ — $ — $ (7) $ 59 Investor dependent 158 — (17) 5 (8) 138 Cash flow dependent and innovation C&I 119 — (1) 3 (12) 109 Private bank 47 1 (1) — (16) 31 CRE — 17 — — 23 40 Other C&I — 4 — — 8 12 Premium wine and other 6 — — — 3 9 Total ACL $ 396 $ 22 $ (19) $ 8 $ (9) $ 398 Nine months ended September 30, 2022 Beginning Balance December 31, 2021 Charge-offs Recoveries Provision (Reduction) for Credit Loss for Loans Foreign Currency Translation Adjustments Ending Balance September 30, 2022 (Dollars in millions) Global fund banking $ 67 $ — $ 6 $ 18 $ — $ 91 Investor dependent 146 (53) 13 126 2 234 Cash flow dependent and innovation C&I 118 (9) — 27 — 136 Private Bank 33 — 2 12 — 47 CRE 36 — — (9) — 27 Other C&I 14 (3) 1 — — 12 Premium wine and other 8 (1) 1 10 (8) 10 Total ACL $ 422 $ (66) $ 23 $ 184 $ (6) $ 557 Nine months ended September 30, 2021 Beginning Balance December 31, 2020 Initial Allowance on PCD Loans Charge-offs Recoveries Provision (Reduction) for Credit Loss for Loans Ending Balance September 30, 2021 (Dollars in millions) Global fund banking $ 46 $ — $ (80) $ — $ 93 $ 59 Investor dependent 213 — (37) 13 (51) 138 Cash flow dependent and innovation C&I 125 — (8) 3 (11) 109 Private Bank 53 1 (3) — (20) 31 CRE — 17 — — 23 40 Other C&I — 4 — — 8 12 Premium wine and other 9 — (1) — 1 9 PPP 2 — — — (2) — Total ACL $ 448 $ 22 $ (129) $ 16 $ 41 $ 398 The following table summarizes the aging of our loans broken out by class of financing receivable as of September 30, 2022 and December 31, 2021: (Dollars in millions) 30 - 59 60 - 89 Equal to or Greater Total Past Current Total Loans Past Due September 30, 2022: Global fund banking $ — $ — $ — $ — $ 40,337 $ 40,337 $ — Investor dependent: Early stage 2 2 1 5 1,906 1,911 — Growth stage 26 13 2 41 4,357 4,398 — Total investor dependent 28 15 3 46 6,263 6,309 — Cash flow dependent - SLBO 4 — — 4 1,841 1,845 — Innovation C&I 6 3 — 9 8,312 8,321 — Private bank 1 12 5 18 10,084 10,102 1 CRE 1 7 5 13 2,596 2,609 — Premium wine 3 — — 3 1,114 1,117 — Other C&I — 3 — 3 1,084 1,087 — Other — — — — 374 374 — PPP — — 6 6 22 28 5 Total loans $ 43 $ 40 $ 19 $ 102 $ 72,027 $ 72,129 $ 6 December 31, 2021: Global fund banking $ — $ — $ — $ — $ 37,958 $ 37,958 $ — Investor dependent: Early stage 6 5 — 11 1,582 1,593 — Growth stage 16 — — 16 3,935 3,951 — Total investor dependent 22 5 — 27 5,517 5,544 — Cash flow dependent - SLBO — — — — 1,798 1,798 — Innovation C&I 7 — 7 14 6,659 6,673 7 Private bank 28 1 12 41 8,702 8,743 — CRE 1 — — 1 2,669 2,670 — Premium wine 3 — — 3 982 985 — Other C&I 1 2 1 4 1,253 1,257 — Other — — — — 317 317 — PPP 1 — — 1 330 331 — Total loans $ 63 $ 8 $ 20 $ 91 $ 66,185 $ 66,276 $ 7 Nonaccrual Loans The following table summarizes our nonaccrual loans with no allowance for credit loss at September 30, 2022 and December 31, 2021: September 30, 2022 December 31, 2021 (Dollars in millions) Nonaccrual Loans Nonaccrual Loans with no Allowance for Credit Loss Nonaccrual Loans Nonaccrual Loans with no Allowance for Credit Loss Investor dependent: Early stage $ 4 $ — $ 11 $ — Growth stage 43 1 6 — Total investor dependent 47 1 17 — Cash flow dependent - SLBO 7 — 34 — Innovation C&I 1 — 1 1 Private bank 13 6 21 8 CRE 5 — 5 — Other C&I 3 — 4 — PPP — — 2 — Total nonaccrual loans $ 76 $ 7 $ 84 $ 9 TDRs As of September 30, 2022, we had 39 TDRs with a total carrying value of $85 million where concessions have been granted to borrowers experiencing financial difficulties, in an attempt to maximize collection. We had no unfunded commitments available for funding to the clients associated with these TDRs as of September 30, 2022. The following table summarizes our loans modified in TDRs, broken out by class of financing receivable at September 30, 2022 and December 31, 2021: (Dollars in millions) September 30, 2022 December 31, 2021 Loans modified in TDRs: Investor dependent: Early stage $ 1 $ 12 Growth stage 32 3 Total investor dependent 33 15 Cash flow dependent - SLBO 8 34 Innovation C&I 1 — Private bank 8 12 CRE 33 33 Other C&I 2 2 Total loans modified in TDRs $ 85 $ 96 The following table summarizes the recorded investment in loans modified in TDRs, broken out by class of financing receivable, for modifications made during the three and nine months ended September 30, 2022 and 2021: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Loans modified in TDRs during the period: Investor dependent: Early stage $ 1 $ — $ 1 $ 1 Growth stage 12 8 32 8 Total investor dependent 13 8 33 9 Cash flow dependent - SLBO — — — 12 Innovation C&I 1 — 1 — Private bank — 2 1 2 CRE 5 43 5 43 Total loans modified in TDRs during the period (1) $ 19 $ 53 $ 40 $ 66 (1) There were $4 million of partial charge-offs for the three months ended September 30, 2022 and $9 million of partial charge-offs for the nine months then ended. There were no partial charge-offs for the three months ended September 30, 2021 and $7 million of partial charge-offs for the nine months then ended. During the three months ended September 30, 2022, new TDRs of $19 million were modified through payment deferrals granted to our clients. During the three months ended September 30, 2021, new TDRs of $17 million were modified through payment deferrals granted to our clients, $14 million were modified through term extensions and $22 million were modified through a combination thereof. During the nine months ended September 30, 2022, new TDRs of $38 million were modified through payment deferrals granted to our clients, $1 million were modified through rate reductions and $1 million were modified through settlement. During the nine months ended September 30, 2021, new TDRs of $30 million were modified through payment deferrals granted to our clients, $14 million were modified through term extensions and $22 million were modified through a combination thereof. Of loans modified in TDRs within the previous 12 months, $1 million in Investor Dependent - Early Stage defaulted on the modified terms during the three and nine months ended September 30, 2022. There were no defaults of loans modified in TDRs during the three and nine months ended September 30, 2021. Charge-offs and defaults on previously restructured loans are evaluated to determine the impact to the ACL for loans, if any. The evaluation of these defaults may impact the assumptions used in calculating the reserve on other TDRs and nonaccrual loans as well as management’s overall outlook of macroeconomic factors that affect the reserve on the loan portfolio as a whole. After evaluating the charge-offs and defaults experienced on our TDRs, we determined that no change to our reserving methodology for TDRs was necessary to determine the ACL for loans as of September 30, 2022. ACL: Unfunded Credit Commitments We maintain a separate ACL for unfunded credit commitments that is determined using a methodology that is inherently similar to the methodology used for calculating the ACL for loans. At September 30, 2022, our ACL estimates utilized the Moody's economic forecasts from September 30, 2022 as mentioned above. In the third quarter of 2022, the ACL for unfunded commitments increased by $41 million from the prior quarter, driven primarily by continued growth in our outstanding commitments, as well as the same deterioration in projected economic conditions described above. The following table summarizes the activity relating to our ACL for unfunded credit commitments for the three and nine months ended September 30, 2022 and 2021: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 ACL: unfunded credit commitments, beginning balance $ 224 $ 120 171 $ 121 Provision for (reduction in) credit losses 42 29 96 28 Foreign currency translation adjustments (1) — (2) — ACL: unfunded credit commitments, ending balance (1) $ 265 $ 149 $ 265 $ 149 (1) The “ACL: unfunded credit commitments” is included as a component of “other liabilities” on our unaudited interim consolidated balance sheets. See Note 11 — “Off-Balance Sheet Arrangements, Guarantees and Other Commitments” of this report for additional disclosures related to our commitments to extend credit.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	9 Months Ended
Goodwill and Other Intangible Assets	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill Goodwill at both September 30, 2022 and December 31, 2021 was $375 million, which was a result of goodwill recognized for the acquisitions of SVB Securities, WestRiver Group's debt fund business, Boston Private and MoffettNathanson LLC. Other Intangible Assets The components of net other intangible assets were as follows: September 30, 2022 December 31, 2021 (Dollars in millions) Gross Amount Accumulated Amortization Net Carrying Amount Gross Amount Accumulated Amortization Net Carrying Amount Other intangible assets: Customer relationships $ 135 $ 27 $ 108 $ 135 $ 16 $ 119 Other 57 23 34 57 16 41 Total other intangible assets $ 192 $ 50 $ 142 $ 192 $ 32 $ 160 For the nine months ended September 30, 2022, we recorded amortization expense of $18 million. Assuming no future impairments of other intangible assets or additional acquisitions or dispositions, the following table presents the Company's future expected amortization expense for other intangible assets that will continue to be amortized as of September 30, 2022: Years ended December 31, Other 2022 (excluding the nine months ended September 30, 2022) $ 6 2023 22 2024 20 2025 17 2026 15 2027 and thereafter 62 Total future amortization expense $ 142

Derivative Financial Instrument

Derivative Financial Instruments	9 Months Ended
Derivative Financial Instruments	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments We primarily use derivative financial instruments to manage interest rate risk and currency exchange rate risk and to assist customers with their risk management objectives, which may include currency exchange rate risks and interest rate risks. Also, in connection with negotiating credit facilities and certain other services, we often obtain equity warrant assets, giving us the right to acquire stock in private, venture-backed companies in the technology and life science/healthcare industries. Interest Rate Risk Interest rate risk is our primary market risk and can result from timing and volume differences in the repricing of our interest rate sensitive assets and liabilities and changes in market interest rates. To manage interest rate risk on our interest rate sensitive assets, we have entered into interest rate swap contracts to hedge against future changes in interest rates. Fair Value Hedges To manage interest rate risk on our AFS securities portfolio, we enter into pay-fixed, receive-floating interest rate swap contracts to hedge against exposure to changes in the fair value of the securities resulting from changes in interest rates. We designate these interest rate swap contracts as fair value hedges that qualify for hedge accounting under ASC 815, Derivatives and Hedging ("ASC 815") and have elected to account for a portion of the hedges using the last-of-layer method as outlined in ASC 815. We record the interest rate swaps in other assets and other liabilities. For qualifying fair value hedges, both the changes in the fair value of the derivative and the portion of the fair value adjustments associated with the last-of-layer attributable to the hedged risk are recognized into earnings as they occur. Derivative amounts affecting earnings are recognized consistent with the classification of the hedged item in the line item "investment securities" as part of interest income, a component of consolidated net income. We assess hedge effectiveness under ASC 815 on a quarterly basis to ensure all hedges remain highly effective and hedge accounting under ASC 815 can be applied. In conjunction with the assessment of effectiveness, we assess the hedged item to ensure it is expected to be outstanding at the hedged item’s assumed maturity date and the last-of-layer method of accounting under ASC 815 can be applied. If the hedging relationship no longer exists or no longer qualifies as a hedge per ASC 815, any remaining fair value basis adjustments are allocated to the individual assets in the portfolio and amortized into earnings over a period consistent with the amortization of other discounts and premiums associated with the respective assets. As allowed under GAAP, we apply the "shortcut" method of accounting to a portion of our fair value hedges which assumes there is perfect effectiveness. The following table summarizes the amortized cost basis of hedged assets that are designated and qualify as fair value hedges and the cumulative amount of fair value hedging adjustments included in the carrying value that have been recorded on our unaudited interim consolidated balance sheets as of September 30, 2022 and December 31, 2021: Cumulative Amount of Fair Value Hedging Adjustment Included in the Amortized Cost Basis of the Hedged Assets (Dollars in millions) Amortized Cost Basis of the Hedged Assets Active Terminated September 30, 2022 AFS securities $ 8,773 $ — $ (301) December 31, 2021 AFS securities (1) $ 15,260 $ (131) $ 6 (1) These amounts include the amortized cost basis of closed portfolios used to designate hedging relationships in which the hedged item is the last layer expected to be remaining at the end of the hedging relationship. At December 31, 2021, the amortized cost basis of the closed portfolios used in these hedging relationships was $11.2 billion, the amounts of the designated hedged items was $6.7 billion and the cumulative basis adjustments associated with these hedging relationships was $83 million. Cash Flow Hedges To manage interest rate risk on our variable-interest rate loan portfolio, we enter into interest rate swap contracts to hedge against future changes in interest rates by using hedging instruments to lock in future cash inflows that would otherwise be impacted by movements in the market interest rates. We designate these interest rate swap contracts as cash flow hedges that qualify for hedge accounting under ASC 815 and record them in other assets and other liabilities. For qualifying cash flow hedges, changes in the fair value of the derivative are recorded in AOCI and recognized in earnings as the hedged item affects earnings. Derivative amounts affecting earnings are recognized consistent with the classification of the hedged item in the line item "loans" as part of interest income, a component of consolidated net income. We assess hedge effectiveness under ASC 815 on a quarterly basis to ensure all hedges remain highly effective and hedge accounting under ASC 815 can be applied. If the hedging relationship no longer exists or no longer qualifies as a hedge per ASC 815, any amounts remaining as gain or loss in AOCI are reclassified into earnings in the line item "loans" as part of interest income, a component of consolidated net income. As of March 31, 2020, all derivatives previously classified as hedges with notional balances totaling $5.0 billion and a net asset fair value of $228 million were terminated. As of September 30, 2022, the total unrealized gains on terminated cash flow hedges remaining in AOCI was $73 million ($52 million net of tax). The unrealized gains will be reclassified into interest income as the underlying forecasted transactions impact earnings through the original maturity of the hedged forecasted transactions. The total remaining term over which the unrealized gains will be reclassified into earnings is approximately three years. Currency Exchange Risk Derivatives not designated as hedging instruments We enter into foreign exchange forward contracts to economically reduce our foreign exchange exposure risk associated with the net difference between foreign currency denominated assets and liabilities. Gains or losses from changes in currency rates on foreign currency denominated instruments are recorded in the line item “other” as part of noninterest income, a component of consolidated net income. We may experience ineffectiveness in the economic hedging relationship, because the instruments are revalued based upon changes in the currency’s spot rate on the principal value, while the forwards are revalued on a discounted cash flow basis. We record forward agreements in gain positions in other assets and loss positions in other liabilities, while net changes in fair value are recorded in the line item “other” as part of noninterest income, a component of consolidated net income. Derivatives designated as hedging instruments We enter into net investment hedges to hedge against the foreign currency risk of a net investment in foreign operations. Certain foreign exchange contracts are designated as net investment hedges to minimize our exposure to variability in the foreign currency translation of net investments in non-U.S. subsidiaries. For qualifying net investment hedges under ASC 815, changes in the spot rate of the net investment hedges of foreign operations are recorded in OCI in the line item "foreign currency translation (losses) gains, net of hedges." We assess hedge effectiveness under ASC 815 at least quarterly to ensure all hedges remain effective and hedge accounting can be applied. Net investment hedge pretax gains (losses) of $94 million were recognized in AOCI related to foreign exchange contracts for the three and nine months ending September 30, 2022. Other Derivative Instruments We issue loans to clients with conversion features allowing SVBFG to convert the contingent conversion rights to stock in private or public companies. All of our contingent conversion rights qualify as derivatives and are reported at fair value as a component of other assets on our consolidated balance sheet. Any changes in fair value after the grant date are recognized as net gains or losses in the line item "other" in noninterest income, a component of consolidated net income. We enter into total return swaps related to certain of our equity funds, which manages the risk of exposure from the volatility of equity investments in the funds. We do not designate any total return swaps as derivative instruments that qualify for hedge accounting. Gains or losses from changes in fair value are recognized as net gains or losses in the line item "other" in noninterest income, a component of consolidated net income. Also included in our derivative instruments are equity warrant assets and client forward, option, swap, and interest rate contracts. For further description of these other derivative instruments, refer to Note 2 — “Summary of Significant Accounting Policies" under Part II, Item 8 of our 2021 Form 10-K. Counterparty Credit Risk We are exposed to credit risk if counterparties to our derivative contracts do not perform as expected. We mitigate counterparty credit risk through credit approvals, limits, and monitoring procedures and by obtaining collateral, as appropriate. With respect to measuring counterparty credit risk for derivative instruments, we measure the fair value of a group of financial assets and financial liabilities on a net risk basis by counterparty portfolio. The total notional or contractual amounts and fair value of our derivative financial instruments at September 30, 2022 and December 31, 2021 were as follows: September 30, 2022 December 31, 2021 Notional or Fair Value Notional or Fair Value (Dollars in millions) Derivative Assets (1) Derivative Liabilities (1) Derivative Assets (1) Derivative Liabilities (1) Derivatives designated as hedging instruments: Interest rate risks: Interest rate swaps (2) $ — $ — $ — $ 10,700 $ 18 $ — Currency exchange risks: Foreign exchange contracts 1,546 94 — — — — Total derivatives designated as hedging instruments 94 — 18 — Derivatives not designated as hedging instruments: Currency exchange risks: Foreign exchange contracts 2,860 46 — 701 16 — Foreign exchange contracts 308 — 13 62 — 2 Other derivative instruments: Equity warrant assets 353 351 — 322 277 — Contingent conversion rights 52 6 — — — — Client foreign exchange contracts 10,658 500 — 8,245 146 — Client foreign exchange contracts 10,615 — 499 7,764 — 126 Total return swaps 110 25 — — — — Client foreign currency options 266 11 — 688 9 — Client foreign currency options 266 — 11 688 — 9 Client interest rate derivatives (2) 2,248 128 — 2,178 99 — Client interest rate derivatives 2,447 — 235 2,315 — 101 Total derivatives not designated as hedging instruments 1,067 758 547 238 Total gross derivatives 1,161 758 565 238 Less: netting adjustment (3) (495) (234) (137) (120) Total derivatives $ 666 $ 524 $ 428 $ 118 (1) Derivative assets and liabilities are included in "accrued interest receivable and other assets" and "other liabilities " , respectively, on our consolidated balance sheets. (2) The amount reported reflects reductions of approximately $117 million and $112 million of derivative assets at September 30, 2022 and December 31, 2021, respectively, reflecting variation margin treated as settlement of the related derivative fair values for legal and accounting purposes as required by central clearing houses. (3) For some counterparties, the collateral amounts of financial instruments may exceed the derivative receivables and derivative payables balances. Where this is the case, the total amount reported is limited to the net derivative receivables and net derivative payables balances with that counterparty. There was approximately $6 million of cash collateral in excess of net derivative receivables and $1 million of cash collateral in excess of net derivative payables balances not included in the netting adjustment at September 30, 2022, and December 31, 2021, respectively. A summary of our derivative activity and the related impact on our consolidated statements of income for the three and nine months ended September 30, 2022 and 2021 is as follows: Three months ended September 30, Nine months ended September 30, (Dollars in millions) Statement of income location 2022 2021 2022 2021 Derivatives designated as hedging instruments: Interest rate risks: Amounts reclassified from AOCI into income Interest income - loans $ 14 $ 16 $ 43 $ 47 Change in fair value of interest rate swaps hedging investment securities Interest income - investment securities taxable (2) 5 384 18 Change in fair value of hedged investment securities Interest income - investment securities taxable 1 (6) (385) (19) Net gains associated with interest rate risk derivatives $ 13 $ 15 $ 42 $ 46 Derivatives not designated as hedging instruments: Currency exchange risks: Gains (losses) on revaluations of internal foreign currency instruments, net Other noninterest income $ 47 $ (14) 26 $ (35) (Losses) gains on internal foreign exchange forward contracts, net Other noninterest income (51) 14 (31) 35 Net losses associated with internal currency risk $ (4) $ — $ (5) $ — Other derivative instruments: Gains on revaluations of client foreign currency instruments, net Other noninterest income $ 12 $ 1 $ 7 $ 16 (Losses) gains on client foreign exchange forward contracts, net Other noninterest income (2) (5) 5 (15) Net gains (losses) associated with client currency risk $ 10 $ (4) $ 12 $ 1 (Losses) gains on total return swaps Other noninterest income $ (2) $ — $ 25 $ — Net gains on equity warrant assets Gains on equity warrant assets, net $ 40 $ 147 $ 120 $ 491 Net gains on other derivatives Other noninterest income $ 2 $ 2 $ 8 $ 4 Balance Sheet Offsetting Certain of our derivative and other financial instruments are subject to enforceable master netting arrangements with our counterparties. These agreements provide for the net settlement of multiple contracts with a single counterparty through a single payment, in a single currency, in the event of default on or termination of any one contract. The following table summarizes our assets subject to enforceable master netting arrangements as of September 30, 2022 and December 31, 2021: Gross Amounts of Recognized Assets Gross Amounts Offset in the Statement of Financial Position (1) Net Amounts of Assets Presented in the Statement of Financial Position (1) Gross Amounts Not Offset in the Statement of Financial Position Net Amount (Dollars in millions) Financial Instruments Cash Collateral Received September 30, 2022 Derivatives $ 597 $ (229) $ (266) $ 102 $ — $ 102 Reverse repurchase, securities borrowing, and similar arrangements 397 — — 397 (397) — Total $ 994 $ (229) $ (266) $ 499 $ (397) $ 102 December 31, 2021 Derivatives $ 165 $ (87) $ (50) $ 28 $ — $ 28 Reverse repurchase, securities borrowing, and similar arrangements 607 — — 607 (607) — Total $ 772 $ (87) $ (50) $ 635 $ (607) $ 28 (1) During the third quarter of 2022, we changed our accounting policy to report the fair values of our derivative assets and liabilities subject to ISDA master netting arrangements on a net basis where a right of setoff exists. The net derivative fair values have been further adjusted for cash collateral received/pledged. The change in accounting policy was applied retrospectively, and prior periods have been revised to conform with current period presentation. The following table summarizes our liabilities subject to enforceable master netting arrangements as of September 30, 2022 and December 31, 2021: Gross Amounts of Recognized Liabilities Gross Amounts Offset in the Statement of Financial Position (1) Net Amounts of Liabilities Presented in the Statement of Financial Position (1) Gross Amounts Not Offset in the Statement of Financial Position Net Amount (Dollars in millions) Financial Instruments Cash Collateral Pledged September 30, 2022 Derivatives $ 256 $ (229) $ (5) $ 22 $ — $ 22 Repurchase, securities lending, and similar arrangements 36 — — 36 — 36 Total $ 292 $ (229) $ (5) $ 58 $ — $ 58 December 31, 2021 Derivatives $ 148 $ (87) $ (33) $ 28 $ — $ 28 Repurchase, securities lending, and similar arrangements 61 — — 61 — 61 Total $ 209 $ (87) $ (33) $ 89 $ — $ 89 (1) During the third quarter of 2022, we changed our accounting policy to report the fair values of our derivative assets and liabilities subject to ISDA master netting arrangements on a net basis where a right of setoff exists. The net derivative fair values have been further adjusted for cash collateral received/pledged. The change in accounting policy was applied retrospectively, and prior periods have been revised to conform with current period presentation.

Noninterest Income

Noninterest Income	9 Months Ended
Noninterest Income	Sep. 30, 2022
Other Income and Expenses [Abstract]
Noninterest Income	Noninterest Income All of the Company's revenue from contracts with customers within the scope of ASC 606, R evenue from Contracts with Customer s, is recognized within noninterest income. Included below is a summary of noninterest income for the three and nine months ended September 30, 2022 and 2021: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Noninterest income: Gains (losses) on investment securities, net $ (127) $ 189 $ (199) $ 661 Gains on equity warrant assets, net 40 147 120 491 Client investment fees 119 20 237 55 Wealth management and trust fees 19 22 63 22 Foreign exchange fees 74 65 216 189 Credit card fees 37 34 114 93 Deposit service charges 32 29 94 82 Lending related fees 20 21 65 55 Letters of credit and standby letters of credit fees 15 13 43 39 Investment banking revenue 75 90 293 335 Commissions 24 17 73 58 Other 31 25 119 97 Total noninterest income $ 359 $ 672 $ 1,238 $ 2,177 Gains on investment securities, net Net gains (losses) on investment securities include both gains and losses from our non-marketable and other equity securities, which include public equity securities held as a result of exercised equity warrant assets, gains and losses from sales of our AFS debt securities portfolio, when applicable, and carried interest. Our non-marketable and other equity securities portfolio primarily represents investments in venture capital and private equity funds, SPD-SVB, debt and credit funds, private and public portfolio companies, which include public equity securities held as a result of exercised equity warrant assets, and qualified affordable housing projects. We experience variability in the performance of our non-marketable and other equity securities from period to period, which results in net gains or losses on investment securities (both realized and unrealized). This variability is due to a number of factors, including unrealized changes in the values of our investments, changes in the amount of realized gains from distributions, changes in liquidity events and general economic and market conditions. Unrealized gains and losses from non-marketable and other equity securities for any single period are typically driven by valuation changes. The extent to which any unrealized gains or losses will become realized is subject to a variety of factors, including, among other things, the expiration of certain sales restrictions to which these equity securities may be subject to (e.g., lock-up agreements), changes in prevailing market prices, market conditions, the actual sales or distributions of securities, and the timing of such actual sales or distributions, which, to the extent such securities are managed by our managed funds, are subject to our funds' separate discretionary sales/distributions and governance processes. Carried interest is comprised of preferential allocations of profits recognizable when the return on assets of our individual managed fund of funds and direct venture funds exceeds certain performance targets and is payable to us, as the general partners of the managed funds. The carried interest we earn is often shared with employees, who are also members of the general partner entities. We record carried interest on a quarterly basis by measuring fund performance to date versus the performance target. For our unconsolidated managed funds, carried interest is recorded as gains on investment securities, net. For our consolidated managed funds, it is recorded as a component of net income attributable to noncontrolling interests. Carried interest allocated to others is recorded as a component of net income attributable to noncontrolling interests. Any carried interest paid to us (or our employees) may be subject to reversal to the extent fund performance declines to a level where inception to date carried interest is lower than actual payments made by the funds. The limited partnership agreements for our funds provide that carried interest is generally not paid to the general partners until the funds have provided a full return of contributed capital to the limited partners. Accrued, but unpaid carried interest may be subject to reversal to the extent that the fund performance declines to a level where inception-to-date carried interest is less than prior amounts recognized. Carried interest income is accounted for under an ownership model based on ASC 323, Equity Method of Accounting and ASC 810, Consolidation. Our AFS securities portfolio is a fixed income investment portfolio that is managed with the objective of earning an appropriate portfolio yield over the long-term while maintaining sufficient liquidity and credit diversification as well as addressing our asset/liability management objectives. Though infrequent, sales of debt securities in our AFS securities portfolio may result in net gains or losses and are conducted pursuant to the guidelines of our investment policy related to the management of our liquidity position and interest rate risk. Gains and losses on investment securities are recognized outside of the scope of ASC 606, as it explicitly excludes noninterest income earned from our investment-related activities. A summary of gains and losses on investment securities for the three and nine months ended September 30, 2022 and 2021 is as follows: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Gains (losses) on non-marketable and other equity securities, net $ (127) $ 189 $ (247) $ 661 Gains (losses) on sales of AFS securities, net — — 48 — Total gains (losses) on investment securities, net $ (127) $ 189 $ (199) $ 661 Gains on equity warrant assets, net In connection with negotiating credit facilities and certain other services, we often obtain rights to acquire stock in the form of equity warrant assets in primarily private, venture-backed companies in the technology and life science/healthcare industries. Any changes in fair value from the grant date fair value of equity warrant assets will be recognized as increases or decreases to other assets on our balance sheet and as net gains or losses on equity warrant assets, in noninterest income, a component of consolidated net income. Gains on equity warrant assets are recognized outside of the scope of ASC 606 as it explicitly excludes noninterest income earned from our derivative-related activities. A summary of net gains on equity warrant assets for the three and nine months ended September 30, 2022 and 2021 is as follows: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Equity warrant assets: Gains on exercises, net $ 9 $ 91 $ 44 $ 381 Terminations (1) (1) (3) (2) Changes in fair value, net 32 57 79 112 Total net gains on equity warrant assets $ 40 $ 147 $ 120 $ 491 Client investment fees Client investment fees include fees earned from discretionary investment management services for managing clients’ portfolios based on their investment policies, strategies and objectives. Revenue is recognized on a monthly basis upon completion of our performance obligation, and consideration is typically received in the subsequent month. Included in our sweep money market fees are Rule 12(b)-1 fees, revenue sharing and customer transactional-based fees. Rule 12(b)-1 fees and revenue sharing are recognized as earned based on client funds that are invested in the period, typically monthly. Transactional based fees are earned and recognized on fixed income securities when the transaction is executed on the clients' behalf. Amounts paid to third-party service providers are predominantly expensed, such that client investment fees are recorded gross of payments made to third parties. A summary of client investment fees by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Client investment fees by type: Sweep money market fees $ 64 $ 12 $ 144 $ 31 Asset management fees (1) 16 7 41 22 Repurchase agreement fees 39 1 52 2 Total client investment fees (2) $ 119 $ 20 $ 237 $ 55 (1) Represents fees earned from investments in third-party money market mutual funds and fixed-income securities managed by SVB Asset Management. (2) Represents fees earned on client investment funds that are maintained at third-party financial institutions and are not recorded on our balance sheet. Wealth management and trust fees Wealth management fees are earned for providing wealth management, retirement plan advisory, family office, financial planning, trust services and other financial advisory services to clients. The Company’s performance obligation under these contracts is satisfied over time as the services are provided. Fees are recognized monthly based on the average monthly, beginning-of-quarter, or, for a small number of clients, end-of-quarter market value of the Private Bank AUM and the applicable fee rate, depending on the terms of the contracts. Fees are also recognized monthly based either on a fixed fee amount or are based on the quarter-end (in arrears) market value of the Private Bank AUM and the applicable fee rate, depending on the terms of the contracts. No performance-based incentives are earned under wealth management contracts. Receivables are recorded on the Consolidated Balance Sheets in the "Accrued interest receivable and other assets" line item. Trust fees are earned when the Company is appointed as trustee for clients. As trustee, the Company administers the client’s trust and manages the assets of the trust, including investments and property. The Company’s performance obligation under these agreements is satisfied over time as the administration and management services are provided. Fees are recognized monthly or, in certain circumstances, quarterly based on a percentage of the market value of the account as outlined in the agreement. Payment frequency is defined in the individual contracts, which primarily stipulate monthly in arrears. No performance-based incentives are earned on trust fee contracts. Receivables are recorded on the Consolidated Balance Sheets in the "Accrued interest receivable and other assets" line item. A summary of wealth management and trust fees by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Wealth management and trust fees by type: Wealth management fees $ 17 $ 20 $ 58 $ 20 Trust fees 2 2 5 2 Total wealth management and trust fees $ 19 $ 22 $ 63 $ 22 Foreign exchange fees Foreign exchange fees represent the income differential between purchases and sales of foreign currency on behalf of our clients, primarily from spot contracts. Foreign exchange spot contract fees recognized upon the completion of a single performance obligation are recognized within the scope of ASC 606. Foreign exchange contracts and option premium fees are recognized outside of the scope of ASC 606 as it explicitly excludes noninterest income earned from our derivative-related activities. A summary of foreign exchange fee income by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Foreign exchange fees by instrument type: Foreign exchange contract commissions $ 74 $ 65 $ 215 $ 188 Option premium fees — — 1 1 Total foreign exchange fees $ 74 $ 65 $ 216 $ 189 Credit card fees Credit card fees include interchange income from credit and debit cards and fees earned from processing transactions for merchants. Interchange income is earned after satisfying our performance obligation of providing nightly settlement services to a payment network. Costs related to rewards programs are recorded when the rewards are earned by the customer and presented as a reduction to interchange fee income. Rewards programs continue to be accounted for under ASC 310, Receivables . Our performance obligations for merchant service fees are to transmit data and funds between the merchant and the payment network. Credit card interchange and merchant service fees are earned daily upon completion of transaction settlement services. Annual card service fees are recognized on a straight-line basis over a 12-month period and continue to be accounted for under ASC 310, Receivables . A summary of credit card fees by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Credit card fees by instrument type: Card interchange fees, net $ 29 $ 29 $ 91 $ 78 Merchant service fees 6 4 18 12 Card service fees 2 1 5 3 Total credit card fees $ 37 $ 34 $ 114 $ 93 Deposit service charges Deposit service charges include fees earned from performing cash management activities and other deposit account services. Deposit services include, but are not limited to, the following: receivables services, which include merchant services, remote capture, lockbox, electronic deposit capture, and fraud control services. Payment and cash management products and services include wire transfer and automated clearing house payment services to enable clients to transfer funds more quickly, as well as business bill pay, business credit and debit cards, account analysis, and disbursement services. Deposit service charges are recognized over the period in which the related performance obligation is provided, generally on a monthly basis, and are presented in the "Disaggregation of revenue from contracts with customers" tables below. Lending related fees Unused commitment fees, minimum finance fees and unused line fees are recognized as earned on a monthly basis. Fees that qualify for syndication treatment are recognized at the completion of the syndicated loan deal for which the fees were received. Lending related fees are recognized outside of the scope of ASC 606 as it explicitly excludes noninterest income earned from our lending-related activities. A summary of lending related fees by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Lending related fees by instrument type: Unused commitment fees $ 14 $ 14 $ 49 $ 42 Other 6 7 16 13 Total lending related fees $ 20 $ 21 $ 65 $ 55 Letters of credit and standby letters of credit fees Standby letters of credit represent conditional commitments issued by us on behalf of a client to guarantee the performance of the client to a third party when certain specified future events have occurred. Fees generated from letters of credit and standby letters of credit are deferred as a component of other liabilities and recognized in noninterest income over the commitment period using the straight-line method, based on the likelihood that the commitment being drawn down will be remote. Letters of credit and standby letters of credit fees are recognized outside of the scope of ASC 606 as it explicitly excludes noninterest income earned from our lending related activities. Investment banking revenue We earn investment banking revenue from clients for providing services related to securities underwriting, private placements and advisory services on strategic matters such as mergers and acquisitions. Underwriting fees are attributable to public and private offerings of equity and debt securities and are recognized at the point in time when the offering has been deemed to be completed by the lead manager of the underwriting group. Once the offering is completed, the performance obligation has been satisfied; we recognize the applicable management fee as well as the underwriting fee, net of consideration payable to customers. Private placement fees are recognized at the point in time when the private placement is completed, which is generally when the client accepts capital from the fund raise. Advisory fees from mergers and acquisitions engagements are generally recognized at the point in time when the related transaction is completed. Expenses are deferred only to the extent they are explicitly reimbursable by the client and the related revenue is recognized at a point in time. All other deal-related expenses are expensed as incurred. We have determined that we act as principal in the majority of these transactions and therefore present expenses gross within other operating expenses. A summary of investment banking revenue by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Investment banking revenue: Underwriting fees $ 24 $ 39 $ 97 $ 248 Advisory fees 40 26 163 39 Private placements and other 11 25 33 48 Total investment banking revenue $ 75 $ 90 $ 293 $ 335 Commissions Commissions include commissions received from customers for the execution of agency-based brokerage transactions in listed and over-the-counter equities. The execution of each trade order represents a distinct performance obligation, and the transaction price is fixed at the point in time or trade order execution. Trade execution is satisfied at the point in time that the customer has control of the asset and as such, fees are recorded on a trade date basis. The Company also earns subscription fees for market intelligence services that are recognized over the period in which they are delivered. Fees received before the subscription period ends are initially recorded as deferred revenue (a contract liability) in other liabilities in our consolidated balance sheet. Commissions are presented in the "Disaggregation of revenue from contracts with customers" table below. Other Other noninterest income primarily includes income from fund management fees, gains from conversion of convertible debt options and service revenue. Fund management fees are comprised of fees charged directly to our managed funds of funds and direct venture funds. Fund management fees are based upon the contractual terms of the limited partnership agreements and are generally recognized as earned over the specified contract period, which is generally equal to the life of the individual fund. Fund management fees are calculated as a percentage of committed capital and collected quarterly in advance and recognized over the quarter. Fund management fees for certain of our limited partnership agreements are calculated as a percentage of distributions made by the funds, and revenue is recorded only at the time of a distribution event. As distribution events are not predetermined for these certain funds, management fees are considered variable and constrained under ASC 606. Gains from conversion of convertible debt options represent unrealized valuation gains on loan conversion derivative assets, and realized gains from the conversion of debt instruments, convertible into a third party’s common stock upon a triggering event such as an IPO. Gains from conversion of convertible debt options are recognized outside of the scope of ASC 606 as it explicitly excludes noninterest income earned from our derivative-related activities. Other service revenue primarily consists of gains or losses from changes in fair value of total return swaps, dividend income on FHLB/FRB stock, correspondent bank rebate income, incentive fees, or performance fees related to carried interest and other fee income. We recognize revenue when our performance obligations are met and record revenues on a daily/monthly, quarterly, semi-annual or annual basis. For event driven revenue sources, we recognize revenue when: (i) persuasive evidence of an arrangement exists, (ii) we have performed the service, provided we have no other remaining obligations to the customer, (iii) the fee is fixed or determinable and (iv) collectability is probable. A summary of other noninterest income by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Other noninterest income by instrument type: Fund management fees $ 16 $ 15 $ 43 $ 51 Net gains on revaluation of foreign currency instruments, net of foreign exchange forward contracts (1) 6 (4) 7 1 Gains on total return swaps (3) — 25 — Other service revenue 12 14 44 45 Total other noninterest income $ 31 $ 25 $ 119 $ 97 (1) Represents the net revaluation of client and internal foreign currency denominated financial instruments. We enter into foreign exchange forward contracts to economically reduce our foreign exchange exposure related to client and internal foreign currency denominated financial instruments. Disaggregation of revenue from contracts with customers The following tables present our revenues from contracts with customers disaggregated by revenue source and segment for the three and nine months ended September 30, 2022 and 2021: Three months ended September 30, 2022 Silicon Valley Bank (3) SVB Private SVB Capital (3) SVB Other Items Total (Dollars in millions) Revenue from contracts with customers: Client investment fees $ 119 $ — $ — $ — $ — $ 119 Wealth management and trust fees — 19 — — — 19 Card interchange fees, gross 54 1 — — — 55 Merchant service fees 7 — — — — 7 Deposit service charges 32 — — — — 32 Investment banking revenue — — — 75 — 75 Commissions — — — 24 — 24 Fund management fees 1 — 13 2 — 16 Other (1) 1 — 2 — — 3 Total revenue from contracts with customers $ 214 $ 20 $ 15 $ 101 $ — $ 350 Revenues outside the scope of ASC 606 (2) 94 2 (69) (1) (17) 9 Total noninterest income $ 308 $ 22 $ (54) $ 100 $ (17) $ 359 (1) Includes certain spot contract commissions, performance fees and correspondent bank rebates. (2) Amounts are accounted for under separate guidance than ASC 606. (3) Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items. " Three months ended September 30, 2021 Silicon Valley Bank (3) SVB Private SVB Capital (3) SVB Other Items Total (Dollars in millions) Revenue from contracts with customers: Client investment fees $ 20 $ — $ — $ — $ — $ 20 Wealth management and trust fees — 22 22 Card interchange fees, gross 52 — — — — 52 Merchant service fees 4 — — — — 4 Deposit service charges 28 — — — 1 29 Investment banking revenue — — — 90 — 90 Commissions — — — 17 — 17 Fund management fees — — 14 1 — 15 Other (1) 61 1 4 — — 66 Total revenue from contracts with customers 165 23 18 108 1 315 Revenues outside the scope of ASC 606 (2) 17 2 127 23 188 357 Total noninterest income $ 182 $ 25 $ 145 $ 131 $ 189 $ 672 (1) Includes certain spot contract commissions, performance fees and correspondent bank rebates. (2) Amounts are accounted for under separate guidance than ASC 606. (3) Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items. " Nine months ended September 30, 2022 Silicon Valley Bank (3) SVB Private SVB Capital (3) SVB Other Items Total (Dollars in millions) Revenue from contracts with customers: Client investment fees $ 236 $ — $ — $ — $ 1 $ 237 Wealth management and trust fees — 63 — — — 63 Card interchange fees, gross 170 1 — — 2 173 Merchant service fees 18 — — — — 18 Deposit service charges 92 1 — — 1 94 Investment banking revenue — — — 293 — 293 Commissions — — — 73 — 73 Fund management fees 1 — 37 5 — 43 Other (1) 69 1 6 — — 76 Total revenue from contracts with customers $ 586 $ 66 $ 43 $ 371 $ 4 $ 1,070 Revenues outside the scope of ASC 606 (2) 195 6 (121) (19) 107 168 Total noninterest income $ 781 $ 72 $ (78) $ 352 $ 111 $ 1,238 (1) Includes certain spot contract commissions, performance fees and correspondent bank rebates. (2) Amounts are accounted for under separate guidance than ASC 606. (3) Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items. " Nine months ended September 30, 2021 Silicon Valley Bank (3) SVB Private SVB Capital (3) SVB Other Items Total (Dollars in millions) Revenue from contracts with customers: Client investment fees $ 53 $ 2 $ — $ — $ — $ 55 Wealth management and trust fees — 22 — — — 22 Card interchange fees, gross 140 1 — — 1 142 Merchant service fees 12 — — — — 12 Deposit service charges 80 — — — 2 82 Investment banking revenue — — — 335 — 335 Commissions — — — 58 — 58 Fund management fees — — 47 4 — 51 Other (1) 178 1 12 — — 191 Total revenue from contracts with customers $ 463 $ 26 $ 59 $ 397 $ 3 $ 948 Revenues outside the scope of ASC 606 (2) 51 2 330 53 793 1,229 Total noninterest income $ 514 $ 28 $ 389 $ 450 $ 796 $ 2,177 (1) Includes certain spot contract commissions, performance fees and correspondent bank rebates. (2) Amounts are accounted for under separate guidance than ASC 606. (3) Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items. " The timing of revenue recognition may differ from the timing of cash settlements or invoicing to customers. We record a receivable when revenue is recognized prior to invoicing, and unearned revenue when revenue is recognized subsequent to receipt of consideration. These assets and liabilities are reported on the consolidated balance sheets on a contract-by-contract basis at the end of each reporting period. During the three and nine months ended September 30, 2022 and 2021, changes in our contract assets, contract liabilities and receivables were not material. Additionally, revenues recognized during the three and nine months ended September 30, 2022 and 2021 that were included in the corresponding contract liability balance at the beginning of the periods were not material.

Segment Reporting

Segment Reporting	9 Months Ended
Segment Reporting	Sep. 30, 2022
Segment Reporting [Abstract]
Segment Reporting	Segment ReportingWe have four reportable segments for management reporting purposes: Silicon Valley Bank, SVB Private, SVB Capital and SVB Securities. The results of our reportable and operating segments are based on our internal management reporting process. We report segment information based on the “management” approach. The management approach designates the internal reporting used by management for making decisions and assessing performance as the source of our reporting segments. During the quarter ended March 31, 2022, we reevaluated our segments. Based on this reevaluation, the Premium Wine reporting division was moved from Silicon Valley Bank to the SVB Private segment. These changes were made to reflect the manner in which the Company is organized for purposes of making operating decisions and assessing performance. For the three and nine months ended September 30, 2021, prior period balances for our Premium Wine reporting division previously reported in "Silicon Valley Bank" have been recast to the reportable segment “SVB Private” to properly reflect organizational changes effective January 1, 2022. The reclassification of historical segment information has no effect on the Company's previously reported consolidated balance sheets, statements of income, or cash flows, and the change did not have any impact on the determination of the reporting units used to assess impairment under ASC 350, Intangibles - Goodwill and Other . Our Silicon Valley Bank and SVB Private segments primary source of revenue is from net interest income, which is primarily the difference between interest earned on loans, net of FTP, and interest paid on deposits, net of FTP. Accordingly, these segments are reported using net interest income, net of FTP. FTP is an internal measurement framework designed to assess the financial impact of a financial institution’s sources and uses of funds. It is the mechanism by which a funding credit is given for deposits raised, and a funding charge is made for funded loans. FTP is calculated at an instrument level based on account characteristics. We also evaluate performance based on provision for credit losses, noninterest income and noninterest expense, which are presented as components of segment operating profit or loss. In calculating each operating segment’s noninterest expense, we consider the direct costs incurred by the operating segment as well as certain allocated direct costs. As part of this review, we allocate certain corporate overhead costs to a corporate account. We do not allocate income tax expense, the provisions for unfunded credit commitments, or HTM securities (included in provision for credit losses) to our segments. Additionally, our management reporting model is predicated on average asset balances; therefore, period-end asset balances are not presented for segment reporting purposes. Changes in an individual client’s primary relationship designation have resulted, and in the future may result, in the inclusion of certain clients in different segments in different periods. Unlike financial reporting, which benefits from the comprehensive structure provided by GAAP, our internal management reporting process is highly subjective, as there is no comprehensive, authoritative guidance for management reporting. Our management reporting process measures the performance of our operating segments based on our internal operating structure, which is subject to change from time to time, and is not necessarily comparable with similar information for other financial services companies. For reporting purposes, SVB Financial Group has four operating segments for which we report our financial information: • Silicon Valley Bank is our commercial bank which offers products and services provided by the Bank and its subsidiaries to commercial clients in key innovation markets. The Bank provides solutions to the financial needs of commercial clients through credit, treasury management, foreign exchange, trade finance, and other services. In addition, the Bank and its subsidiaries offer a variety of investment services and solutions to its clients that enable them to effectively manage their assets. Our commercial bank consists of services provided to clients in the Tech and Healthcare industries, as well as private equity and venture capital firms, and includes clients from international operations in EMEA, Asia and Canada. • SVB Private is our private bank and wealth management segment of the Bank. SVB Private provides a range of personal financial solutions for consumers. Our clients are primarily private equity/venture capital professionals and executive leaders of the innovation companies they support as well as high net worth clients acquired from Boston Private and our premium wine clients. We offer a customized suite of private banking services, including mortgages, home equity lines of credit, restricted and private stock loans, capital call lines of credit, other secured and unsecured lending products and vineyard development loans, as well as planning-based financial strategies, wealth management, family office, financial planning, tax planning and trust services. In addition, we provide real estate secured loans to eligible employees through our EHOP. • SVB Capital is the funds management business of SVB Financial Group, which focuses primarily on venture capital investments. SVB Capital manages funds (primarily venture capital funds) on behalf of third-party limited partners and, on a more limited basis, SVB Financial Group. The SVB Capital family of funds is comprised of direct venture funds that invest in companies and funds of funds that invest in other venture capital funds, as well as debt funds that provide lending and other financing solutions. SVB Capital generates income for the Company primarily from investment returns (including carried interest allocations) and management fees. • SVB Securities is an investment bank focused on the innovation economy and operates as a wholly-owned subsidiary of SVB Financial Group. SVB Securities provides investment banking services across all major sub-sectors of Healthcare and Technology. Healthcare sub-sectors include Biopharma, Digital Health and HealthTech, Healthcare Services, Medical Devices and Tools and Diagnostics. Technology sub-sectors include Consumer Internet, Commerce Enablement and Marketing Software, Digital Infrastructure and Tech-Enabled Services, Education Technology, Enterprise Software, Industrial Technology and FinTech. SVB Securities focuses on four main product and service offerings: Capital Raising, M&A Advisory, Equity Research and Sales and Trading. The following table presents a summary of financial results of our reportable segments along with a reconciliation to our consolidated interim results. Our reportable segment information for the three and nine months ended September 30, 2022 and 2021 is as follows: (Dollars in millions) Silicon Valley SVB Private SVB Capital (1) SVB Other Items (2) Total Three months ended September 30, 2022 Net interest income $ 1,107 $ 111 $ — $ 1 $ (21) $ 1,198 (Provision for) reduction of credit losses (32) 3 — — (43) (72) Noninterest income (loss) 308 22 (54) 100 (17) 359 Noninterest expense (3) (381) (85) (17) (131) (278) (892) Income (loss) before income tax expense (4) $ 1,002 $ 51 $ (71) $ (30) $ (359) $ 593 Total average loans, amortized cost $ 55,177 $ 15,181 $ — $ — $ 740 $ 71,098 Total average assets (5) (6) 175,620 17,032 883 898 21,307 215,740 Total average deposits 172,427 12,436 — — 693 185,556 Three months ended September 30, 2021 Net interest income (7) $ 766 $ 74 $ — $ — $ 12 $ 852 Provision for credit losses 29 (20) — — (30) (21) Noninterest income 182 25 145 131 189 672 Noninterest expense (3) (7) (336) (93) (15) (142) (293) (879) Income before income tax expense (4) (7) $ 641 $ (14) $ 130 $ (11) $ (122) $ 624 Total average loans, amortized cost (7) $ 44,789 $ 13,515 $ — $ — $ 987 $ 59,291 Total average assets (5) (6) (7) 151,352 15,930 730 837 13,841 182,690 Total average deposits (7) 148,879 13,431 — — 1,082 163,392 Nine months ended September 30, 2022 Net interest income $ 2,993 $ 296 $ — $ 1 $ 157 $ 3,447 Provision for credit losses (174) (9) — — (96) (279) Noninterest income (loss) 781 72 (78) 352 111 1,238 Noninterest expense (3) (1,148) (267) (53) (406) (739) (2,613) Income before income tax expense (4) $ 2,452 $ 92 $ (131) $ (53) $ (567) $ 1,793 Total average loans, amortized cost $ 53,855 $ 14,711 $ — $ — $ 592 $ 69,158 Total average assets (5) (6) 178,209 16,456 956 912 20,119 216,652 Total average deposits 175,370 13,327 — — 731 189,428 Nine months ended September 30, 2021 Net interest income (7) $ 2,084 $ 146 $ — $ — $ 10 $ 2,240 (Provision for) reduction of credit losses (27) (16) — — (32) (75) Noninterest income 514 28 389 450 796 2,177 Noninterest expense (3) (7) (911) (126) (48) (376) (707) (2,168) Income before income tax expense (4) (7) $ 1,660 $ 32 $ 341 $ 74 $ 67 2,174 Total average loans, amortized cost (7) $ 41,591 $ 8,610 $ — $ — $ 1,642 $ 51,843 Total average assets (5) (6) (7) 130,177 9,459 641 778 11,897 152,952 Total average deposits (7) 128,006 7,108 — — 999 136,113 (1) Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of net interest income, noninterest income, noninterest expense and total average assets are shown net of noncontrolling interests for all periods presented. Noncontrolling interest is included within “Other Items." (2) The “Other Items” column reflects the adjustments necessary to reconcile the results of the reportable segments to the consolidated financial statements prepared in conformity with GAAP. Net interest income consists primarily of interest earned from our fixed income investment portfolio, net of FTP. Noninterest income consists primarily of gains or losses on equity warrant assets, gains or losses on the sale of AFS securities and gains or losses on equity securities from exercised warrant assets. Noninterest expense consists primarily of expenses associated with corporate support functions such as finance, human resources, marketing, legal and other expenses. (3) The Silicon Valley Bank segment includes direct depreciation and amortization of $13 million and $10 million for the three months ended September 30, 2022 and 2021, respectively and $34 million and $25 million for the nine months ended September 30, 2022 and 2021, respectively. (4) The internal reporting model used by management to assess segment performance does not calculate income tax expense by segment. Our effective tax rate is a reasonable approximation of the segment rates. (5) Total average assets equal the greater of total average assets or the sum of total average liabilities and total average stockholders' equity for each segment to reconcile the results to the consolidated financial statements prepared in conformity with GAAP. (6) Included in the total average assets for SVB Securities and SVB Private is goodwill of $174 million and $201 million, respectively, for the three and nine months ended September 30, 2022, and included in the total average assets for SVB Securities and SVB Private is goodwill of $138 million and $201 million for the three and nine months ended September 30, 2021, respectively. (7) For the three and nine months ended September 30, 2021, prior period balances for our Premium Wine reporting division previously reported in "Silicon Valley Bank" have been allocated to the reportable segment “SVB Private” to properly reflect organizational changes effective January 1, 2022. The reallocation had no impact on the "Total" amount.

Off-Balance Sheet Arrangements,

Off-Balance Sheet Arrangements, Guarantees and Other Commitments	9 Months Ended
	Sep. 30, 2022
Disclosure Off Balance Sheet Arrangements Guarantees And Other Commitments Additional Information [Abstract]
Off-Balance Sheet Arrangements, Guarantees and Other Commitments	Off-Balance Sheet Arrangements, Guarantees and Other Commitments In the normal course of business, we use financial instruments with off-balance sheet risk to meet the financing needs of our customers. These financial instruments include commitments to extend credit, commercial and standby letters of credit and commitments to invest in venture capital and private equity fund investments. These instruments involve, to varying degrees, elements of credit risk. Credit risk is defined as the possibility of sustaining a loss because other parties to the financial instrument fail to perform in accordance with the terms of the contract. Commitments to Extend Credit The following table summarizes information related to our commitments to extend credit at September 30, 2022 and December 31, 2021: (Dollars in millions) September 30, 2022 December 31, 2021 Loan commitments (1) $ 51,769 $ 40,327 Standby letters of credit (2) 3,824 3,612 Commercial letters of credit (3) 105 77 Total unfunded credit commitments $ 55,698 $ 44,016 Allowance for unfunded credit commitments (4) 265 171 (1) Represents commitments which are available for funding, due to clients meeting all collateral, compliance and financial covenants required under loan commitment agreements. (2) See below for additional information on our standby letters of credit. (3) Commercial letters of credit are issued primarily for inventory purchases by a client and are typically short-term in nature. (4) Our allowance for credit losses for unfunded credit commitments includes an allowance for both our unfunded loan commitments and our letters of credit. The table below summarizes our standby letters of credit at September 30, 2022. The maximum potential amount of future payments represents the amount that could be remitted under letters of credit if there were a total default by the guaranteed parties, without consideration of possible recoveries under recourse provisions or from the collateral held or pledged. (Dollars in millions) Expires in One Expires After Total Amount Maximum Amount Financial standby letters of credit $ 3,617 $ 126 $ 3,743 $ 3,743 Performance standby letters of credit 72 9 81 81 Total $ 3,689 $ 135 $ 3,824 $ 3,824 Deferred fees related to financial and performance standby letters of credit were $20 million at both September 30, 2022 and December 31, 2021. Commitments to Invest in Venture Capital and Private Equity Funds We make commitments to invest in venture capital and private equity funds, which generally make investments in privately-held companies. Commitments to invest in these funds are generally made for a 10-year period from the inception of the fund. Although the limited partnership agreements governing these investments typically do not restrict the general partners from calling 100% of committed capital in one year, it is customary for these funds to call most of the capital commitments over 5 to 7 years, and in certain cases, the funds may not call 100% of committed capital. The actual timing of future cash requirements to fund these commitments is generally dependent upon the investment cycle, overall market conditions, and the nature and type of industry in which the privately held companies operate. The following table details our total capital commitments, unfunded capital commitments, and our ownership percentage in each fund at September 30, 2022: (Dollars in millions) SVBFG Capital Commitments SVBFG Unfunded Commitments SVBFG Ownership of each Fund Redwood Evergreen Fund, LP $ 250 $ 119 100.0 % CP II, LP (1) 1 — 5.1 Capital Preferred Return Fund, LP 13 — 20.0 Growth Partners, LP 25 1 33.0 Strategic Investors Fund, LP 15 1 12.6 Strategic Investors Fund II, LP 15 1 8.6 Strategic Investors Fund III, LP 15 1 5.9 Strategic Investors Fund IV, LP 12 2 5.0 Strategic Investors Fund V funds 1 — Various Other venture capital and private equity fund investments (equity method accounting) 18 5 Various Debt funds (equity method accounting) 59 — Various Other fund investments (2) 248 12 Various Total $ 672 $ 142 (1) Our ownership includes direct ownership of 1.3 percent and indirect ownership interest of 3.8 percent through our investment in Strategic Investors Fund II, LP. (2) Represents commitments to 147 funds (primarily venture capital funds) where our ownership interest is generally less than 5.0 percent of the voting interests of each such fund. At September 30, 2022 we had $3 million of remaining unfunded commitments to venture capital and private equity funds by our consolidated managed funds of funds (including our interest and the noncontrolling interests).

Income Taxes

Income Taxes	9 Months Ended
Income Taxes	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes We are subject to income tax and non-income based taxes by the U.S. federal tax authorities as well as various state and foreign tax authorities. We have identified the U.S. federal and California state jurisdictions as major tax filings. The state of California is currently examining the years 2013-2016. Our U.S. federal tax returns remain open to full examination for 2019 and subsequent tax years. Our California tax returns remain open to full examination for 2017 and subsequent tax years. At September 30, 2022, our unrecognized tax benefit was $42 million, the recognition of which would reduce our income tax expense by $34 million. We are unable to estimate the unrecognized tax benefit that will materially change in the next 12 months. We recognize interest and penalties related to income tax matters as part of income before income taxes. Interest and penalties were not material for the three and nine months ended September 30, 2022.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
Fair Value of Financial Instruments	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair Value Measurements Our AFS securities, derivative instruments and certain non-marketable and other equity securities are financial instruments recorded at fair value on a recurring basis. We make estimates regarding valuation of assets and liabilities measured at fair value in preparing our interim consolidated financial statements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (the “exit price”) in an orderly transaction between market participants at the measurement date. There is a three-level hierarchy for disclosure of assets and liabilities recorded at fair value. The classification of assets and liabilities within the hierarchy is based on whether the inputs to the valuation methodology used for measurement are observable or unobservable and on the significance of those inputs in the fair value measurement. Observable inputs reflect market-derived or market-based information obtained from independent sources, while unobservable inputs reflect our estimates about market data and views of market participants. The three levels for measuring fair value are based on the reliability of inputs and are as follows: Level 1 Fair value measurements based on quoted prices in active markets for identical assets or liabilities that we have the ability to access. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these instruments does not entail a significant degree of judgment. Assets utilizing Level 1 inputs include U.S. Treasury securities, foreign government debt securities, exchange-traded equity securities, certain marketable securities accounted for under fair value accounting, and assets and liabilities related to the deferred compensation plan assumed during the merger with Boston Private. Level 2 Fair value measurements based on quoted prices in markets that are not active or for which all significant inputs are observable, directly or indirectly. Valuations for the AFS securities are provided by independent pricing service providers who have experience in valuing these securities and are compared to the average of quoted market prices obtained from independent brokers. We perform a monthly analysis on the values received from third parties to ensure that the prices represent a reasonable estimate of the fair value. The procedures include, but are not limited to, initial and ongoing review of third-party pricing methodologies, review of pricing trends and monitoring of trading volumes. Additional corroboration, such as obtaining a non-binding price from a broker, may be obtained depending on the frequency of trades of the security and the level of liquidity or depth of the market. Prices received from independent brokers represent a reasonable estimate of the fair value and are validated through the use of observable market inputs including comparable trades, yield curve, spreads and, when available, market indices. If we determine that there is a more appropriate fair value based upon the available market data, the price received from the third party is adjusted accordingly. Below is a summary of the significant inputs used for each class of Level 2 assets and liabilities: U.S. agency debentures: Fair value measurements of U.S. agency debentures are based on the characteristics specific to bonds held, such as issuer name, issuance date, coupon rate, maturity date and any applicable issuer call option features. Valuations are based on market spreads relative to similar term benchmark market interest rates, generally U.S. Treasury securities. Agency-issued MBS: Agency-issued MBS are pools of individual conventional mortgage loans underwritten to U.S. agency standards with similar coupon rates, tenor, and other attributes such as geographic location, loan size and origination vintage. Fair value measurements of these securities are based on observable price adjustments relative to benchmark market interest rates taking into consideration estimated loan prepayment speeds. Agency-issued CMO: Agency-issued CMO are structured into classes or tranches with defined cash flow characteristics and are collateralized by U.S. agency-issued mortgage pass-through securities. Fair value measurements of these securities incorporate similar characteristics of mortgage pass-through securities such as coupon rate, tenor, geographic location, loan size and origination vintage, in addition to incorporating the effect of estimated prepayment speeds on the cash flow structure of the class or tranche. These measurements incorporate observable market spreads over an estimated average life after considering the inputs listed above. Agency-issued CMBS: Fair value measurements of these securities are based on spreads to benchmark market interest rates (usually U.S. Treasury rates or rates observable in the swaps market), prepayment speeds, loan default rate assumptions and loan loss severity assumptions on underlying loans. Derivative assets and liabilities: Fair value measurements of these assets and liabilities are priced based on the following: • Foreign exchange forward and option contract assets and liabilities are priced based on spot and forward foreign currency rates and option volatility assumptions. • Interest rate derivative and interest rate swap assets and liabilities are priced considering the coupon rate of the fixed leg of the contract and the variable coupon rate on the floating leg of the contract. Valuation is based on both spot and forward rates on the swap yield curve and the credit worthiness of the contract counterparty. • Total return swaps are based upon the performance of the reference asset, the variable coupon rate and spread of the floating leg of the contract. Other equity securities: Fair value measurements of equity securities of public companies are priced based on quoted market prices less a discount if the securities are subject to certain sales restrictions. Certain sales restriction discounts generally range from 10 percent to 20 percent depending on the duration of the sale restrictions which typically range from three Equity warrant assets (public portfolio): Fair value measurements of equity warrant assets of publicly-traded portfolio companies are valued based on the Black-Scholes option pricing model. The model uses the price of publicly-traded companies (underlying stock price), stated strike prices, warrant expiration dates, the risk-free interest rate and market-observable option volatility assumptions. Level 3 The fair value measurement is derived from valuation techniques that use significant assumptions not observable in the market. These unobservable assumptions reflect our own estimates of assumptions we believe market participants would use in pricing the asset. The valuation techniques are consistent with the market approach, income approach and/or the cost approach used to measure fair value. Below is a summary of the valuation techniques used for each class of Level 3 assets: Venture capital and private equity fund investments not measured at net asset value: Fair value measurements are based on consideration of a range of factors including, but not limited to, the price at which the investment was acquired, the term and nature of the investment, local market conditions, values for comparable securities, and as it relates to the private company, the current and projected operating performance, exit strategies and financing transactions subsequent to the acquisition of the investment. The significant unobservable inputs used in the fair value measurement include the information about each portfolio company, including actual and forecasted results, cash position, recent or planned transactions and market comparable companies. Significant changes to any one of these inputs in isolation could result in a significant change in the fair value measurement; however, we generally consider all factors available through ongoing communication with the portfolio companies and venture capital fund managers to determine whether there are changes to the portfolio company or the environment that indicate a change in the fair value measurement. Equity warrant assets (public portfolio): Fair value measurements of equity warrant assets of publicly-traded portfolio companies are valued based on the Black-Scholes option pricing model. The model uses the price of publicly-traded companies (underlying stock price), stated strike prices, warrant expiration dates, the risk-free interest rate and market-observable option volatility assumptions. Modeled asset values are further adjusted by applying a discount of up to 20 percent for certain warrants that have certain sales restrictions or other features that indicate a discount to fair value is warranted. As sale restrictions are lifted, discounts are adjusted downward to zero once all restrictions expire or are removed. Equity warrant assets (private portfolio): Fair value measurements of equity warrant assets of private portfolio companies are priced based on a Black-Scholes option pricing model to estimate the asset value by using stated strike prices, option expiration dates, risk-free interest rates and option volatility assumptions. Option volatility assumptions used in the Black-Scholes model are based on public market indices whose members operate in similar industries as companies in our private company portfolio. Option expiration dates are modified to account for estimates to actual life relative to stated expiration. Overall model asset values are further adjusted for a general lack of liquidity due to the private nature of the associated underlying company. There is a direct correlation between changes in the volatility and remaining life assumptions in isolation and the fair value measurement while there is an inverse correlation between changes in the liquidity discount assumption and the fair value measurement. Contingent conversion rights (public portfolio): Fair value measurements of contingent conversion rights of publicly-traded portfolio companies are valued based on the Black-Scholes option pricing model. The model uses the price of publicly-traded companies (underlying stock price), stated strike prices, warrant expiration dates, the risk-free interest rate and market-observable option volatility assumptions. Modeled asset values are further adjusted by applying a discount of up to 20 percent for certain conversion rights that have certain sales restrictions or other features that indicate a discount to fair value is warranted. As sale restrictions are lifted, discounts are adjusted downward to zero once all restrictions expire or are removed. Contingent conversion rights (private portfolio): Fair value measurements are based on consideration of a range of factors including, but not limited to, actual and forecasted enterprise values, probability of conversion event occurring and limitations and conversion pricing outlined in the convertible debt agreement. Additionally, we have ongoing communication with the portfolio companies and relationship teams, to determine whether there is a material change in fair value. We use company provided valuation reports, if available, to support our valuation assumptions. These factors are specific to each portfolio company and a weighted average or range of values of the unobservable inputs is not meaningful. The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2022: (Dollars in millions) Level 1 Level 2 Level 3 Netting Adjustments (1) Balance at September 30, 2022 Assets: AFS securities: U.S. Treasury securities $ 16,845 $ — $ — $ — $ 16,845 U.S. agency debentures — 100 — — 100 Foreign government debt securities 913 — — — 913 Residential MBS: Agency-issued MBS — 6,683 — — 6,683 Agency-issued CMO—fixed rate — 714 — — 714 Agency-issued CMBS — 1,456 — — 1,456 Total AFS securities 17,758 8,953 — — 26,711 Non-marketable and other equity securities (fair value accounting): Non-marketable securities: Venture capital and private equity fund investments measured at net asset value — — — — 270 Other equity securities in public companies 27 2 — — 29 Total non-marketable and other equity securities (fair value accounting) 27 2 — — 299 Other assets: Derivative assets — 804 — (495) 309 Equity warrant assets — 6 345 — 351 Contingent conversion rights — — 6 — 6 Other assets 4 — — — 4 Total assets $ 17,789 $ 9,765 $ 351 $ (495) $ 27,680 Liabilities: Derivative liabilities $ — $ 758 $ — $ (234) $ 524 Other liabilities 4 — — — 4 Total liabilities $ 4 $ 758 $ — $ (234) $ 528 (1) Amounts represent the impact of legally enforceable master netting arrangements and also cash collateral held or placed with the same counterparties The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2021: (Dollars in millions) Level 1 Level 2 Level 3 Netting Adjustments (1) (2) Balance at December 31, 2021 Assets: AFS securities: U.S. Treasury securities $ 15,850 $ — $ — $ — $ 15,850 U.S. agency debentures — 196 — — 196 Foreign government debt securities 61 — — — 61 Residential MBS: Agency-issued MBS — 8,589 — — 8,589 Agency-issued CMO—fixed rate — 982 — — 982 Agency-issued CMBS — 1,543 — — 1,543 Total AFS securities 15,911 11,310 — — 27,221 Non-marketable and other equity securities (fair value accounting): Non-marketable securities: Venture capital and private equity fund investments measured at net asset value — — — — 338 Other equity securities in public companies 43 74 — — 117 Total non-marketable and other equity securities (fair value accounting) 43 74 — — 455 Other assets: Derivative assets (2) — 288 — (137) 151 Equity warrant assets — 8 269 — 277 Other assets 8 — — — 8 Total assets $ 15,962 $ 11,680 $ 269 $ (137) $ 28,112 Liabilities: Derivative liabilities (2) $ — $ 238 $ — $ (120) $ 118 Other liabilities 8 — — — 8 Total liabilities $ 8 $ 238 $ — $ (120) $ 126 The following table presents additional information about Level 3 assets measured at fair value on a recurring basis for the three and nine months ended September 30, 2022 and 2021: (Dollars in millions) Beginning Balance Total Net Gains (Losses) Included in Net Income Sales/Exits Issuances Transfers Out of Level 3 Ending Balance Three months ended September 30, 2022 Equity warrant assets (1) $ 318 $ 39 $ (21) $ 9 $ — $ 345 Contingent conversion rights (2) 6 — — — — 6 Three months ended September 30, 2021 Equity warrant assets (1) 257 149 (146) 6 (1) 265 Nine months ended September 30, 2022 Equity warrant assets (1) 269 124 (67) 21 (2) 345 Contingent conversion rights (2) — (1) — 7 — 6 Nine months ended September 30, 2021 Equity warrant assets (1) 192 490 (431) 18 (4) 265 (1) Realized and unrealized gains (losses) are recorded in the line item “Gains on equity warrant assets, net," a component of noninterest income. (2) Unrealized gains and losses are recorded in the line item "Other noninterest income," a component of noninterest income. The following table presents the amount of net unrealized gains and losses included in earnings attributable to Level 3 assets still held at September 30, 2022 and 2021: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Other assets: Equity warrant assets (1) $ 26 $ 21 $ 84 $ 113 Contingent conversion rights (2) — — (1) — Total unrealized gains, net $ 26 $ 21 $ 83 $ 113 (1) Unrealized gains and losses are recorded in the line item “Gains on equity warrant assets, net, " a component of noninterest income. (2) Unrealized gains and losses are recorded in the line item "Other noninterest income," a component of noninterest income. The extent to which any unrealized gains or losses will become realized is subject to a variety of factors, including, among other things, the expiration of current sales restrictions to which these securities are subject, the actual sales of securities and the timing of such actual sales. The following table presents quantitative information about the significant unobservable inputs used for certain of our Level 3 fair value measurements at September 30, 2022 and December 31, 2021. We have not included in this table our venture capital and private equity fund investments (fair value accounting) as we use net asset value per share (as obtained from the general partners of the investments) as a practical expedient to determine fair value. (Dollars in millions) Fair value Valuation Technique Significant Unobservable Inputs Input Range Weighted September 30, 2022: Equity warrant assets (private portfolio) 345 Black-Scholes option pricing model Volatility 23.8 - 51.3 42.3 Risk-Free interest rate 3.3 - 4.4 4.2 Marketability discount (2) 17.1 17.1 Remaining life assumption (3) 40.0 40.0 Contingent conversion rights (private portfolio) 6 Private company equity pricing (4) (4) (4) December 31, 2021: Equity warrant assets (public portfolio) 2 Black-Scholes option pricing model Volatility 27.8% - 55.0% 43.7 % Risk-Free interest rate 0.6- 1.5 1.1 Sales restrictions discount (1) 10.0 - 20.0 10.7 Equity warrant assets (private portfolio) 267 Black-Scholes option pricing model Volatility 24.7 - 55.0 43.0 Risk-Free interest rate 0.06 - 1.40 0.8 Marketability discount (2) 20.1 20.1 Remaining life assumption (3) 40.0 40.0 (1) We adjust quoted market prices of public companies, which are subject to certain sales restrictions. Sales restriction discounts generally range from 10 percent to 20 percent depending on the duration of the sales restrictions, which typically range from three (2) Our marketability discount is applied to all private company warrants to account for a general lack of liquidity due to the private nature of the associated underlying company. The quantitative measure used is based upon various option-pricing models. On a quarterly basis, a sensitivity analysis is performed on our marketability discount. (3) We adjust the contractual remaining term of private company warrants based on our estimate of the actual remaining life, which we determine by utilizing historical data on terminations and exercises. At September 30, 2022, the weighted average contractual remaining term was 6.2 years, compared to our estimated remaining life of 2.5 years. On a quarterly basis, a sensitivity analysis is performed on our remaining life assumption. (4) In determining the fair value of our private contingent conversion rights portfolio (not valued using the Black-Scholes model), we evaluate a variety of factors related to each underlying private portfolio company including, but not limited to, actual and forecasted enterprise values, the probability of a conversion event occurring and limitations and conversion pricing outlined in the convertible debt agreement. Additionally, we have ongoing communication with the portfolio companies and relationship teams, to determine whether there is a material change in fair value. We use company provided valuation reports, if available, to support our valuation assumptions. These factors are specific to each portfolio company and a weighted average or range of values of the unobservable inputs is not meaningful. For the three and nine months ended September 30, 2022 and 2021, we did not have any transfers between Level 3 and Level 1. All transfers from Level 3 to Level 2 for the three and nine months ended September 30, 2022 and 2021 were due to the transfer of equity warrant assets from our private portfolio to our public portfolio (see our Level 3 reconciliation above). Financial Instruments not Carried at Fair Value FASB guidance over financial instruments requires that we disclose estimated fair values for our financial instruments not carried at fair value. The following fair value hierarchy table presents the estimated fair values of our financial instruments that are not carried at fair value at September 30, 2022 and December 31, 2021: Estimated Fair Value (Dollars in millions) Carrying Amount Total Level 1 Level 2 Level 3 September 30, 2022: Financial assets: Cash and cash equivalents $ 13,968 $ 13,968 $ 13,968 $ — $ — HTM securities 93,286 77,370 — 77,370 — Non-marketable securities not measured at net asset value 431 431 — — 431 Non-marketable securities measured at net asset value 660 660 — — — Net loans 71,572 72,489 — — 72,489 FHLB and Federal Reserve Bank stock 665 665 — — 665 Financial liabilities: Short-term borrowings 13,552 13,552 — 13,552 — Non-maturity deposits (1) 171,545 171,545 171,545 — — Time deposits 5,274 4,916 — 4,916 — 3.50% Senior Notes 349 336 — 336 — 3.125% Senior Notes 496 407 — 407 — 1.800% Senior Notes due 2031 495 358 — 358 — 2.100% Senior Notes due 2028 496 408 — 408 — 1.800% Senior Notes due 2026 646 559 — 559 — 4.345% Senior Notes due 2028 348 327 — 327 — 4.570% Senior Notes due 2033 447 396 — 396 — Junior subordinated debentures 91 91 — 91 — Off-balance sheet financial assets: Commitments to extend credit — 49 — — 49 December 31, 2021: Financial assets: Cash and cash equivalents $ 14,586 $ 14,586 $ 14,586 $ — $ — HTM securities 98,195 97,227 — 97,227 — Non-marketable securities not measured at net asset value 424 424 — — 424 Non-marketable securities measured at net asset value 710 710 — — — Net loans 65,854 67,335 — — 67,335 FHLB and Federal Reserve Bank stock 107 107 — — 107 Financial liabilities: Short-term borrowings 71 71 — 71 — Non-maturity deposits (1) 187,464 187,464 187,464 — — Time deposits 1,739 1,728 — 1,728 — 3.50% Senior Notes 349 370 — 370 — 3.125% Senior Notes 496 526 — 526 — 1.800% Senior Notes due 2031 494 474 — 474 — 2.100% Senior Notes due 2028 496 501 — 501 — 1.800% Senior Notes due 2026 645 649 — 649 — Junior subordinated debentures 90 92 — 92 — Off-balance sheet financial assets: Commitments to extend credit — 47 — — 47 (1) Includes noninterest-bearing demand deposits, interest-bearing checking accounts, money market accounts and interest-bearing sweep deposits. Investments in Entities that Calculate Net Asset Value Per Share FASB guidance over certain fund investments requires that we disclose the fair value of funds, significant investment strategies of the investees, redemption features of the investees, restrictions on the ability to sell investments, estimate of the period of time over which the underlying assets are expected to be liquidated by the investee and unfunded commitments related to the investments. Our investments in debt funds and venture capital and private equity fund investments generally cannot be redeemed. Alternatively, we expect distributions, if any, to be received primarily through IPO and M&A activity of the underlying assets of the fund. Subject to applicable requirements under the Volcker Rule, we do not have any plans to sell any of these fund investments. If we decide to sell these investments in the future, the investee fund’s management must approve of the buyer before the sale of the investments can be completed. The fair values of the fund investments have been estimated using the net asset value per share of the investments, adjusted for any differences between our measurement date and the date of the fund investment’s net asset value by using the most recently available financial information from the investee general partner, for example June 30 th for our September 30 th consolidated financial statements, adjusted for any contributions paid, distributions received from the investment, and significant fund transactions or market events during the reporting period. The following table is a summary of the estimated fair values of these investments and remaining unfunded commitments for each major category of these investments as of September 30, 2022: (Dollars in millions) Carrying Amount Fair Value Unfunded Commitments Non-marketable securities (fair value accounting): Venture capital and private equity fund investments (1) $ 270 $ 270 $ 13 Non-marketable securities (equity method accounting): Venture capital and private equity fund investments (2) 639 639 11 Debt funds (2) 4 4 — Other investments (2) 17 17 1 Total $ 930 $ 930 $ 25 (1) Venture capital and private equity fund investments within non-marketable securities (fair value accounting) include investments made by our managed funds of funds and one of our direct venture funds (consolidated VIEs) and investments in venture capital and private equity fund investments (unconsolidated VIEs). Collectively, these investments in venture capital and private equity funds are primarily in U.S. and global technology and life science/healthcare companies. Included in the fair value and unfunded commitments of fund investments under fair value accounting are $42 million and $2 million, respectively, attributable to noncontrolling interests. It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds and any potential extensions of terms of the funds. (2) Venture capital and private equity fund investments, debt funds, and other fund investments within non-marketable securities (equity method accounting) include funds that invest in or lend money to primarily U.S. and global technology and life science/healthcare companies. It is estimated that we will receive distributions from the funds over the next 5 to 8 years, depending on the age of the funds and any potential extensions of the terms of the funds.

Legal Matters

Legal Matters	9 Months Ended
Legal Matters	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Legal Matters	Legal Matters Certain lawsuits and claims arising in the ordinary course of business have been filed or are pending against us and/or our affiliates, and we may from time to time be involved in other legal or regulatory proceedings. In accordance with applicable accounting guidance, we establish accruals for all such matters, including expected settlements, when we believe it is probable that a loss has been incurred and the amount of the loss is reasonably estimable. When a loss contingency is not both probable and estimable, we do not establish an accrual. Any such loss estimates are inherently uncertain, based on currently available information and are subject to management’s judgment and various assumptions. Due to the inherent subjectivity of these estimates and unpredictability of outcomes of legal proceedings, any amounts accrued may not represent the ultimate resolution of such matters. To the extent we believe any potential loss relating to such matters may have a material impact on our liquidity, consolidated financial position, results of operations, and/or our business as a whole and is reasonably possible but not probable, we aim to disclose information relating to such potential loss. Assessments of litigation and claims exposure are difficult because they involve inherently unpredictable factors including, but not limited to, the following: whether the proceeding is in the early stages of litigation; whether damages are unspecified, unsupported, or uncertain; whether there is a potential for punitive or other pecuniary damages; whether the matter involves legal uncertainties, including novel issues of law; whether the matter involves multiple parties and/or jurisdictions; whether discovery has not begun or is not complete; whether meaningful settlement discussions have commenced; and whether the lawsuit involves class allegations. Assessments of class action litigation, which is generally more complex than other types of litigation, are particularly difficult, especially in the early stages of the proceeding when it is not known whether a class will be certified or how a potential class, if certified, will be defined. As a result, even if a loss is reasonably possible, the Company may be unable to estimate reasonably possible losses with respect to some matters. We also aim to disclose information relating to any material potential loss that is probable but not reasonably estimable. In such cases, where reasonably practicable, we aim to provide an estimate of loss or range of potential loss. No disclosures are generally made for any loss contingencies that are deemed to be remote. Silicon Valley Bank is among the lenders named as defendants in a complaint originally filed on September 27, 2016 by Unicom Systems, Inc. (“Unicom”) in Los Angeles County Superior Court. The lawsuit alleges breach of the syndicated 2015 Credit Agreement between Unicom and the defendants, breach of the implied covenant of good faith and fair dealing, and seeks monetary damages and declaratory relief. Pursuant to the Credit Agreement and California law, the matter has been referred to a duly appointed judicial referee for trial. The parties have engaged in extensive fact discovery which we currently expect to be concluded in November 2022, with expert witness depositions to follow. Trial is currently scheduled to take place over a three week period in late March 2023. The Company currently estimates that it is reasonably possible that it may experience a loss in relation to the Unicom matter. However, for various reasons including the current stage of discovery proceedings, the uncertainty regarding damage claims and certain of the other factors noted above, the Company is unable to estimate the reasonably possible loss or range of losses at this time. Based upon information available to us, our review of lawsuits and claims filed or pending against us to date and consultation with our outside legal counsel, we have not recognized a material accrual liability for any such matters, nor do we currently expect that these matters will result in a material liability to the Company. However, the outcome of litigation and other legal and regulatory matters is inherently uncertain, and it is possible that one or more of such matters currently pending or threatened could have an unanticipated material adverse effect on our liquidity, consolidated financial position, results of operations, and/or our business as a whole, in the future.

Related Parties

Related Parties	9 Months Ended
Related Parties	Sep. 30, 2022
Related Party Transactions [Abstract]
Related Parties	Related PartiesWe have no material related party transactions requiring disclosure. In the ordinary course of business, the Bank may extend credit to related parties, including executive officers, directors, principal shareholders and their related interests. Additionally, we provide real estate secured loans to eligible employees through our EHOP. For additional details, see Note 19 — “Employee Compensation and Benefit Plans" under Part II, Item 8 of our 2021 Form 10-K.

Basis of Presentation (Policies

Basis of Presentation (Policies)	9 Months Ended
Basis of Presentation (Policies)	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	SVB Financial Group is a diversified financial services company, as well as a bank holding company and a financial holding company. SVB Financial was incorporated in the state of Delaware in March 1999. Through our various subsidiaries and divisions, we offer a diverse set of banking and financial products and services to support our clients of all sizes and stages throughout their life cycles. In these notes to our unaudited interim consolidated financial statements, when we refer to “SVB,” “SVB Financial Group,” “SVBFG," the “Company,” “we,” “our,” “us” or use similar words, we mean SVB Financial Group and all of its subsidiaries collectively, including Silicon Valley Bank (the “Bank”), unless the context requires otherwise. When we refer to “SVB Financial” or the “Parent” we are referring only to the parent company, SVB Financial Group (not including subsidiaries).The accompanying unaudited interim consolidated financial statements reflect all adjustments of a normal and recurring nature that are, in the opinion of management, necessary to fairly present our financial position, results of operations and cash flows in accordance with GAAP. Such unaudited interim consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q pursuant to the rules and regulations of the SEC. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of results to be expected for any future periods. These unaudited interim consolidated financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2021 (“2021 Form 10-K”).
Use of Estimates	The preparation of unaudited interim consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates may change as new information is obtained. Among the more significant estimates are those that relate to: 1) ACL for loans and for unfunded credit commitments, 2) valuation of non-marketable and other equity securities, 3) valuation of equity warrant assets, 4) goodwill, intangible assets and other purchase accounting related adjustments, and 5) income taxes.
Principles of Consolidation and Presentation	Our unaudited interim consolidated financial statements include the accounts of SVB Financial Group and consolidated entities. All significant intercompany accounts and transactions with consolidated entities have been eliminated. For a further description of our accounting policies regarding consolidation refer to Consolidated Financial Statements and Supplementary Data
Reclassifications	Certain prior period amounts have been reclassified to conform to current period presentation to account for the change in presentation of derivative asset and liability positions and the related cash collateral disclosed in the Summary of Significant Accounting Polices in Part 1, Item 1 of this report. These changes are included in our Consolidated Balance Sheets (unaudited) and Consolidated Statements of Cash Flows (unaudited) as well as the Cash and Cash Equivalents, Derivative Financial Instruments and Fair Value of Financial Instruments footnotes.
Derivatives, Offsetting Fair Value	During the third quarter of 2022, we changed our presentation of derivative asset and liability positions and the related cash collateral in the unaudited interim consolidated balance sheets. The balances are presented net by counterparty when a legally enforceable right of setoff exists under a master netting arrangement in accordance with ASC 815, Derivatives and Hedging . Previously, fair values of derivative positions were reported in the line items “Accrued interest receivable and other assets” and “Other liabilities” gross. The related cash collateral was reported in the line items "Cash and cash equivalents" and "Short-term borrowings". For impact on presentation, please refer to the balance sheet offsetting section of Note 8 – “Derivative Financial Instruments”. This change had no impact on our net income. We concluded that this presentation was preferable as it better reflects the credit risk of derivatives traded under master netting arrangements. This change represents a change in accounting principle under ASC 250, Accounting Changes and Error Corrections
Loans and Leases Receivable, Allowance for Loan Losses	In the third quarter of 2022, we also adjusted the allowance models for the CRE and Other C&I loan portfolios to more precisely forecast lifetime loan losses for those portfolios. As a result, the allowance model for the CRE loan portfolio uses a reasonable and supportable forecast period that is less than, but approximately, three years; the Company continues to use a three-year reasonable and supportable forecast period for all other loan loss models. Subsequent to the forecast period period, the CRE and Other C&I models' reversion to average historical losses uses an approach that gradually trends towards the mean historical loss over the remaining contractual lives of loans, whereas all other loan models continue to use an autoregressive approach. The impact on overall reserves as a result of these changes was not material. This change represents a change in accounting estimate under ASC 250, Accounting Changes and Error Corrections , with prospective application.

Stockholders' Equity and EPS (T

Stockholders' Equity and EPS (Tables)	9 Months Ended
Stockholders' Equity and EPS (Tables)	Sep. 30, 2022
Equity and Earnings Per Share [Abstract]
Reclassification out of Accumulated Other Comprehensive Income	The following table summarizes the items reclassified out of AOCI into the Consolidated Statements of Income (unaudited) for the three and nine months ended September 30, 2022 and 2021: Three months ended September 30, Nine months ended September 30, (Dollars in millions) Income Statement Location 2022 2021 2022 2021 Reclassification adjustment for losses (gains) included in net income Gains (losses) on investment securities, net $ — $ — $ (48) $ — Related tax expense Income tax expense — — 14 — Reclassification adjustment for gains on cash flow hedges included in net income Net interest income (14) (16) (43) (47) Related tax expense Income tax expense 4 4 12 13 Total reclassification adjustment for gains included in net income, net of tax $ (10) $ (12) $ (65) $ (34)
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)	The table below summarizes the activity relating to net gains and losses on our cash flow hedges included in AOCI for the three and nine months ended September 30, 2022 and 2021. Over the next 12 months, we expect that approximately $46 million in AOCI at September 30, 2022, related to unrealized gains will be reclassified out of AOCI and recognized in net income. Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Balance, beginning of period, net of tax $ 62 $ 107 $ 83 $ 129 Net realized (gain) loss reclassified to net income, net of tax (10) (12) (31) (34) Balance, end of period, net of tax $ 52 $ 95 $ 52 $ 95
Reconciliation of Basic EPS to Diluted EPS	The following is a reconciliation of basic EPS to diluted EPS for the three and nine months ended September 30, 2022 and 2021: Three months ended September 30, Nine months ended September 30, (Dollars in millions except per share amounts, shares in thousands) 2022 2021 2022 2021 Numerator: Net income available to common stockholders $ 429 $ 365 $ 1,234 $ 1,399 Denominator: Weighted average common shares outstanding—basic 59,096 57,723 58,945 54,772 Weighted average effect of dilutive securities: Stock options and ESPP 165 268 206 278 Restricted stock units and awards 288 530 384 567 Weighted average common shares outstanding—diluted 59,549 58,521 59,535 55,617 Earnings per common share: Basic $ 7.26 $ 6.33 $ 20.94 $ 25.54 Diluted 7.21 6.24 20.73 25.16
Schedule of Antidilutive Securities Excluded from Computation of Earnings per Share	The following table summarizes the weighted-average common shares excluded from the diluted EPS calculation due to the antidilutive effect for the three and nine months ended September 30, 2022 and 2021: Three months ended September 30, Nine months ended September 30, (Shares in thousands) 2022 2021 2022 2021 Stock options 142 56 105 31 Restricted stock units 477 — 99 — Total 619 56 204 31
Schedule of Stock by Class	The following table summarizes our preferred stock at September 30, 2022: Series Description Amount outstanding (in millions) Carrying value Shares issued and outstanding Par Value Ownership interest per depositary share Liquidation preference per depositary share 2022 dividends paid per depositary share Series A 5.25% Fixed-Rate Non-Cumulative Perpetual Preferred Stock $ 350 $ 340 350,000 $ 0.001 1/40 th $ 25 $ 0.984375 Series B 4.100% Fixed-Rate Non-Cumulative Perpetual Preferred Stock 750 739 7,500 0.001 1/100 th 1,000 30.75 Series C 4.000% Fixed-Rate Non-Cumulative Perpetual Preferred Stock 1,000 985 10,000 0.001 1/100 th 1,000 30.00 Series D 4.250% Fixed-Rate Non-Cumulative Perpetual Preferred Stock 1,000 989 10,000 0.001 1/100 th 1,000 33.88 Series E 4.700% Fixed-Rate Non-Cumulative Perpetual Preferred Stock 600 593 6,000 0.001 1/100 th 1,000 37.47
Schedule of Stockholders Equity	The following table summarizes the changes in our consolidated equity for the three months ended September 30, 2022 and 2021: Preferred Common Stock Additional Retained Accumulated Total SVBFG Noncontrolling Interests Total (Dollars in millions, except share data) Shares Amount Balance at June 30, 2021 $ 2,064 54,530,307 $ — $ 2,755 $ 6,706 $ 142 $ 11,667 $ 300 $ 11,967 Common stock issued under employee benefit plans and ESOP, net of restricted stock cancellations — 32,195 — 2 — — 2 — 2 Issuance of Common Stock — 2,227,000 — 1,245 — — 1,245 — 1,245 Issuance of common stock for the acquisition of Boston Private — 1,887,981 — 1,060 1,060 1,060 Net income — — — — 387 — 387 88 475 Capital calls and distributions, net — — — — — — — (19) (19) Other comprehensive income (loss), net of tax — — — — — (77) (77) — (77) Share-based compensation, net — — — 38 — — 38 — 38 Dividends on preferred stock — — — — (22) — (22) — (22) Balance at September 30, 2021 $ 2,064 58,677,483 $ — $ 5,100 $ 7,071 $ 65 $ 14,300 $ 369 $ 14,669 Balance at June 30, 2022 $ 3,646 59,081,326 $ — $ 5,223 $ 8,247 $ (1,198) $ 15,918 $ 358 $ 16,276 Common stock issued under employee benefit plans and ESOP, net of restricted stock cancellations — 22,798 — (2) — — (2) — (2) Net income — — — — 469 — 469 (51) 418 Capital calls and distributions, net — — — — — — — (6) (6) Other comprehensive income (loss), net of tax — — — — — (887) (887) — (887) Share-based compensation, net — — — 51 — — 51 — 51 Dividends on preferred stock — — — — (40) — (40) — (40) Balance at September 30, 2022 $ 3,646 59,104,124 $ — $ 5,272 $ 8,676 $ (2,085) $ 15,509 $ 301 $ 15,810

Variable Interest Entities (Tab

Variable Interest Entities (Tables)	9 Months Ended
Variable Interest Entities (Tables)	Sep. 30, 2022
Investments In Variable Interest Entities [Abstract]
Schedule of Variable Interest Entities	The following table presents the carrying amounts and classification of variable interests in consolidated and unconsolidated VIEs as of September 30, 2022 and December 31, 2021: (Dollars in millions) Consolidated VIEs Unconsolidated VIEs Maximum Exposure to Loss in Unconsolidated VIEs September 30, 2022: Assets: Cash and cash equivalents $ 7 $ — $ — Non-marketable and other equity securities (1) 767 1,369 1,369 Accrued interest receivable and other assets (2) 35 6 — Total assets $ 809 $ 1,375 $ 1,369 Liabilities: Other liabilities (1) $ 23 $ 672 $ — Long term debt (2) — 91 — Total liabilities $ 23 $ 763 $ — December 31, 2021: Assets: Cash and cash equivalents $ 13 $ — $ — Non-marketable and other equity securities (1) 768 1,233 1,233 Accrued interest receivable and other assets (2) 31 6 — Total assets $ 812 $ 1,239 $ 1,233 Liabilities: Other liabilities (1) $ 18 $ 482 $ — Long term debt (2) — 90 — Total liabilities $ 18 $ 572 $ — (1) Included in our unconsolidated non-marketable and other equity securities portfolio at September 30, 2022 and December 31, 2021 are investments in qualified affordable housing projects of $1.2 billion and $954 million, respectively, and related other liabilities consisting of unfunded commitments of $672 million and $482 million, respectively. (2) Included in our unconsolidated accrued interest receivable and other assets are investments in statutory trusts for junior subordinated debt and included in long term debt previously issued by Boston Private and assumed in the acquisition of $6 million and $91 million at September 30, 2022 and $6 million and $90 million at December 31, 2021.

Cash and Cash Equivalents (Tabl

Cash and Cash Equivalents (Tables)	9 Months Ended
Cash and Cash Equivalents (Tables)	Sep. 30, 2022
Cash and Cash Equivalents [Abstract]
Schedule of Cash and Cash Equivalents	The following table details our cash and cash equivalents at September 30, 2022 and December 31, 2021: (Dollars in millions) September 30, 2022 December 31, 2021 Cash and due from banks $ 1,411 $ 2,168 Interest bearing deposits with the Federal Reserve Bank 7,550 5,686 Interest bearing deposits with other institutions 4,610 5,773 Securities purchased under agreements to resell (1) 397 607 Other short-term investment securities — 352 Total cash and cash equivalents $ 13,968 $ 14,586 (1) At September 30, 2022 and December 31, 2021, securities purchased und er agreements to resell were collateralized by U.S. Treasury securities and U.S. agency securities with aggregate fair value s of $402 million a n d $620 million, respectively. None of these securities were sold or repledged as of September 30, 2022 and December 31, 2021.

Investment Securities (Tables)

Investment Securities (Tables)	9 Months Ended
Investment Securities (Tables)	Sep. 30, 2022
Investments, Debt and Equity Securities [Abstract]
Debt Securities, Available-for-sale	The major components of our AFS investment securities portfolio at September 30, 2022 and December 31, 2021 are as follows: September 30, 2022 (Dollars in millions) Amortized Unrealized Unrealized Carrying AFS securities, at fair value: U.S. Treasury securities $ 18,041 $ — $ (1,196) $ 16,845 U.S. agency debentures 120 — (20) 100 Foreign government debt securities 1,062 — (149) 913 Residential MBS: Agency-issued MBS 7,883 — (1,200) 6,683 Agency-issued CMO—fixed rate 792 — (78) 714 Agency-issued CMBS 1,604 — (148) 1,456 Total AFS securities $ 29,502 $ — $ (2,791) $ 26,711 December 31, 2021 (Dollars in millions) Amortized Unrealized Unrealized Carrying AFS securities, at fair value: U.S. Treasury securities $ 15,799 $ 121 $ (70) $ 15,850 U.S. agency debentures 200 — (4) 196 Foreign government debt securities 61 — — 61 Residential MBS: Agency-issued MBS 8,786 13 (210) 8,589 Agency-issued CMO—fixed rate 988 3 (9) 982 Agency-issued CMBS 1,536 27 (20) 1,543 Total AFS securities $ 27,370 $ 164 $ (313) $ 27,221
Activity of Available-for-Sale Securities	The following table summarizes sale activity of AFS securities during the three and nine months ended September 30, 2022 and 2021 as recorded in the line item “Gains on investment securities, net," a component of noninterest income: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Sales proceeds $ — $ 168 $ 8,511 $ 168 Net realized gains and losses: Gross realized gains — — 146 — Gross realized losses — — (98) — Net realized gains (losses) $ — $ — $ 48 $ —
Summary of Unrealized Losses on Available for Sale Securities	The following tables summarize our AFS securities in an unrealized loss position for which an ACL has not been recorded and summarized into categories of AFS securities that were in an unrealized loss for position for less than 12 months, or 12 months or longer, as of September 30, 2022 and December 31, 2021: September 30, 2022 Less than 12 months 12 months or longer Total (Dollars in millions) Fair Value of Unrealized Fair Value of Unrealized Fair Value of Unrealized AFS securities: U.S. Treasury securities $ 13,359 $ (958) $ 3,487 $ (238) $ 16,846 $ (1,196) U.S. agency debentures 20 (1) 80 (19) 100 (20) Foreign government debt securities 913 (149) — — 913 (149) Residential MBS: Agency-issued MBS 2,236 (304) 4,448 (896) 6,684 (1,200) Agency-issued CMO —fixed rate 534 (55) 168 (23) 702 (78) Agency-issued CMBS 806 (59) 649 (89) 1,455 (148) Total AFS securities (1) $ 17,868 $ (1,526) $ 8,832 $ (1,265) $ 26,700 $ (2,791) (1) As of September 30, 2022, we identified a total of 804 investments that were in unrealized loss positions with 289 investments in an unrealized loss position for a period of time greater than 12 months. Based on our analysis of the securities in an unrealized loss position as of September 30, 2022, the decline in value is unrelated to credit loss and is related to changes in market interest rates since purchase, and therefore, changes in value for securities are included in other comprehensive income. Market valuations and credit loss analyses on assets in the AFS securities portfolio are reviewed and monitored on a quarterly basis. As of September 30, 2022, we do not intend to sell any of our securities in an unrealized loss position prior to recovery of our amortized cost basis, and it is more likely than not that we will not be required to sell any of our securities prior to recovery of our amortized cost basis. None of the investments in our AFS securities portfolio were past due as of September 30, 2022. December 31, 2021 Less than 12 months 12 months or longer Total (Dollars in millions) Fair Value of Unrealized Fair Value of Unrealized Fair Value of Unrealized AFS securities: U.S. Treasury securities $ 7,777 $ (70) $ — $ — $ 7,777 $ (70) U.S. agency debentures 196 (4) — — 196 (4) Residential MBS: Agency-issued MBS 8,280 (210) — — 8,280 (210) Agency-issued CMO—fixed rate 740 (9) — — 740 (9) Agency-issued CMBS 603 (11) 163 (9) 766 (20) Total AFS securities (1) $ 17,596 $ (304) $ 163 $ (9) $ 17,759 $ (313) (1) As of December 31, 2021, we identified a total of 475 investments that were in unrealized loss positions, of which 4 investments are in an unrealized loss position for a period of time greater than 12 months. None of the investments in our AFS securities portfolio were past due as of December 31, 2021.
Summary of Remaining Contractual Principal Maturities and Fully Taxable Equivalent Yields on Securities	The following table summarizes the fixed income securities, carried at fair value, classified as AFS as of September 30, 2022 by the remaining contractual principal maturities. For U.S. Treasury securities, U.S. agency debentures and foreign government debt securities, the expected maturity is the actual contractual maturity of the notes. Expected maturities for MBS may differ significantly from their contractual maturities because mortgage borrowers have the right to prepay outstanding loan obligations with or without penalties. MBS classified as AFS typically have original contractual maturities from 10 to 30 years, whereas expected average lives of these securities tend to be significantly shorter and vary based upon structure and prepayments in lower interest rate environments. September 30, 2022 (Dollars in millions) Total One Year After One After Five After U.S. Treasury securities $ 16,845 $ 936 $ 15,133 $ 776 $ — U.S. agency debentures 100 — 34 66 — Foreign government debt securities 913 41 46 826 — Residential MBS: Agency-issued MBS 6,683 — — 45 6,638 Agency-issued CMO—fixed rate 714 — — — 714 Agency-issued CMBS 1,456 — 100 1,356 — Total $ 26,711 $ 977 $ 15,313 $ 3,069 $ 7,352 September 30, 2022 Total One Year After One Year to After Five Years to After (Dollars in millions) Net Carry Value Fair Value Net Carry Value Fair Value Net Carry Value Fair Value Net Carry Value Fair Value Net Carry Value Fair Value U.S. agency debentures $ 486 $ 433 $ 1 $ 1 $ 118 $ 111 $ 367 $ 321 $ — $ — Residential MBS: Agency-issued MBS 59,200 49,183 1 1 2 2 1,148 1,063 58,049 48,117 Agency-issued CMO—fixed rate 10,741 8,928 — — 87 83 154 146 10,500 8,699 Agency-issued CMO—variable rate 83 82 — — — — — — 83 82 Agency-issued CMBS 14,644 12,340 45 44 159 146 968 802 13,472 11,348 Municipal bonds and notes 7,428 5,817 25 25 235 222 1,265 1,114 5,903 4,456 Corporate bonds 704 587 — — 115 102 589 485 — — Total $ 93,286 $ 77,370 $ 72 $ 71 $ 716 $ 666 $ 4,491 $ 3,931 $ 88,007 $ 72,702
Held-to-maturity Securities	The components of our HTM investment securities portfolio at September 30, 2022 and December 31, 2021 are as follows: September 30, 2022 (Dollars in millions) Amortized Unrealized Unrealized Fair Value ACL HTM securities, at cost: U.S. agency debentures (1) $ 486 $ — $ (53) $ 433 $ — Residential MBS: Agency-issued MBS 59,200 — (10,017) 49,183 — Agency-issued CMO—fixed rate 10,741 — (1,813) 8,928 — Agency-issued CMO—variable rate 83 — (1) 82 — Agency-issued CMBS 14,644 — (2,304) 12,340 — Municipal bonds and notes 7,429 — (1,612) 5,817 1 Corporate bonds 709 — (122) 587 5 Total HTM securities $ 93,292 $ — $ (15,922) $ 77,370 $ 6 (1) Consists of pools of Small Business Investment Company debentures issued and guaranteed by the U.S. Small Business Administration, an independent agency of the United States. December 31, 2021 (Dollars in millions) Amortized Unrealized Unrealized Fair Value ACL HTM securities, at amortized cost: U.S. agency debentures (1) $ 609 $ 8 $ (2) $ 615 $ — Residential MBS: Agency-issued MBS 64,439 124 (887) 63,676 — Agency-issued CMO—fixed rate 10,226 9 (145) 10,090 — Agency-issued CMO—variable rate 100 1 — 101 — Agency-issued CMBS 14,959 39 (277) 14,721 — Municipal bonds and notes 7,157 185 (27) 7,315 1 Corporate bonds 712 2 (5) 709 6 Total HTM securities $ 98,202 $ 368 $ (1,343) $ 97,227 $ 7 (1) Consists of pools of Small Business Investment Company debentures issued and guaranteed by the U.S. Small Business Administration, an independent agency of the United States.
Debt Securities, Held-to-maturity, Credit Quality Indicator	On a quarterly basis, management monitors the credit quality for HTM securities through the use of standard credit ratings. The following table summarizes our amortized cost of HTM securities aggregated by credit quality indicator at September 30, 2022 and December 31, 2021: (Dollars in millions) September 30, 2022 December 31, 2021 Municipal bonds and notes: Aaa $ 4,270 $ 3,774 Aa1 1,880 2,031 Aa2 1,081 1,154 Aa3 171 172 A1 27 26 Total municipal bonds and notes $ 7,429 $ 7,157 Corporate bonds: Aaa $ 39 $ 39 Aa2 42 42 Aa3 105 105 A1 282 251 A2 230 264 A3 11 11 Total corporate bonds $ 709 $ 712
Schedule of Nonmarketable and Other Securities	The major components of our non-marketable and other equity securities portfolio at September 30, 2022 and December 31, 2021 are as follows: (Dollars in millions) September 30, 2022 December 31, 2021 Non-marketable and other equity securities: Non-marketable securities (fair value accounting): Consolidated venture capital and private equity fund investments (1) $ 147 $ 130 Unconsolidated venture capital and private equity fund investments (2) 123 208 Other investments without a readily determinable fair value (3) 176 164 Other equity securities in public companies (fair value accounting) (4) 29 117 Non-marketable securities (equity method accounting) (5): Venture capital and private equity fund investments 639 671 Debt funds 4 5 Other investments 272 294 Investments in qualified affordable housing projects, net (6) 1,205 954 Total non-marketable and other equity securities $ 2,595 $ 2,543 (1) The following table shows the amounts of venture capital and private equity fund investments held by the following consolidated funds and our ownership percentage of each fund at September 30, 2022 and December 31, 2021 (fair value accounting): September 30, 2022 December 31, 2021 (Dollars in millions) Amount Ownership % Amount Ownership % Strategic Investors Fund, LP $ 2 12.6 % $ 2 12.6 % Capital Preferred Return Fund, LP 30 20.0 61 20.0 Growth Partners, LP 25 33.0 67 33.0 Redwood Evergreen Fund, LP 90 100.0 — — Total consolidated venture capital and private equity fund investments $ 147 $ 130 (2) The carrying value represents investments in 141 and 150 funds (primarily venture capital funds) at September 30, 2022 and December 31, 2021, respectively, where our ownership interest is typically less than 5% of the voting interests of each such fund and in which we do not have the ability to exercise significant influence over the partnerships operating activities and financial policies. We carry our unconsolidated venture capital and private equity fund investments at fair value based on the fund investments' net asset values per share as obtained from the general partners of the investments. For each fund investment, we adjust the net asset value per share for differences between our measurement date and the date of the fund investment’s net asset value by using the most recently available financial information from the investee general partner, for example June 30 th for our September 30 th consolidated financial statements, adjusted for any contributions paid, distributions received from the investment, and significant fund transactions or market events during the reporting period. (3) These investments include direct equity investments in private companies. The carrying value is based on the price at which the investment was acquired plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments. We consider a range of factors when adjusting the fair value of these investments, including, but not limited to, the term and nature of the investment, local market conditions, values for comparable securities, current and projected operating performance, exit strategies, financing transactions subsequent to the acquisition of the investment, and a discount for certain investments that have lock-up restrictions or other features that indicate a discount to fair value is warranted. The following table shows the changes to the carrying amount of other investments without a readily determinable fair value for the nine months ended September 30, 2022: (Dollars in millions) Nine months ended September 30, 2022 Cumulative Adjustments Measurement alternative: Carrying value at September 30, 2022 $ 176 Carrying value adjustments: Impairment $ — $ (1) Upward changes for observable prices — 52 Downward changes for observable prices (6) (11) (4) Investments classified as other equity securities (fair value accounting) represent shares held in public companies as a result of exercising public equity warrant assets and direct equity investments in public companies held by our consolidated funds. Changes in equity securities measured at fair value are recognized through net income. (5) The following table shows the carrying value and our ownership percentage of each investment at September 30, 2022 and December 31, 2021 (equity method accounting): September 30, 2022 December 31, 2021 (Dollars in millions) Amount Ownership % Amount Ownership % Venture capital and private equity fund investments: Strategic Investors Fund II, LP $ 2 8.6 % $ 3 8.6 % Strategic Investors Fund III, LP 13 5.9 25 5.9 Strategic Investors Fund IV, LP 23 5.0 36 5.0 Strategic Investors Fund V funds 59 Various 87 Various CP II, LP (i) 2 5.1 2 5.1 Other venture capital and private equity fund investments 540 Various 518 Various Total venture capital and private equity fund investments $ 639 $ 671 Debt funds: Gold Hill Capital 2008, LP (ii) $ 3 15.5 % $ 4 15.5 % Other debt funds 1 Various 1 Various Total debt funds $ 4 $ 5 Other investments: SPD Silicon Valley Bank Co., Ltd. $ 143 50.0 % $ 154 50.0 % Other investments 129 Various 140 Various Total other investments $ 272 $ 294 (i) Our ownership includes direct ownership interest of 1.3 percent and indirect ownership interest of 3.8 percent through our investments in Strategic Investors Fund II, LP. (ii) Our ownership includes direct ownership interest of 11.5 percent and an indirect interest in the fund through our investment in Gold Hill Capital 2008, LLC of 4.0 percent. (6) The following table presents the balances of our investments in qualified affordable housing projects and related unfunded commitments included as a component of “Other liabilities” on our consolidated balance sheets at September 30, 2022 and December 31, 2021: (Dollars in millions) September 30, 2022 December 31, 2021 Investments in qualified affordable housing projects, net $ 1,205 $ 954 Other liabilities 672 482 The following table presents other information relating to our investments in qualified affordable housing projects for the three and nine months ended September 30, 2022 and 2021: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Tax credits and other tax benefits recognized $ 30 $ 9 $ 80 $ 63 Amortization expense included in provision for income taxes (i) 17 17 52 48 (i) All investments are amortized using the proportional amortization method, and amortization expense is included in the provision for income taxes.
Gain Loss On Investment Securities	The following table presents the net gains and losses on non-marketable and other equity securities for the three and nine months ended September 30, 2022 and 2021 as recorded in the line item “Gains on investment securities, net," a component of noninterest income: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Net (losses) gains on non-marketable and other equity securities: Non-marketable securities (fair value accounting): Consolidated venture capital and private equity fund investments $ (52) $ 36 $ (100) $ 72 Unconsolidated venture capital and private equity fund investments (61) 47 (80) 79 Other investments without a readily determinable fair value — (2) (3) 11 Other equity securities in public companies (fair value accounting) (8) (39) (52) 53 Non-marketable securities (equity method accounting): Venture capital and private equity fund investments (12) 144 (20) 438 Debt funds (1) — (1) 2 Other investments 7 3 9 6 Total net (losses) gains on non-marketable and other equity securities $ (127) $ 189 $ (247) $ 661 Less: realized net gains (losses) on sales of non-marketable and other equity securities 13 (17) (16) 110 Net (losses) gains on non-marketable and other equity securities still held $ (140) $ 206 $ (231) $ 551

Loans and Allowance for Credi_2

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments (Tables)	9 Months Ended
	Sep. 30, 2022
Receivables [Abstract]
Loans and Allowance for Loan Losses	The composition of loans at amortized cost basis broken out by class of financing receivable at September 30, 2022 and December 31, 2021 is presented in the following table: (Dollars in millions) September 30, 2022 December 31, 2021 Global fund banking $ 40,337 $ 37,958 Investor dependent: Early stage 1,911 1,593 Growth stage 4,398 3,951 Total investor dependent 6,309 5,544 Cash flow dependent - SLBO 1,845 1,798 Innovation C&I 8,321 6,673 Private bank 10,102 8,743 CRE 2,609 2,670 Premium wine 1,117 985 Other C&I 1,087 1,257 Other 374 317 PPP 28 331 Total loans (1) (2) (3) $ 72,129 $ 66,276 ACL (557) (422) Net loans $ 71,572 $ 65,854 (1) Total loans at amortized cost is net of unearned income, deferred fees and costs, and net unamortized premiums and discounts of $244 million and $250 million at September 30, 2022 and December 31, 2021, respectively. (2) Included within our total loan portfolio are credit card loans of $582 million and $583 million at September 30, 2022 and December 31, 2021, respectively. (3) Included within our total loan portfolio are construction loans of $454 million and $367 million at September 30, 2022 and December 31, 2021, respectively.
Credit Quality Indicators, Broken out by Portfolio Segment and Class of Financing Receivables	The following tables summarize the credit quality indicators, broken out by class of financing receivable and vintage year, as of September 30, 2022 and December 31, 2021: Term Loans by Origination Year September 30, 2022 (Dollars in millions) 2022 2021 2020 2019 2018 Prior Revolving Loans Revolving Loans Converted to Term Loans Unallocated (1) Total Global fund banking: Risk rating: Pass $ 512 $ 95 $ 63 $ 31 $ 1 $ 10 $ 39,616 $ — $ — $ 40,328 Criticized — — — — — — 9 — — 9 Nonperforming — — — — — — — — — — Total global fund banking $ 512 $ 95 $ 63 $ 31 $ 1 $ 10 $ 39,625 $ — $ — $ 40,337 Investor dependent: Early stage: Risk rating: Pass $ 727 $ 626 $ 73 $ 36 $ 2 $ 1 $ 191 $ — $ — $ 1,656 Criticized 67 122 27 7 — 2 26 — — 251 Nonperforming 1 1 — — — — 2 — — 4 Total early stage $ 795 $ 749 $ 100 $ 43 $ 2 $ 3 $ 219 $ — $ — $ 1,911 Term Loans by Origination Year September 30, 2022 (Dollars in millions) 2022 2021 2020 2019 2018 Prior Revolving Loans Revolving Loans Converted to Term Loans Unallocated (1) Total Growth stage: Risk rating: Pass $ 1,684 $ 1,456 $ 360 $ 72 $ 28 $ 6 $ 243 $ 5 $ — $ 3,854 Criticized 147 233 53 14 5 — 49 — — 501 Nonperforming 19 18 2 — — — 4 — — 43 Total growth stage $ 1,850 $ 1,707 $ 415 $ 86 $ 33 $ 6 $ 296 $ 5 $ — $ 4,398 Total investor dependent $ 2,645 $ 2,456 $ 515 $ 129 $ 35 $ 9 $ 515 $ 5 $ — $ 6,309 Cash flow dependent - SLBO: Risk rating: Pass $ 678 $ 609 $ 199 $ 203 $ 14 $ 39 $ 30 $ — $ — $ 1,772 Criticized 20 — 16 2 1 22 5 — — 66 Nonperforming — — — — 5 — 2 — — 7 Total cash flow dependent - SLBO $ 698 $ 609 $ 215 $ 205 $ 20 $ 61 $ 37 $ — $ — $ 1,845 Innovation C&I Risk rating: Pass $ 1,788 $ 1,734 $ 773 $ 166 $ 18 $ 54 $ 3,102 $ — $ — $ 7,635 Criticized 49 148 121 32 11 — 324 — — 685 Nonperforming — — — — — — 1 — — 1 Total innovation C&I $ 1,837 $ 1,882 $ 894 $ 198 $ 29 $ 54 $ 3,427 $ — $ — $ 8,321 Private bank: Risk rating: Pass $ 2,210 $ 2,817 $ 1,753 $ 948 $ 441 $ 1,054 $ 818 $ 5 $ — $ 10,046 Criticized — 16 — 2 — 15 10 — — 43 Nonperforming — — 1 2 1 8 1 — — 13 Total private bank $ 2,210 $ 2,833 $ 1,754 $ 952 $ 442 $ 1,077 $ 829 $ 5 $ — $ 10,102 CRE Risk rating: Pass $ 406 $ 292 $ 181 $ 240 $ 143 $ 894 $ 96 $ 5 $ — $ 2,257 Criticized 2 4 51 135 24 114 17 — — 347 Nonperforming — — — 5 — — — — — 5 Total CRE $ 408 $ 296 $ 232 $ 380 $ 167 $ 1,008 $ 113 $ 5 $ — $ 2,609 Premium wine: Risk rating: Pass $ 255 $ 213 $ 91 $ 137 $ 47 $ 144 $ 156 $ 34 $ — $ 1,077 Criticized 1 5 — 7 9 9 9 — — 40 Nonperforming — — — — — — — — — — Total premium wine $ 256 $ 218 $ 91 $ 144 $ 56 $ 153 $ 165 $ 34 $ — $ 1,117 Other C&I Risk rating: Pass $ 31 $ 149 $ 161 $ 70 $ 81 $ 304 $ 234 $ 10 $ — $ 1,040 Criticized 1 — 3 6 3 19 11 1 — 44 Nonperforming — — 1 — 1 1 — — — 3 Total other C&I $ 32 $ 149 $ 165 $ 76 $ 85 $ 324 $ 245 $ 11 $ — $ 1,087 Other: Risk rating: Pass $ 25 $ 151 $ 172 $ 30 $ — $ — $ 11 $ — $ (44) $ 345 Criticized — 3 17 9 — — — — — 29 Nonperforming — — — — — — — — — — Total other $ 25 $ 154 $ 189 $ 39 $ — $ — $ 11 $ — $ (44) $ 374 PPP: Risk rating: Pass $ — $ 16 $ 3 $ — $ — $ — $ — $ — $ — $ 19 Criticized — 3 6 — — — — — — 9 Nonperforming — — — — — — — — — — Total PPP $ — $ 19 $ 9 $ — $ — $ — $ — $ — $ — $ 28 Term Loans by Origination Year September 30, 2022 (Dollars in millions) 2022 2021 2020 2019 2018 Prior Revolving Loans Revolving Loans Converted to Term Loans Unallocated (1) Total Total loans $ 8,623 $ 8,711 $ 4,127 $ 2,154 $ 835 $ 2,696 $ 44,967 $ 60 $ (44) $ 72,129 (1) These amounts consist of fees and clearing items that have not yet been allocated at the loan level. Term Loans by Origination Year December 31, 2021 (Dollars in millions) 2021 2020 2019 2018 2017 Prior Revolving Loans Revolving Loans Converted to Term Loans Unallocated (1) Total Global fund banking: Risk rating: Pass $ 764 $ 115 $ 36 $ 6 $ 8 $ 4 $ 36,955 $ — $ — $ 37,888 Criticized 50 18 — — — 1 1 — — 70 Nonperforming — — — — — — — — — — Total global fund banking $ 814 $ 133 $ 36 $ 6 $ 8 $ 5 $ 36,956 $ — $ — $ 37,958 Investor dependent: Early stage: Risk rating: Pass $ 754 $ 287 $ 122 $ 26 $ 6 $ 1 $ 171 $ — $ — $ 1,367 Criticized 64 87 30 5 — — 29 — — 215 Nonperforming 2 5 3 — — — 1 — — 11 Total early stage $ 820 $ 379 $ 155 $ 31 $ 6 $ 1 $ 201 $ — $ — $ 1,593 Growth stage: Risk rating: Pass $ 2,072 $ 910 $ 265 $ 78 $ 14 $ 1 $ 286 $ 5 $ — $ 3,631 Criticized 159 85 27 6 3 — 34 — — 314 Nonperforming 2 — 1 2 — — 1 — — 6 Total growth stage $ 2,233 $ 995 $ 293 $ 86 $ 17 $ 1 $ 321 $ 5 $ — $ 3,951 Total investor dependent $ 3,053 $ 1,374 $ 448 $ 117 $ 23 $ 2 $ 522 $ 5 $ — $ 5,544 Cash flow dependent - SLBO: Risk rating: Pass $ 875 $ 384 $ 252 $ 72 $ 76 $ 2 $ 35 $ — $ — $ 1,696 Criticized — — 20 25 — 13 10 — — 68 Nonperforming — — 12 10 7 — 5 — — 34 Total cash flow dependent - SLBO $ 875 $ 384 $ 284 $ 107 $ 83 $ 15 $ 50 $ — $ — $ 1,798 Innovation C&I: Risk rating: Pass $ 2,230 $ 1,058 $ 288 $ 123 $ 58 $ — $ 2,411 $ — $ — $ 6,168 Criticized 64 130 62 12 — — 236 — — 504 Nonperforming — — — — — — 1 — — 1 Total Innovation C&I $ 2,294 $ 1,188 $ 350 $ 135 $ 58 $ — $ 2,648 $ — $ — $ 6,673 Private bank: Risk rating: Pass $ 2,952 $ 2,015 $ 1,122 $ 520 $ 432 $ 952 $ 705 $ 8 $ — $ 8,706 Criticized — — 2 — 2 9 3 — — 16 Nonperforming — — 2 9 — 8 2 — — 21 Total private bank $ 2,952 $ 2,015 $ 1,126 $ 529 $ 434 $ 969 $ 710 $ 8 $ — $ 8,743 CRE Risk rating: Pass $ 326 $ 215 $ 344 $ 155 $ 236 $ 868 $ 110 $ 2 $ — $ 2,256 Criticized 3 39 114 37 47 139 18 12 — 409 Nonperforming — — 5 — — — — — — 5 Total CRE $ 329 $ 254 $ 463 $ 192 $ 283 $ 1,007 $ 128 $ 14 $ — $ 2,670 Premium wine: Risk rating: Pass $ 217 $ 112 $ 156 $ 69 $ 71 $ 162 $ 125 $ 34 $ — $ 946 Criticized 1 7 11 9 — — 11 — — 39 Nonperforming — — — — — — — — — — Total Premium wine $ 218 $ 119 $ 167 $ 78 $ 71 $ 162 $ 136 $ 34 $ — $ 985 Other C&I Risk rating: Pass $ 181 $ 175 $ 82 $ 86 $ 28 $ 301 $ 350 $ 11 $ — $ 1,214 Criticized 5 6 6 7 2 — 8 5 — 39 Nonperforming — — — 2 — 1 1 — — 4 Total other C&I $ 186 $ 181 $ 88 $ 95 $ 30 $ 302 $ 359 $ 16 $ — $ 1,257 Other: Term Loans by Origination Year December 31, 2021 (Dollars in millions) 2021 2020 2019 2018 2017 Prior Revolving Loans Revolving Loans Converted to Term Loans Unallocated (1) Total Risk rating: Pass $ 61 $ 144 $ 82 $ 20 $ 14 $ — $ 7 $ — $ (21) $ 307 Criticized — 7 1 — 2 — — — — 10 Nonperforming — — — — — — — — — — Total other $ 61 $ 151 $ 83 $ 20 $ 16 $ — $ 7 $ — $ (21) $ 317 PPP: Risk rating: Pass $ 226 $ 72 $ — $ — $ — $ — $ — $ — $ — $ 298 Criticized 22 9 — — — — — — — 31 Nonperforming 2 — — — — — — — — 2 Total PPP $ 250 $ 81 $ — $ — $ — $ — $ — $ — $ — $ 331 Total loans $ 11,032 $ 5,880 $ 3,045 $ 1,279 $ 1,006 $ 2,462 $ 41,516 $ 77 $ (21) $ 66,276 (1) These amounts consist of fees and clearing items that have not yet been allocated at the loan level.
Activity in Allowance for Loan Losses Broken out by Portfolio Segment	The following tables summarize the activity relating to our ACL for loans for the three and nine months ended September 30, 2022 and 2021, broken out by portfolio segment: Three months ended September 30, 2022 Beginning Balance June 30, 2022 Charge-offs Recoveries Provision (Reduction) for Credit Loss for Loans Foreign Currency Translation Adjustments Ending Balance September 30, 2022 (Dollars in millions) Global fund banking $ 89 $ — $ 6 $ (4) $ — $ 91 Investor dependent 224 (20) 4 25 1 234 Cash flow dependent and innovation C&I 130 (5) — 11 — 136 Private bank 45 — — 2 — 47 CRE 34 — — (7) — 27 Other C&I 12 (1) 1 — — 12 Premium wine and other 11 — — 3 (4) 10 Total ACL $ 545 $ (26) $ 11 $ 30 $ (3) $ 557 Three months ended September 30, 2021 Beginning Balance June 30, 2021 Initial Charge-offs Recoveries Provision (Reduction) for Credit Loss for Loans Ending Balance September 30, 2021 (Dollars in millions) Global fund banking $ 66 $ — $ — $ — $ (7) $ 59 Investor dependent 158 — (17) 5 (8) 138 Cash flow dependent and innovation C&I 119 — (1) 3 (12) 109 Private bank 47 1 (1) — (16) 31 CRE — 17 — — 23 40 Other C&I — 4 — — 8 12 Premium wine and other 6 — — — 3 9 Total ACL $ 396 $ 22 $ (19) $ 8 $ (9) $ 398 Nine months ended September 30, 2022 Beginning Balance December 31, 2021 Charge-offs Recoveries Provision (Reduction) for Credit Loss for Loans Foreign Currency Translation Adjustments Ending Balance September 30, 2022 (Dollars in millions) Global fund banking $ 67 $ — $ 6 $ 18 $ — $ 91 Investor dependent 146 (53) 13 126 2 234 Cash flow dependent and innovation C&I 118 (9) — 27 — 136 Private Bank 33 — 2 12 — 47 CRE 36 — — (9) — 27 Other C&I 14 (3) 1 — — 12 Premium wine and other 8 (1) 1 10 (8) 10 Total ACL $ 422 $ (66) $ 23 $ 184 $ (6) $ 557 Nine months ended September 30, 2021 Beginning Balance December 31, 2020 Initial Allowance on PCD Loans Charge-offs Recoveries Provision (Reduction) for Credit Loss for Loans Ending Balance September 30, 2021 (Dollars in millions) Global fund banking $ 46 $ — $ (80) $ — $ 93 $ 59 Investor dependent 213 — (37) 13 (51) 138 Cash flow dependent and innovation C&I 125 — (8) 3 (11) 109 Private Bank 53 1 (3) — (20) 31 CRE — 17 — — 23 40 Other C&I — 4 — — 8 12 Premium wine and other 9 — (1) — 1 9 PPP 2 — — — (2) — Total ACL $ 448 $ 22 $ (129) $ 16 $ 41 $ 398 The following table summarizes the activity relating to our ACL for unfunded credit commitments for the three and nine months ended September 30, 2022 and 2021: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 ACL: unfunded credit commitments, beginning balance $ 224 $ 120 171 $ 121 Provision for (reduction in) credit losses 42 29 96 28 Foreign currency translation adjustments (1) — (2) — ACL: unfunded credit commitments, ending balance (1) $ 265 $ 149 $ 265 $ 149 (1) The “ACL: unfunded credit commitments” is included as a component of “other liabilities” on our unaudited interim consolidated balance sheets. See Note 11 — “Off-Balance Sheet Arrangements, Guarantees and Other Commitments” of this report for additional disclosures related to our commitments to extend credit.
Financing Receivable, Past Due	The following table summarizes the aging of our loans broken out by class of financing receivable as of September 30, 2022 and December 31, 2021: (Dollars in millions) 30 - 59 60 - 89 Equal to or Greater Total Past Current Total Loans Past Due September 30, 2022: Global fund banking $ — $ — $ — $ — $ 40,337 $ 40,337 $ — Investor dependent: Early stage 2 2 1 5 1,906 1,911 — Growth stage 26 13 2 41 4,357 4,398 — Total investor dependent 28 15 3 46 6,263 6,309 — Cash flow dependent - SLBO 4 — — 4 1,841 1,845 — Innovation C&I 6 3 — 9 8,312 8,321 — Private bank 1 12 5 18 10,084 10,102 1 CRE 1 7 5 13 2,596 2,609 — Premium wine 3 — — 3 1,114 1,117 — Other C&I — 3 — 3 1,084 1,087 — Other — — — — 374 374 — PPP — — 6 6 22 28 5 Total loans $ 43 $ 40 $ 19 $ 102 $ 72,027 $ 72,129 $ 6 December 31, 2021: Global fund banking $ — $ — $ — $ — $ 37,958 $ 37,958 $ — Investor dependent: Early stage 6 5 — 11 1,582 1,593 — Growth stage 16 — — 16 3,935 3,951 — Total investor dependent 22 5 — 27 5,517 5,544 — Cash flow dependent - SLBO — — — — 1,798 1,798 — Innovation C&I 7 — 7 14 6,659 6,673 7 Private bank 28 1 12 41 8,702 8,743 — CRE 1 — — 1 2,669 2,670 — Premium wine 3 — — 3 982 985 — Other C&I 1 2 1 4 1,253 1,257 — Other — — — — 317 317 — PPP 1 — — 1 330 331 — Total loans $ 63 $ 8 $ 20 $ 91 $ 66,185 $ 66,276 $ 7
Financing Receivable, Nonaccrual	The following table summarizes our nonaccrual loans with no allowance for credit loss at September 30, 2022 and December 31, 2021: September 30, 2022 December 31, 2021 (Dollars in millions) Nonaccrual Loans Nonaccrual Loans with no Allowance for Credit Loss Nonaccrual Loans Nonaccrual Loans with no Allowance for Credit Loss Investor dependent: Early stage $ 4 $ — $ 11 $ — Growth stage 43 1 6 — Total investor dependent 47 1 17 — Cash flow dependent - SLBO 7 — 34 — Innovation C&I 1 — 1 1 Private bank 13 6 21 8 CRE 5 — 5 — Other C&I 3 — 4 — PPP — — 2 — Total nonaccrual loans $ 76 $ 7 $ 84 $ 9
Summary of Loans Modified in Troubled Debt Restructurings ("TDRs") by Risk-based Segment	The following table summarizes our loans modified in TDRs, broken out by class of financing receivable at September 30, 2022 and December 31, 2021: (Dollars in millions) September 30, 2022 December 31, 2021 Loans modified in TDRs: Investor dependent: Early stage $ 1 $ 12 Growth stage 32 3 Total investor dependent 33 15 Cash flow dependent - SLBO 8 34 Innovation C&I 1 — Private bank 8 12 CRE 33 33 Other C&I 2 2 Total loans modified in TDRs $ 85 $ 96
Recorded Investment in Loans Modified in TDRs	The following table summarizes the recorded investment in loans modified in TDRs, broken out by class of financing receivable, for modifications made during the three and nine months ended September 30, 2022 and 2021: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Loans modified in TDRs during the period: Investor dependent: Early stage $ 1 $ — $ 1 $ 1 Growth stage 12 8 32 8 Total investor dependent 13 8 33 9 Cash flow dependent - SLBO — — — 12 Innovation C&I 1 — 1 — Private bank — 2 1 2 CRE 5 43 5 43 Total loans modified in TDRs during the period (1) $ 19 $ 53 $ 40 $ 66 (1) There were $4 million of partial charge-offs for the three months ended September 30, 2022 and $9 million of partial charge-offs for the nine months then ended. There were no partial charge-offs for the three months ended September 30, 2021 and $7 million of partial charge-offs for the nine months then ended.
Activity Relating to ACL for Unfunded Credit Commitments	The following tables summarize the activity relating to our ACL for loans for the three and nine months ended September 30, 2022 and 2021, broken out by portfolio segment: Three months ended September 30, 2022 Beginning Balance June 30, 2022 Charge-offs Recoveries Provision (Reduction) for Credit Loss for Loans Foreign Currency Translation Adjustments Ending Balance September 30, 2022 (Dollars in millions) Global fund banking $ 89 $ — $ 6 $ (4) $ — $ 91 Investor dependent 224 (20) 4 25 1 234 Cash flow dependent and innovation C&I 130 (5) — 11 — 136 Private bank 45 — — 2 — 47 CRE 34 — — (7) — 27 Other C&I 12 (1) 1 — — 12 Premium wine and other 11 — — 3 (4) 10 Total ACL $ 545 $ (26) $ 11 $ 30 $ (3) $ 557 Three months ended September 30, 2021 Beginning Balance June 30, 2021 Initial Charge-offs Recoveries Provision (Reduction) for Credit Loss for Loans Ending Balance September 30, 2021 (Dollars in millions) Global fund banking $ 66 $ — $ — $ — $ (7) $ 59 Investor dependent 158 — (17) 5 (8) 138 Cash flow dependent and innovation C&I 119 — (1) 3 (12) 109 Private bank 47 1 (1) — (16) 31 CRE — 17 — — 23 40 Other C&I — 4 — — 8 12 Premium wine and other 6 — — — 3 9 Total ACL $ 396 $ 22 $ (19) $ 8 $ (9) $ 398 Nine months ended September 30, 2022 Beginning Balance December 31, 2021 Charge-offs Recoveries Provision (Reduction) for Credit Loss for Loans Foreign Currency Translation Adjustments Ending Balance September 30, 2022 (Dollars in millions) Global fund banking $ 67 $ — $ 6 $ 18 $ — $ 91 Investor dependent 146 (53) 13 126 2 234 Cash flow dependent and innovation C&I 118 (9) — 27 — 136 Private Bank 33 — 2 12 — 47 CRE 36 — — (9) — 27 Other C&I 14 (3) 1 — — 12 Premium wine and other 8 (1) 1 10 (8) 10 Total ACL $ 422 $ (66) $ 23 $ 184 $ (6) $ 557 Nine months ended September 30, 2021 Beginning Balance December 31, 2020 Initial Allowance on PCD Loans Charge-offs Recoveries Provision (Reduction) for Credit Loss for Loans Ending Balance September 30, 2021 (Dollars in millions) Global fund banking $ 46 $ — $ (80) $ — $ 93 $ 59 Investor dependent 213 — (37) 13 (51) 138 Cash flow dependent and innovation C&I 125 — (8) 3 (11) 109 Private Bank 53 1 (3) — (20) 31 CRE — 17 — — 23 40 Other C&I — 4 — — 8 12 Premium wine and other 9 — (1) — 1 9 PPP 2 — — — (2) — Total ACL $ 448 $ 22 $ (129) $ 16 $ 41 $ 398 The following table summarizes the activity relating to our ACL for unfunded credit commitments for the three and nine months ended September 30, 2022 and 2021: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 ACL: unfunded credit commitments, beginning balance $ 224 $ 120 171 $ 121 Provision for (reduction in) credit losses 42 29 96 28 Foreign currency translation adjustments (1) — (2) — ACL: unfunded credit commitments, ending balance (1) $ 265 $ 149 $ 265 $ 149 (1) The “ACL: unfunded credit commitments” is included as a component of “other liabilities” on our unaudited interim consolidated balance sheets. See Note 11 — “Off-Balance Sheet Arrangements, Guarantees and Other Commitments” of this report for additional disclosures related to our commitments to extend credit.

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	9 Months Ended
Goodwill and Other Intangible Assets (Tables)	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination	The components of net other intangible assets were as follows: September 30, 2022 December 31, 2021 (Dollars in millions) Gross Amount Accumulated Amortization Net Carrying Amount Gross Amount Accumulated Amortization Net Carrying Amount Other intangible assets: Customer relationships $ 135 $ 27 $ 108 $ 135 $ 16 $ 119 Other 57 23 34 57 16 41 Total other intangible assets $ 192 $ 50 $ 142 $ 192 $ 32 $ 160
Finite-lived Intangible Assets Amortization Expense	For the nine months ended September 30, 2022, we recorded amortization expense of $18 million. Assuming no future impairments of other intangible assets or additional acquisitions or dispositions, the following table presents the Company's future expected amortization expense for other intangible assets that will continue to be amortized as of September 30, 2022: Years ended December 31, Other 2022 (excluding the nine months ended September 30, 2022) $ 6 2023 22 2024 20 2025 17 2026 15 2027 and thereafter 62 Total future amortization expense $ 142

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	9 Months Ended
Derivative Financial Instruments (Tables)	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments	The following table summarizes the amortized cost basis of hedged assets that are designated and qualify as fair value hedges and the cumulative amount of fair value hedging adjustments included in the carrying value that have been recorded on our unaudited interim consolidated balance sheets as of September 30, 2022 and December 31, 2021: Cumulative Amount of Fair Value Hedging Adjustment Included in the Amortized Cost Basis of the Hedged Assets (Dollars in millions) Amortized Cost Basis of the Hedged Assets Active Terminated September 30, 2022 AFS securities $ 8,773 $ — $ (301) December 31, 2021 AFS securities (1) $ 15,260 $ (131) $ 6 (1) These amounts include the amortized cost basis of closed portfolios used to designate hedging relationships in which the hedged item is the last layer expected to be remaining at the end of the hedging relationship. At December 31, 2021, the amortized cost basis of the closed portfolios used in these hedging relationships was $11.2 billion, the amounts of the designated hedged items was $6.7 billion and the cumulative basis adjustments associated with these hedging relationships was $83 million.
Total Notional or Contractual Amounts, Fair Value, Collateral and Net Exposure of Derivative Financial Instruments	The total notional or contractual amounts and fair value of our derivative financial instruments at September 30, 2022 and December 31, 2021 were as follows: September 30, 2022 December 31, 2021 Notional or Fair Value Notional or Fair Value (Dollars in millions) Derivative Assets (1) Derivative Liabilities (1) Derivative Assets (1) Derivative Liabilities (1) Derivatives designated as hedging instruments: Interest rate risks: Interest rate swaps (2) $ — $ — $ — $ 10,700 $ 18 $ — Currency exchange risks: Foreign exchange contracts 1,546 94 — — — — Total derivatives designated as hedging instruments 94 — 18 — Derivatives not designated as hedging instruments: Currency exchange risks: Foreign exchange contracts 2,860 46 — 701 16 — Foreign exchange contracts 308 — 13 62 — 2 Other derivative instruments: Equity warrant assets 353 351 — 322 277 — Contingent conversion rights 52 6 — — — — Client foreign exchange contracts 10,658 500 — 8,245 146 — Client foreign exchange contracts 10,615 — 499 7,764 — 126 Total return swaps 110 25 — — — — Client foreign currency options 266 11 — 688 9 — Client foreign currency options 266 — 11 688 — 9 Client interest rate derivatives (2) 2,248 128 — 2,178 99 — Client interest rate derivatives 2,447 — 235 2,315 — 101 Total derivatives not designated as hedging instruments 1,067 758 547 238 Total gross derivatives 1,161 758 565 238 Less: netting adjustment (3) (495) (234) (137) (120) Total derivatives $ 666 $ 524 $ 428 $ 118 (1) Derivative assets and liabilities are included in "accrued interest receivable and other assets" and "other liabilities " , respectively, on our consolidated balance sheets. (2) The amount reported reflects reductions of approximately $117 million and $112 million of derivative assets at September 30, 2022 and December 31, 2021, respectively, reflecting variation margin treated as settlement of the related derivative fair values for legal and accounting purposes as required by central clearing houses. (3) For some counterparties, the collateral amounts of financial instruments may exceed the derivative receivables and derivative payables balances. Where this is the case, the total amount reported is limited to the net derivative receivables and net derivative payables balances with that counterparty. There was approximately $6 million of cash collateral in excess of net derivative receivables and $1 million of cash collateral in excess of net derivative payables balances not included in the netting adjustment at September 30, 2022, and December 31, 2021, respectively.
Summary of Derivative Activity and Related Impact on Consolidated Statements of Income	A summary of our derivative activity and the related impact on our consolidated statements of income for the three and nine months ended September 30, 2022 and 2021 is as follows: Three months ended September 30, Nine months ended September 30, (Dollars in millions) Statement of income location 2022 2021 2022 2021 Derivatives designated as hedging instruments: Interest rate risks: Amounts reclassified from AOCI into income Interest income - loans $ 14 $ 16 $ 43 $ 47 Change in fair value of interest rate swaps hedging investment securities Interest income - investment securities taxable (2) 5 384 18 Change in fair value of hedged investment securities Interest income - investment securities taxable 1 (6) (385) (19) Net gains associated with interest rate risk derivatives $ 13 $ 15 $ 42 $ 46 Derivatives not designated as hedging instruments: Currency exchange risks: Gains (losses) on revaluations of internal foreign currency instruments, net Other noninterest income $ 47 $ (14) 26 $ (35) (Losses) gains on internal foreign exchange forward contracts, net Other noninterest income (51) 14 (31) 35 Net losses associated with internal currency risk $ (4) $ — $ (5) $ — Other derivative instruments: Gains on revaluations of client foreign currency instruments, net Other noninterest income $ 12 $ 1 $ 7 $ 16 (Losses) gains on client foreign exchange forward contracts, net Other noninterest income (2) (5) 5 (15) Net gains (losses) associated with client currency risk $ 10 $ (4) $ 12 $ 1 (Losses) gains on total return swaps Other noninterest income $ (2) $ — $ 25 $ — Net gains on equity warrant assets Gains on equity warrant assets, net $ 40 $ 147 $ 120 $ 491 Net gains on other derivatives Other noninterest income $ 2 $ 2 $ 8 $ 4
Offsetting Assets	The following table summarizes our assets subject to enforceable master netting arrangements as of September 30, 2022 and December 31, 2021: Gross Amounts of Recognized Assets Gross Amounts Offset in the Statement of Financial Position (1) Net Amounts of Assets Presented in the Statement of Financial Position (1) Gross Amounts Not Offset in the Statement of Financial Position Net Amount (Dollars in millions) Financial Instruments Cash Collateral Received September 30, 2022 Derivatives $ 597 $ (229) $ (266) $ 102 $ — $ 102 Reverse repurchase, securities borrowing, and similar arrangements 397 — — 397 (397) — Total $ 994 $ (229) $ (266) $ 499 $ (397) $ 102 December 31, 2021 Derivatives $ 165 $ (87) $ (50) $ 28 $ — $ 28 Reverse repurchase, securities borrowing, and similar arrangements 607 — — 607 (607) — Total $ 772 $ (87) $ (50) $ 635 $ (607) $ 28 (1) During the third quarter of 2022, we changed our accounting policy to report the fair values of our derivative assets and liabilities subject to ISDA master netting arrangements on a net basis where a right of setoff exists. The net derivative fair values have been further adjusted for cash collateral received/pledged. The change in accounting policy was applied retrospectively, and prior periods have been revised to conform with current period presentation.
Offsetting Liabilities	The following table summarizes our liabilities subject to enforceable master netting arrangements as of September 30, 2022 and December 31, 2021: Gross Amounts of Recognized Liabilities Gross Amounts Offset in the Statement of Financial Position (1) Net Amounts of Liabilities Presented in the Statement of Financial Position (1) Gross Amounts Not Offset in the Statement of Financial Position Net Amount (Dollars in millions) Financial Instruments Cash Collateral Pledged September 30, 2022 Derivatives $ 256 $ (229) $ (5) $ 22 $ — $ 22 Repurchase, securities lending, and similar arrangements 36 — — 36 — 36 Total $ 292 $ (229) $ (5) $ 58 $ — $ 58 December 31, 2021 Derivatives $ 148 $ (87) $ (33) $ 28 $ — $ 28 Repurchase, securities lending, and similar arrangements 61 — — 61 — 61 Total $ 209 $ (87) $ (33) $ 89 $ — $ 89 (1) During the third quarter of 2022, we changed our accounting policy to report the fair values of our derivative assets and liabilities subject to ISDA master netting arrangements on a net basis where a right of setoff exists. The net derivative fair values have been further adjusted for cash collateral received/pledged. The change in accounting policy was applied retrospectively, and prior periods have been revised to conform with current period presentation.

Noninterest Income (Tables)

Noninterest Income (Tables)	9 Months Ended
Noninterest Income (Tables)	Sep. 30, 2022
Other Income and Expenses [Abstract]
Summary of Noninterest Income	Included below is a summary of noninterest income for the three and nine months ended September 30, 2022 and 2021: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Noninterest income: Gains (losses) on investment securities, net $ (127) $ 189 $ (199) $ 661 Gains on equity warrant assets, net 40 147 120 491 Client investment fees 119 20 237 55 Wealth management and trust fees 19 22 63 22 Foreign exchange fees 74 65 216 189 Credit card fees 37 34 114 93 Deposit service charges 32 29 94 82 Lending related fees 20 21 65 55 Letters of credit and standby letters of credit fees 15 13 43 39 Investment banking revenue 75 90 293 335 Commissions 24 17 73 58 Other 31 25 119 97 Total noninterest income $ 359 $ 672 $ 1,238 $ 2,177
Components of Gains and Losses (Realized and Unrealized) on Investment Securities	A summary of gains and losses on investment securities for the three and nine months ended September 30, 2022 and 2021 is as follows: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Gains (losses) on non-marketable and other equity securities, net $ (127) $ 189 $ (247) $ 661 Gains (losses) on sales of AFS securities, net — — 48 — Total gains (losses) on investment securities, net $ (127) $ 189 $ (199) $ 661
Components of Gains on Equity Warrant Assets	A summary of net gains on equity warrant assets for the three and nine months ended September 30, 2022 and 2021 is as follows: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Equity warrant assets: Gains on exercises, net $ 9 $ 91 $ 44 $ 381 Terminations (1) (1) (3) (2) Changes in fair value, net 32 57 79 112 Total net gains on equity warrant assets $ 40 $ 147 $ 120 $ 491
Components of Client Investment Fees	A summary of client investment fees by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Client investment fees by type: Sweep money market fees $ 64 $ 12 $ 144 $ 31 Asset management fees (1) 16 7 41 22 Repurchase agreement fees 39 1 52 2 Total client investment fees (2) $ 119 $ 20 $ 237 $ 55 (1) Represents fees earned from investments in third-party money market mutual funds and fixed-income securities managed by SVB Asset Management. (2) Represents fees earned on client investment funds that are maintained at third-party financial institutions and are not recorded on our balance sheet.
Components of Wealth Management and Trust Fees	A summary of wealth management and trust fees by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Wealth management and trust fees by type: Wealth management fees $ 17 $ 20 $ 58 $ 20 Trust fees 2 2 5 2 Total wealth management and trust fees $ 19 $ 22 $ 63 $ 22
Components of Foreign Exchange Fees	A summary of foreign exchange fee income by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Foreign exchange fees by instrument type: Foreign exchange contract commissions $ 74 $ 65 $ 215 $ 188 Option premium fees — — 1 1 Total foreign exchange fees $ 74 $ 65 $ 216 $ 189
Components of Credit Card Fees	A summary of credit card fees by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Credit card fees by instrument type: Card interchange fees, net $ 29 $ 29 $ 91 $ 78 Merchant service fees 6 4 18 12 Card service fees 2 1 5 3 Total credit card fees $ 37 $ 34 $ 114 $ 93
Components of Lending Related Fees	A summary of lending related fees by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Lending related fees by instrument type: Unused commitment fees $ 14 $ 14 $ 49 $ 42 Other 6 7 16 13 Total lending related fees $ 20 $ 21 $ 65 $ 55
Schedule of Investment Banking Revenue	A summary of investment banking revenue by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Investment banking revenue: Underwriting fees $ 24 $ 39 $ 97 $ 248 Advisory fees 40 26 163 39 Private placements and other 11 25 33 48 Total investment banking revenue $ 75 $ 90 $ 293 $ 335
Summary of Other Noninterest Income	A summary of other noninterest income by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Other noninterest income by instrument type: Fund management fees $ 16 $ 15 $ 43 $ 51 Net gains on revaluation of foreign currency instruments, net of foreign exchange forward contracts (1) 6 (4) 7 1 Gains on total return swaps (3) — 25 — Other service revenue 12 14 44 45 Total other noninterest income $ 31 $ 25 $ 119 $ 97 (1) Represents the net revaluation of client and internal foreign currency denominated financial instruments. We enter into foreign exchange forward contracts to economically reduce our foreign exchange exposure related to client and internal foreign currency denominated financial instruments.
Disaggregation of Revenue	The following tables present our revenues from contracts with customers disaggregated by revenue source and segment for the three and nine months ended September 30, 2022 and 2021: Three months ended September 30, 2022 Silicon Valley Bank (3) SVB Private SVB Capital (3) SVB Other Items Total (Dollars in millions) Revenue from contracts with customers: Client investment fees $ 119 $ — $ — $ — $ — $ 119 Wealth management and trust fees — 19 — — — 19 Card interchange fees, gross 54 1 — — — 55 Merchant service fees 7 — — — — 7 Deposit service charges 32 — — — — 32 Investment banking revenue — — — 75 — 75 Commissions — — — 24 — 24 Fund management fees 1 — 13 2 — 16 Other (1) 1 — 2 — — 3 Total revenue from contracts with customers $ 214 $ 20 $ 15 $ 101 $ — $ 350 Revenues outside the scope of ASC 606 (2) 94 2 (69) (1) (17) 9 Total noninterest income $ 308 $ 22 $ (54) $ 100 $ (17) $ 359 (1) Includes certain spot contract commissions, performance fees and correspondent bank rebates. (2) Amounts are accounted for under separate guidance than ASC 606. (3) Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items. " Three months ended September 30, 2021 Silicon Valley Bank (3) SVB Private SVB Capital (3) SVB Other Items Total (Dollars in millions) Revenue from contracts with customers: Client investment fees $ 20 $ — $ — $ — $ — $ 20 Wealth management and trust fees — 22 22 Card interchange fees, gross 52 — — — — 52 Merchant service fees 4 — — — — 4 Deposit service charges 28 — — — 1 29 Investment banking revenue — — — 90 — 90 Commissions — — — 17 — 17 Fund management fees — — 14 1 — 15 Other (1) 61 1 4 — — 66 Total revenue from contracts with customers 165 23 18 108 1 315 Revenues outside the scope of ASC 606 (2) 17 2 127 23 188 357 Total noninterest income $ 182 $ 25 $ 145 $ 131 $ 189 $ 672 (1) Includes certain spot contract commissions, performance fees and correspondent bank rebates. (2) Amounts are accounted for under separate guidance than ASC 606. (3) Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items. " Nine months ended September 30, 2022 Silicon Valley Bank (3) SVB Private SVB Capital (3) SVB Other Items Total (Dollars in millions) Revenue from contracts with customers: Client investment fees $ 236 $ — $ — $ — $ 1 $ 237 Wealth management and trust fees — 63 — — — 63 Card interchange fees, gross 170 1 — — 2 173 Merchant service fees 18 — — — — 18 Deposit service charges 92 1 — — 1 94 Investment banking revenue — — — 293 — 293 Commissions — — — 73 — 73 Fund management fees 1 — 37 5 — 43 Other (1) 69 1 6 — — 76 Total revenue from contracts with customers $ 586 $ 66 $ 43 $ 371 $ 4 $ 1,070 Revenues outside the scope of ASC 606 (2) 195 6 (121) (19) 107 168 Total noninterest income $ 781 $ 72 $ (78) $ 352 $ 111 $ 1,238 (1) Includes certain spot contract commissions, performance fees and correspondent bank rebates. (2) Amounts are accounted for under separate guidance than ASC 606. (3) Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items. " Nine months ended September 30, 2021 Silicon Valley Bank (3) SVB Private SVB Capital (3) SVB Other Items Total (Dollars in millions) Revenue from contracts with customers: Client investment fees $ 53 $ 2 $ — $ — $ — $ 55 Wealth management and trust fees — 22 — — — 22 Card interchange fees, gross 140 1 — — 1 142 Merchant service fees 12 — — — — 12 Deposit service charges 80 — — — 2 82 Investment banking revenue — — — 335 — 335 Commissions — — — 58 — 58 Fund management fees — — 47 4 — 51 Other (1) 178 1 12 — — 191 Total revenue from contracts with customers $ 463 $ 26 $ 59 $ 397 $ 3 $ 948 Revenues outside the scope of ASC 606 (2) 51 2 330 53 793 1,229 Total noninterest income $ 514 $ 28 $ 389 $ 450 $ 796 $ 2,177 (1) Includes certain spot contract commissions, performance fees and correspondent bank rebates. (2) Amounts are accounted for under separate guidance than ASC 606. (3) Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items. "

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
Segment Reporting (Tables)	Sep. 30, 2022
Segment Reporting [Abstract]
Segment Reporting	Our reportable segment information for the three and nine months ended September 30, 2022 and 2021 is as follows: (Dollars in millions) Silicon Valley SVB Private SVB Capital (1) SVB Other Items (2) Total Three months ended September 30, 2022 Net interest income $ 1,107 $ 111 $ — $ 1 $ (21) $ 1,198 (Provision for) reduction of credit losses (32) 3 — — (43) (72) Noninterest income (loss) 308 22 (54) 100 (17) 359 Noninterest expense (3) (381) (85) (17) (131) (278) (892) Income (loss) before income tax expense (4) $ 1,002 $ 51 $ (71) $ (30) $ (359) $ 593 Total average loans, amortized cost $ 55,177 $ 15,181 $ — $ — $ 740 $ 71,098 Total average assets (5) (6) 175,620 17,032 883 898 21,307 215,740 Total average deposits 172,427 12,436 — — 693 185,556 Three months ended September 30, 2021 Net interest income (7) $ 766 $ 74 $ — $ — $ 12 $ 852 Provision for credit losses 29 (20) — — (30) (21) Noninterest income 182 25 145 131 189 672 Noninterest expense (3) (7) (336) (93) (15) (142) (293) (879) Income before income tax expense (4) (7) $ 641 $ (14) $ 130 $ (11) $ (122) $ 624 Total average loans, amortized cost (7) $ 44,789 $ 13,515 $ — $ — $ 987 $ 59,291 Total average assets (5) (6) (7) 151,352 15,930 730 837 13,841 182,690 Total average deposits (7) 148,879 13,431 — — 1,082 163,392 Nine months ended September 30, 2022 Net interest income $ 2,993 $ 296 $ — $ 1 $ 157 $ 3,447 Provision for credit losses (174) (9) — — (96) (279) Noninterest income (loss) 781 72 (78) 352 111 1,238 Noninterest expense (3) (1,148) (267) (53) (406) (739) (2,613) Income before income tax expense (4) $ 2,452 $ 92 $ (131) $ (53) $ (567) $ 1,793 Total average loans, amortized cost $ 53,855 $ 14,711 $ — $ — $ 592 $ 69,158 Total average assets (5) (6) 178,209 16,456 956 912 20,119 216,652 Total average deposits 175,370 13,327 — — 731 189,428 Nine months ended September 30, 2021 Net interest income (7) $ 2,084 $ 146 $ — $ — $ 10 $ 2,240 (Provision for) reduction of credit losses (27) (16) — — (32) (75) Noninterest income 514 28 389 450 796 2,177 Noninterest expense (3) (7) (911) (126) (48) (376) (707) (2,168) Income before income tax expense (4) (7) $ 1,660 $ 32 $ 341 $ 74 $ 67 2,174 Total average loans, amortized cost (7) $ 41,591 $ 8,610 $ — $ — $ 1,642 $ 51,843 Total average assets (5) (6) (7) 130,177 9,459 641 778 11,897 152,952 Total average deposits (7) 128,006 7,108 — — 999 136,113 (1) Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of net interest income, noninterest income, noninterest expense and total average assets are shown net of noncontrolling interests for all periods presented. Noncontrolling interest is included within “Other Items." (2) The “Other Items” column reflects the adjustments necessary to reconcile the results of the reportable segments to the consolidated financial statements prepared in conformity with GAAP. Net interest income consists primarily of interest earned from our fixed income investment portfolio, net of FTP. Noninterest income consists primarily of gains or losses on equity warrant assets, gains or losses on the sale of AFS securities and gains or losses on equity securities from exercised warrant assets. Noninterest expense consists primarily of expenses associated with corporate support functions such as finance, human resources, marketing, legal and other expenses. (3) The Silicon Valley Bank segment includes direct depreciation and amortization of $13 million and $10 million for the three months ended September 30, 2022 and 2021, respectively and $34 million and $25 million for the nine months ended September 30, 2022 and 2021, respectively. (4) The internal reporting model used by management to assess segment performance does not calculate income tax expense by segment. Our effective tax rate is a reasonable approximation of the segment rates. (5) Total average assets equal the greater of total average assets or the sum of total average liabilities and total average stockholders' equity for each segment to reconcile the results to the consolidated financial statements prepared in conformity with GAAP. (6) Included in the total average assets for SVB Securities and SVB Private is goodwill of $174 million and $201 million, respectively, for the three and nine months ended September 30, 2022, and included in the total average assets for SVB Securities and SVB Private is goodwill of $138 million and $201 million for the three and nine months ended September 30, 2021, respectively. (7) For the three and nine months ended September 30, 2021, prior period balances for our Premium Wine reporting division previously reported in "Silicon Valley Bank" have been allocated to the reportable segment “SVB Private” to properly reflect organizational changes effective January 1, 2022. The reallocation had no impact on the "Total" amount.

Off-Balance Sheet Arrangement_2

Off-Balance Sheet Arrangements, Guarantees and Other Commitments (Tables)	9 Months Ended
	Sep. 30, 2022
Disclosure Off Balance Sheet Arrangements Guarantees And Other Commitments Additional Information [Abstract]
Summary Information Related to Commitments to Extend Credit (Excluding Letters of Credit)	The following table summarizes information related to our commitments to extend credit at September 30, 2022 and December 31, 2021: (Dollars in millions) September 30, 2022 December 31, 2021 Loan commitments (1) $ 51,769 $ 40,327 Standby letters of credit (2) 3,824 3,612 Commercial letters of credit (3) 105 77 Total unfunded credit commitments $ 55,698 $ 44,016 Allowance for unfunded credit commitments (4) 265 171 (1) Represents commitments which are available for funding, due to clients meeting all collateral, compliance and financial covenants required under loan commitment agreements. (2) See below for additional information on our standby letters of credit. (3) Commercial letters of credit are issued primarily for inventory purchases by a client and are typically short-term in nature. (4) Our allowance for credit losses for unfunded credit commitments includes an allowance for both our unfunded loan commitments and our letters of credit.
Summary of Commercial and Standby Letters of Credit	The table below summarizes our standby letters of credit at September 30, 2022. The maximum potential amount of future payments represents the amount that could be remitted under letters of credit if there were a total default by the guaranteed parties, without consideration of possible recoveries under recourse provisions or from the collateral held or pledged. (Dollars in millions) Expires in One Expires After Total Amount Maximum Amount Financial standby letters of credit $ 3,617 $ 126 $ 3,743 $ 3,743 Performance standby letters of credit 72 9 81 81 Total $ 3,689 $ 135 $ 3,824 $ 3,824
Total Capital Commitments, Unfunded Capital Commitments, and Ownership in Each Fund	The following table details our total capital commitments, unfunded capital commitments, and our ownership percentage in each fund at September 30, 2022: (Dollars in millions) SVBFG Capital Commitments SVBFG Unfunded Commitments SVBFG Ownership of each Fund Redwood Evergreen Fund, LP $ 250 $ 119 100.0 % CP II, LP (1) 1 — 5.1 Capital Preferred Return Fund, LP 13 — 20.0 Growth Partners, LP 25 1 33.0 Strategic Investors Fund, LP 15 1 12.6 Strategic Investors Fund II, LP 15 1 8.6 Strategic Investors Fund III, LP 15 1 5.9 Strategic Investors Fund IV, LP 12 2 5.0 Strategic Investors Fund V funds 1 — Various Other venture capital and private equity fund investments (equity method accounting) 18 5 Various Debt funds (equity method accounting) 59 — Various Other fund investments (2) 248 12 Various Total $ 672 $ 142 (1) Our ownership includes direct ownership of 1.3 percent and indirect ownership interest of 3.8 percent through our investment in Strategic Investors Fund II, LP. (2) Represents commitments to 147 funds (primarily venture capital funds) where our ownership interest is generally less than 5.0 percent of the voting interests of each such fund.

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	9 Months Ended
Fair Value of Financial Instruments (Tables)	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Hierarchy Tables Present Information about Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2022: (Dollars in millions) Level 1 Level 2 Level 3 Netting Adjustments (1) Balance at September 30, 2022 Assets: AFS securities: U.S. Treasury securities $ 16,845 $ — $ — $ — $ 16,845 U.S. agency debentures — 100 — — 100 Foreign government debt securities 913 — — — 913 Residential MBS: Agency-issued MBS — 6,683 — — 6,683 Agency-issued CMO—fixed rate — 714 — — 714 Agency-issued CMBS — 1,456 — — 1,456 Total AFS securities 17,758 8,953 — — 26,711 Non-marketable and other equity securities (fair value accounting): Non-marketable securities: Venture capital and private equity fund investments measured at net asset value — — — — 270 Other equity securities in public companies 27 2 — — 29 Total non-marketable and other equity securities (fair value accounting) 27 2 — — 299 Other assets: Derivative assets — 804 — (495) 309 Equity warrant assets — 6 345 — 351 Contingent conversion rights — — 6 — 6 Other assets 4 — — — 4 Total assets $ 17,789 $ 9,765 $ 351 $ (495) $ 27,680 Liabilities: Derivative liabilities $ — $ 758 $ — $ (234) $ 524 Other liabilities 4 — — — 4 Total liabilities $ 4 $ 758 $ — $ (234) $ 528 (1) Amounts represent the impact of legally enforceable master netting arrangements and also cash collateral held or placed with the same counterparties The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2021: (Dollars in millions) Level 1 Level 2 Level 3 Netting Adjustments (1) (2) Balance at December 31, 2021 Assets: AFS securities: U.S. Treasury securities $ 15,850 $ — $ — $ — $ 15,850 U.S. agency debentures — 196 — — 196 Foreign government debt securities 61 — — — 61 Residential MBS: Agency-issued MBS — 8,589 — — 8,589 Agency-issued CMO—fixed rate — 982 — — 982 Agency-issued CMBS — 1,543 — — 1,543 Total AFS securities 15,911 11,310 — — 27,221 Non-marketable and other equity securities (fair value accounting): Non-marketable securities: Venture capital and private equity fund investments measured at net asset value — — — — 338 Other equity securities in public companies 43 74 — — 117 Total non-marketable and other equity securities (fair value accounting) 43 74 — — 455 Other assets: Derivative assets (2) — 288 — (137) 151 Equity warrant assets — 8 269 — 277 Other assets 8 — — — 8 Total assets $ 15,962 $ 11,680 $ 269 $ (137) $ 28,112 Liabilities: Derivative liabilities (2) $ — $ 238 $ — $ (120) $ 118 Other liabilities 8 — — — 8 Total liabilities $ 8 $ 238 $ — $ (120) $ 126
Additional Information about Level 3 Assets Measured at Fair Value on a Recurring Basis	The following table presents additional information about Level 3 assets measured at fair value on a recurring basis for the three and nine months ended September 30, 2022 and 2021: (Dollars in millions) Beginning Balance Total Net Gains (Losses) Included in Net Income Sales/Exits Issuances Transfers Out of Level 3 Ending Balance Three months ended September 30, 2022 Equity warrant assets (1) $ 318 $ 39 $ (21) $ 9 $ — $ 345 Contingent conversion rights (2) 6 — — — — 6 Three months ended September 30, 2021 Equity warrant assets (1) 257 149 (146) 6 (1) 265 Nine months ended September 30, 2022 Equity warrant assets (1) 269 124 (67) 21 (2) 345 Contingent conversion rights (2) — (1) — 7 — 6 Nine months ended September 30, 2021 Equity warrant assets (1) 192 490 (431) 18 (4) 265 (1) Realized and unrealized gains (losses) are recorded in the line item “Gains on equity warrant assets, net," a component of noninterest income. (2) Unrealized gains and losses are recorded in the line item "Other noninterest income," a component of noninterest income.
Unrealized Gains Included in Earnings Attributable to Level 3 Assets Held	The following table presents the amount of net unrealized gains and losses included in earnings attributable to Level 3 assets still held at September 30, 2022 and 2021: Three months ended September 30, Nine months ended September 30, (Dollars in millions) 2022 2021 2022 2021 Other assets: Equity warrant assets (1) $ 26 $ 21 $ 84 $ 113 Contingent conversion rights (2) — — (1) — Total unrealized gains, net $ 26 $ 21 $ 83 $ 113 (1) Unrealized gains and losses are recorded in the line item “Gains on equity warrant assets, net, " a component of noninterest income. (2) Unrealized gains and losses are recorded in the line item "Other noninterest income," a component of noninterest income.
Quantitative Information About Significant Unobservable Inputs	The following table presents quantitative information about the significant unobservable inputs used for certain of our Level 3 fair value measurements at September 30, 2022 and December 31, 2021. We have not included in this table our venture capital and private equity fund investments (fair value accounting) as we use net asset value per share (as obtained from the general partners of the investments) as a practical expedient to determine fair value. (Dollars in millions) Fair value Valuation Technique Significant Unobservable Inputs Input Range Weighted September 30, 2022: Equity warrant assets (private portfolio) 345 Black-Scholes option pricing model Volatility 23.8 - 51.3 42.3 Risk-Free interest rate 3.3 - 4.4 4.2 Marketability discount (2) 17.1 17.1 Remaining life assumption (3) 40.0 40.0 Contingent conversion rights (private portfolio) 6 Private company equity pricing (4) (4) (4) December 31, 2021: Equity warrant assets (public portfolio) 2 Black-Scholes option pricing model Volatility 27.8% - 55.0% 43.7 % Risk-Free interest rate 0.6- 1.5 1.1 Sales restrictions discount (1) 10.0 - 20.0 10.7 Equity warrant assets (private portfolio) 267 Black-Scholes option pricing model Volatility 24.7 - 55.0 43.0 Risk-Free interest rate 0.06 - 1.40 0.8 Marketability discount (2) 20.1 20.1 Remaining life assumption (3) 40.0 40.0 (1) We adjust quoted market prices of public companies, which are subject to certain sales restrictions. Sales restriction discounts generally range from 10 percent to 20 percent depending on the duration of the sales restrictions, which typically range from three (2) Our marketability discount is applied to all private company warrants to account for a general lack of liquidity due to the private nature of the associated underlying company. The quantitative measure used is based upon various option-pricing models. On a quarterly basis, a sensitivity analysis is performed on our marketability discount. (3) We adjust the contractual remaining term of private company warrants based on our estimate of the actual remaining life, which we determine by utilizing historical data on terminations and exercises. At September 30, 2022, the weighted average contractual remaining term was 6.2 years, compared to our estimated remaining life of 2.5 years. On a quarterly basis, a sensitivity analysis is performed on our remaining life assumption. (4) In determining the fair value of our private contingent conversion rights portfolio (not valued using the Black-Scholes model), we evaluate a variety of factors related to each underlying private portfolio company including, but not limited to, actual and forecasted enterprise values, the probability of a conversion event occurring and limitations and conversion pricing outlined in the convertible debt agreement. Additionally, we have ongoing communication with the portfolio companies and relationship teams, to determine whether there is a material change in fair value. We use company provided valuation reports, if available, to support our valuation assumptions. These factors are specific to each portfolio company and a weighted average or range of values of the unobservable inputs is not meaningful.
Summary of Estimated Fair Values of Financial Instruments Not Carried at Fair Value	The following fair value hierarchy table presents the estimated fair values of our financial instruments that are not carried at fair value at September 30, 2022 and December 31, 2021: Estimated Fair Value (Dollars in millions) Carrying Amount Total Level 1 Level 2 Level 3 September 30, 2022: Financial assets: Cash and cash equivalents $ 13,968 $ 13,968 $ 13,968 $ — $ — HTM securities 93,286 77,370 — 77,370 — Non-marketable securities not measured at net asset value 431 431 — — 431 Non-marketable securities measured at net asset value 660 660 — — — Net loans 71,572 72,489 — — 72,489 FHLB and Federal Reserve Bank stock 665 665 — — 665 Financial liabilities: Short-term borrowings 13,552 13,552 — 13,552 — Non-maturity deposits (1) 171,545 171,545 171,545 — — Time deposits 5,274 4,916 — 4,916 — 3.50% Senior Notes 349 336 — 336 — 3.125% Senior Notes 496 407 — 407 — 1.800% Senior Notes due 2031 495 358 — 358 — 2.100% Senior Notes due 2028 496 408 — 408 — 1.800% Senior Notes due 2026 646 559 — 559 — 4.345% Senior Notes due 2028 348 327 — 327 — 4.570% Senior Notes due 2033 447 396 — 396 — Junior subordinated debentures 91 91 — 91 — Off-balance sheet financial assets: Commitments to extend credit — 49 — — 49 December 31, 2021: Financial assets: Cash and cash equivalents $ 14,586 $ 14,586 $ 14,586 $ — $ — HTM securities 98,195 97,227 — 97,227 — Non-marketable securities not measured at net asset value 424 424 — — 424 Non-marketable securities measured at net asset value 710 710 — — — Net loans 65,854 67,335 — — 67,335 FHLB and Federal Reserve Bank stock 107 107 — — 107 Financial liabilities: Short-term borrowings 71 71 — 71 — Non-maturity deposits (1) 187,464 187,464 187,464 — — Time deposits 1,739 1,728 — 1,728 — 3.50% Senior Notes 349 370 — 370 — 3.125% Senior Notes 496 526 — 526 — 1.800% Senior Notes due 2031 494 474 — 474 — 2.100% Senior Notes due 2028 496 501 — 501 — 1.800% Senior Notes due 2026 645 649 — 649 — Junior subordinated debentures 90 92 — 92 — Off-balance sheet financial assets: Commitments to extend credit — 47 — — 47 (1) Includes noninterest-bearing demand deposits, interest-bearing checking accounts, money market accounts and interest-bearing sweep deposits.
Summary of Estimated Fair Values of Investments and Remaining Unfunded Commitments for Each Major Category of Investments	The following table is a summary of the estimated fair values of these investments and remaining unfunded commitments for each major category of these investments as of September 30, 2022: (Dollars in millions) Carrying Amount Fair Value Unfunded Commitments Non-marketable securities (fair value accounting): Venture capital and private equity fund investments (1) $ 270 $ 270 $ 13 Non-marketable securities (equity method accounting): Venture capital and private equity fund investments (2) 639 639 11 Debt funds (2) 4 4 — Other investments (2) 17 17 1 Total $ 930 $ 930 $ 25 (1) Venture capital and private equity fund investments within non-marketable securities (fair value accounting) include investments made by our managed funds of funds and one of our direct venture funds (consolidated VIEs) and investments in venture capital and private equity fund investments (unconsolidated VIEs). Collectively, these investments in venture capital and private equity funds are primarily in U.S. and global technology and life science/healthcare companies. Included in the fair value and unfunded commitments of fund investments under fair value accounting are $42 million and $2 million, respectively, attributable to noncontrolling interests. It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds and any potential extensions of terms of the funds. (2) Venture capital and private equity fund investments, debt funds, and other fund investments within non-marketable securities (equity method accounting) include funds that invest in or lend money to primarily U.S. and global technology and life science/healthcare companies. It is estimated that we will receive distributions from the funds over the next 5 to 8 years, depending on the age of the funds and any potential extensions of the terms of the funds.

Stockholders' Equity and EPS -

Stockholders' Equity and EPS - Reclassification out of AOCI (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gains (losses) on investment securities, net	$ (127)	$ 189	$ (199)	$ 661
Related tax benefit	(175)	(149)	(489)	(509)
Net interest income	1,198	852	3,447	2,240
Total reclassification adjustment for gains included in net income, net of tax	429	365	1,234	1,399
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total reclassification adjustment for gains included in net income, net of tax	(10)	(12)	(65)	(34)
Accumulated Net Investment Gain (Loss) Attributable to Parent \| Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gains (losses) on investment securities, net	0	0	(48)	0
Related tax benefit	0	0	14	0
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent \| Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Related tax benefit	4	4	12	13
Net interest income	$ (14)	$ (16)	$ (43)	$ (47)

Stockholders' Equity and EPS _2

Stockholders' Equity and EPS - Activity Related to Net Gains on Cash Flow Hedges in AOCI (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Cash flow hedge gains expected to reclassified out of AOCI over next 12 months			$ 46
Balance, beginning of period, net of tax	$ 16,276	$ 11,967	16,609	$ 8,433
Balance, end of period, net of tax	15,810	14,669	15,810	14,669
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance, beginning of period, net of tax	62	107	83	129
Net realized (gain) loss reclassified to net income, net of tax	(10)	(12)	(31)	(34)
Balance, end of period, net of tax	$ 52	$ 95	$ 52	$ 95

Stockholders' Equity and EPS _3

Stockholders' Equity and EPS - Reconciliation of Basic EPS to Diluted EPS (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Numerator:
Net income available to common stockholders	$ 429	$ 365	$ 1,234	$ 1,399
Denominator:
Weighted average common shares outstanding-basic (in shares)	59,096	57,723	58,945	54,772
Weighted average common shares outstanding—diluted (in shares)	59,549	58,521	59,535	55,617
Earnings per common share:
Basic (dollars per share)	$ 7.26	$ 6.33	$ 20.94	$ 25.54
Diluted (dollars per share)	$ 7.21	$ 6.24	$ 20.73	$ 25.16
Stock options and ESPP
Denominator:
Weighted average effect of dilutive securities (in shares)	165	268	206	278
Restricted stock units and awards
Denominator:
Weighted average effect of dilutive securities (in shares)	288	530	384	567

Stockholders' Equity and EPS _4

Stockholders' Equity and EPS - Common Shares Excluded from Diluted EPS Calculation as They Were Deemed to be Anti-Dilutive (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from diluted earnings per share calculation	619	56	204	31
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from diluted earnings per share calculation	142	56	105	31
Restricted stock units and awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from diluted earnings per share calculation	477	0	99	0

Stockholders' Equity and EPS _5

Stockholders' Equity and EPS - Preferred Stock Summary (Details) $ / shares in Units, $ in Millions	9 Months Ended
	Sep. 30, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares
Class of Stock [Line Items]
Carrying value \| $	$ 3,646	$ 3,646
Shares issued and outstanding \| shares	383,500	383,500
Par Value	$ 0.001	$ 0.001
Series A Preferred Stock
Class of Stock [Line Items]
Amount outstanding \| $	$ 350
Carrying value \| $	$ 340
Shares issued and outstanding \| shares	350,000
Par Value	$ 0.001
Preferred stock, depository share ownership interest	0.025
Preferred stock, liquidation preference per depositary share	$ 25
2021 dividends paid per depository share, usd per share	$ 0.984375
Preferred stock, dividend rate, percentage	5.25%
Preferred stock, dividend rate, percentage	5.25%
Series B Preferred Stock
Class of Stock [Line Items]
Amount outstanding \| $	$ 750
Carrying value \| $	$ 739
Shares issued and outstanding \| shares	7,500
Par Value	$ 0.001
Preferred stock, depository share ownership interest	0.01
Preferred stock, liquidation preference per depositary share	$ 1,000
2021 dividends paid per depository share, usd per share	$ 30.75
Preferred stock, dividend rate, percentage	4.10%
Preferred stock, dividend rate, percentage	4.10%
Series C Preferred Stock
Class of Stock [Line Items]
Amount outstanding \| $	$ 1,000
Carrying value \| $	$ 985
Shares issued and outstanding \| shares	10,000
Par Value	$ 0.001
Preferred stock, depository share ownership interest	0.01
Preferred stock, liquidation preference per depositary share	$ 1,000
2021 dividends paid per depository share, usd per share	$ 30
Preferred stock, dividend rate, percentage	4%
Preferred stock, dividend rate, percentage	4%
Series D Preferred Stock
Class of Stock [Line Items]
Amount outstanding \| $	$ 1,000
Carrying value \| $	$ 989
Shares issued and outstanding \| shares	10,000
Par Value	$ 0.001
Preferred stock, depository share ownership interest	0.01
Preferred stock, liquidation preference per depositary share	$ 1,000
2021 dividends paid per depository share, usd per share	$ 33.88
Preferred stock, dividend rate, percentage	4.25%
Preferred stock, dividend rate, percentage	4.25%
Series E Preferred Stock
Class of Stock [Line Items]
Amount outstanding \| $	$ 600
Carrying value \| $	$ 593
Shares issued and outstanding \| shares	6,000
Par Value	$ 0.001
Preferred stock, depository share ownership interest	0.01
Preferred stock, liquidation preference per depositary share	$ 1,000
2021 dividends paid per depository share, usd per share	$ 37.47
Preferred stock, dividend rate, percentage	4.70%
Preferred stock, dividend rate, percentage	4.70%

Stockholders' Equity and EPS _6

Stockholders' Equity and EPS - QTD Stockholders' Equity (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Stockholders Equity Note [Line Items]
Balance, beginning of period, net of tax	$ 16,276	$ 11,967	$ 16,609	$ 8,433
Common stock issued under employee benefit plans, net of restricted stock cancellations	(2)	2	(31)	(1)
Issuance of stock		1,245		2,363
Issuance of common stock for the acquisition of Boston Private		1,060		1,060
Net income	418	475	1,304	1,665
Capital calls and distributions, net	(6)	(19)	(19)	(70)
Other comprehensive income (loss), net of tax	(887)	(77)	(2,076)	(558)
Share-based compensation, net	51	38	146	93
Dividends on preferred stock	(40)	(22)	(123)	(40)
Balance, end of period, net of tax	15,810	14,669	15,810	14,669
Noncumulative Preferred Stock
Stockholders Equity Note [Line Items]
Issuance of stock				1,724
Preferred Stock
Stockholders Equity Note [Line Items]
Balance, beginning of period, net of tax	3,646	2,064	3,646	340
Balance, end of period, net of tax	$ 3,646	$ 2,064	$ 3,646	2,064
Preferred Stock \| Noncumulative Preferred Stock
Stockholders Equity Note [Line Items]
Issuance of stock				$ 1,724
Common Stock
Stockholders Equity Note [Line Items]
Balance (in shares)	59,081,326	54,530,307	58,748,469	51,888,463
Balance, beginning of period, net of tax	$ 0	$ 0	$ 0	$ 0
Common stock issued under employee benefit plans, net of restricted stock cancellations (in shares)	22,798	32,195	355,655	374,039
Common stock issued under employee benefit plans, net of restricted stock cancellations			$ 0	$ 0
Issuance of stock (in shares)		2,227,000		4,527,000
Issuance of stock		$ 0		$ 0
Issuance of common stock for the acquisition of Boston Private (in shares)		1,887,981		1,887,981
Issuance of common stock for the acquisition of Boston Private		$ 0
Balance (in shares)	59,104,124	58,677,483	59,104,124	58,677,483
Balance, end of period, net of tax	$ 0	$ 0	$ 0	$ 0
Additional Paid-in Capital
Stockholders Equity Note [Line Items]
Balance, beginning of period, net of tax	5,223	2,755	5,157	1,585
Common stock issued under employee benefit plans, net of restricted stock cancellations	(2)	2	(31)	(1)
Issuance of stock		1,245		2,363
Issuance of common stock for the acquisition of Boston Private		1,060		1,060
Share-based compensation, net	51	38	146	93
Balance, end of period, net of tax	5,272	5,100	5,272	5,100
Retained Earnings
Stockholders Equity Note [Line Items]
Balance, beginning of period, net of tax	8,247	6,706	7,442	5,672
Net income	469	387	1,357	1,439
Dividends on preferred stock	(40)	(22)	(123)	(40)
Balance, end of period, net of tax	8,676	7,071	8,676	7,071
Accumulated Other Comprehensive Income (Loss)
Stockholders Equity Note [Line Items]
Balance, beginning of period, net of tax	(1,198)	142	(9)	623
Other comprehensive income (loss), net of tax	(887)	(77)	(2,076)	(558)
Balance, end of period, net of tax	(2,085)	65	(2,085)	65
Total SVBFG Stockholders’ Equity
Stockholders Equity Note [Line Items]
Balance, beginning of period, net of tax	15,918	11,667	16,236	8,220
Common stock issued under employee benefit plans, net of restricted stock cancellations	(2)	2	(31)	(1)
Issuance of stock		1,245		2,363
Issuance of common stock for the acquisition of Boston Private		1,060		1,060
Net income	469	387	1,357	1,439
Other comprehensive income (loss), net of tax	(887)	(77)	(2,076)	(558)
Share-based compensation, net	51	38	146	93
Dividends on preferred stock	(40)	(22)	(123)	(40)
Balance, end of period, net of tax	15,509	14,300	15,509	14,300
Total SVBFG Stockholders’ Equity \| Noncumulative Preferred Stock
Stockholders Equity Note [Line Items]
Issuance of stock				1,724
Noncontrolling Interests
Stockholders Equity Note [Line Items]
Balance, beginning of period, net of tax	358	300	373	213
Net income	(51)	88	(53)	226
Capital calls and distributions, net	(6)	(19)	(19)	(70)
Balance, end of period, net of tax	$ 301	$ 369	$ 301	$ 369

Variable Interest Entities - Ca

Variable Interest Entities - Carrying Amounts and Classification of Significant Variable Interests (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Variable Interest Entity [Line Items]
Cash and cash equivalents	$ 13,968	$ 14,586
Non-marketable and other equity securities	2,595	2,543
Accrued interest receivable and other assets	3,523	1,791
Total assets	212,867	211,308
Other liabilities	2,889	2,467
Long-term debt	3,368	2,570
Total liabilities	197,057	194,699
Maximum exposure to loss in unconsolidated VIEs	1,369	1,233
Investments in qualified affordable housing projects, net	1,205	954
Consolidated
Variable Interest Entity [Line Items]
Cash and cash equivalents	7	13
Non-marketable and other equity securities	767	768
Accrued interest receivable and other assets	35	31
Total assets	809	812
Other liabilities	23	18
Long-term debt	0	0
Total liabilities	23	18
Maximum exposure to loss in unconsolidated VIEs	786
Unconsolidated
Variable Interest Entity [Line Items]
Cash and cash equivalents	0	0
Non-marketable and other equity securities	1,369	1,233
Accrued interest receivable and other assets	6	6
Total assets	1,375	1,239
Other liabilities	672	482
Long-term debt	91	90
Total liabilities	763	572
Non-marketable securities \| Unconsolidated
Variable Interest Entity [Line Items]
Maximum exposure to loss in unconsolidated VIEs	$ 1,369	$ 1,233

Variable Interest Entities - Ad

Variable Interest Entities - Additional Information (Details) $ in Millions	Sep. 30, 2022 USD ($) entity	Dec. 31, 2021 USD ($)
Investments In Variable Interest Entities [Abstract]
Number of consolidated entities \| entity	4
Variable Interest Entity [Line Items]
Maximum exposure to loss in unconsolidated VIEs	$ 1,369	$ 1,233
Total assets	212,867	211,308
Other liabilities	2,889	2,467
Qualified Affordable Housing Project Investments, Commitment	672	482
Consolidated
Variable Interest Entity [Line Items]
Maximum exposure to loss in unconsolidated VIEs	786
Total assets	809	812
Other liabilities	23	18
Unconsolidated
Variable Interest Entity [Line Items]
Total assets	1,375	1,239
Other liabilities	$ 672	$ 482

Cash and Cash Equivalents - Sum

Cash and Cash Equivalents - Summary of Cash and Cash Equivalents (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Cash and Cash Equivalents [Abstract]
Cash and due from banks	$ 1,411	$ 2,168
Interest bearing deposits with the Federal Reserve Bank	7,550	5,686
Interest bearing deposits with other institutions	4,610	5,773
Securities purchased under agreements to resell	397	607
Other short-term investment securities	0	352
Total cash and cash equivalents	$ 13,968	$ 14,586

Cash and Cash Equivalents - S_2

Cash and Cash Equivalents - Summary of Cash and Cash Equivalents (Footnote Information) (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Cash and Cash Equivalents [Abstract]
Fair value of securities purchased under agreements to resell	$ 402,000,000	$ 620,000,000
Securities received as collateral, amount repledged and sold	$ 0	$ 0

Investment Securities - Compone

Investment Securities - Components of Available-for-Sale Investment Securities Portfolio (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 29,502	$ 27,370
Unrealized Gains	0	164
Unrealized Losses	(2,791)	(313)
Carrying value	26,711	27,221
U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	18,041	15,799
Unrealized Gains	0	121
Unrealized Losses	(1,196)	(70)
Carrying value	16,845	15,850
U.S. agency debentures
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	120	200
Unrealized Gains	0	0
Unrealized Losses	(20)	(4)
Carrying value	100	196
Foreign government debt securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	1,062	61
Unrealized Gains	0	0
Unrealized Losses	(149)	0
Carrying value	913	61
Agency-issued MBS
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	7,883	8,786
Unrealized Gains	0	13
Unrealized Losses	(1,200)	(210)
Carrying value	6,683	8,589
Agency-issued CMO—fixed rate
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	792	988
Unrealized Gains	0	3
Unrealized Losses	(78)	(9)
Carrying value	714	982
Agency-issued CMBS
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	1,604	1,536
Unrealized Gains	0	27
Unrealized Losses	(148)	(20)
Carrying value	$ 1,456	$ 1,543

Investment Securities - Activit

Investment Securities - Activity of Available-for-Sale Securities (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Investments, Debt and Equity Securities [Abstract]
Sales proceeds	$ 0	$ 168	$ 8,511	$ 168
Gross realized gains	0	0	146	0
Gross realized losses	0	0	(98)	0
Net realized gains (losses)	$ 0	$ 0	$ 48	$ 0

Investment Securities - Summary

Investment Securities - Summary of Unrealized Losses on Available-for-Sale Securities (Details) $ in Millions	Sep. 30, 2022 USD ($) Investment	Dec. 31, 2021 USD ($) Investment
Debt Securities, Available-for-sale [Line Items]
Fair Value of Investments, Less than 12 months	$ 17,868	$ 17,596
Unrealized Losses, Less than 12 months	1,526	304
Fair Value of Investments, 12 months or longer	8,832	163
Unrealized Losses, 12 months or longer	1,265	9
Fair Value of Investments	26,700	17,759
Unrealized Losses	$ 2,791	$ 313
Number of investments in unrealized loss position \| Investment	804	475
Number of investments with unrealized losses greater than 12 months \| Investment	289	4
U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Fair Value of Investments, Less than 12 months	$ 13,359	$ 7,777
Unrealized Losses, Less than 12 months	958	70
Fair Value of Investments, 12 months or longer	3,487	0
Unrealized Losses, 12 months or longer	238	0
Fair Value of Investments	16,846	7,777
Unrealized Losses	1,196	70
U.S. agency debentures
Debt Securities, Available-for-sale [Line Items]
Fair Value of Investments, Less than 12 months	20	196
Unrealized Losses, Less than 12 months	1	4
Fair Value of Investments, 12 months or longer	80	0
Unrealized Losses, 12 months or longer	19	0
Fair Value of Investments	100	196
Unrealized Losses	20	4
Foreign government debt securities
Debt Securities, Available-for-sale [Line Items]
Fair Value of Investments, Less than 12 months	913
Unrealized Losses, Less than 12 months	149
Fair Value of Investments, 12 months or longer	0
Unrealized Losses, 12 months or longer	0
Fair Value of Investments	913
Unrealized Losses	149
Agency-issued MBS
Debt Securities, Available-for-sale [Line Items]
Fair Value of Investments, Less than 12 months	2,236	8,280
Unrealized Losses, Less than 12 months	304	210
Fair Value of Investments, 12 months or longer	4,448	0
Unrealized Losses, 12 months or longer	896	0
Fair Value of Investments	6,684	8,280
Unrealized Losses	1,200	210
Agency-issued CMO—fixed rate
Debt Securities, Available-for-sale [Line Items]
Fair Value of Investments, Less than 12 months	534	740
Unrealized Losses, Less than 12 months	55	9
Fair Value of Investments, 12 months or longer	168	0
Unrealized Losses, 12 months or longer	23	0
Fair Value of Investments	702	740
Unrealized Losses	78	9
Agency-issued CMBS
Debt Securities, Available-for-sale [Line Items]
Fair Value of Investments, Less than 12 months	806	603
Unrealized Losses, Less than 12 months	59	11
Fair Value of Investments, 12 months or longer	649	163
Unrealized Losses, 12 months or longer	89	9
Fair Value of Investments	1,455	766
Unrealized Losses	$ 148	$ 20

Investment Securities - Summa_2

Investment Securities - Summary of Remaining Contractual Principal Maturities for Available-for-Sale Securities (Details) - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
Total	$ 26,711	$ 27,221
One Year or Less	977
After One Year to Five Years	15,313
After Five Years to Ten Years	3,069
After Ten Years	7,352
U.S. treasury securities
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
Total	16,845	15,850
One Year or Less	936
After One Year to Five Years	15,133
After Five Years to Ten Years	776
After Ten Years	0
U.S. agency debentures
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
Total	100	196
One Year or Less	0
After One Year to Five Years	34
After Five Years to Ten Years	66
After Ten Years	0
Foreign government debt securities
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
Total	913	61
One Year or Less	41
After One Year to Five Years	46
After Five Years to Ten Years	826
After Ten Years	0
Agency-issued MBS
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
Total	6,683	8,589
One Year or Less	0
After One Year to Five Years	0
After Five Years to Ten Years	45
After Ten Years	6,638
Agency-issued CMO—fixed rate
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
Total	714	982
One Year or Less	0
After One Year to Five Years	0
After Five Years to Ten Years	0
After Ten Years	714
Agency-issued CMBS
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
Total	1,456	$ 1,543
One Year or Less	0
After One Year to Five Years	100
After Five Years to Ten Years	1,356
After Ten Years	$ 0
Available-for-sale Securities \| Lower Limit
Debt Securities, Available-for-sale [Line Items]
Mortgage-backed securities contractual maturities (in years)	10 years
Available-for-sale Securities \| Upper Limit
Debt Securities, Available-for-sale [Line Items]
Mortgage-backed securities contractual maturities (in years)	30 years

Investment Securities - Compo_2

Investment Securities - Components of Held-to-Maturity Investment Securities (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	$ 93,292	$ 98,202
Unrealized Gains	0	368
Unrealized Losses	(15,922)	(1,343)
Fair Value	77,370	97,227
Held-to-maturity securities, allowance for credit losses	6	7	$ 6	$ 5	$ 1
U.S. agency debentures
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	486	609
Unrealized Gains	0	8
Unrealized Losses	(53)	(2)
Fair Value	433	615
Held-to-maturity securities, allowance for credit losses	0	0
Agency-issued MBS
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	59,200	64,439
Unrealized Gains	0	124
Unrealized Losses	(10,017)	(887)
Fair Value	49,183	63,676
Held-to-maturity securities, allowance for credit losses	0	0
Agency-issued CMO \| Fixed rate
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	10,741	10,226
Unrealized Gains	0	9
Unrealized Losses	(1,813)	(145)
Fair Value	8,928	10,090
Held-to-maturity securities, allowance for credit losses	0	0
Agency-issued CMO \| Variable rate
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	83	100
Unrealized Gains	0	1
Unrealized Losses	(1)	0
Fair Value	82	101
Held-to-maturity securities, allowance for credit losses	0	0
Agency-issued CMBS
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	14,644	14,959
Unrealized Gains	0	39
Unrealized Losses	(2,304)	(277)
Fair Value	12,340	14,721
Held-to-maturity securities, allowance for credit losses	0	0
Municipal bonds and notes
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	7,429	7,157
Unrealized Gains	0	185
Unrealized Losses	(1,612)	(27)
Fair Value	5,817	7,315
Held-to-maturity securities, allowance for credit losses	1	1
Corporate bonds
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	709	712
Unrealized Gains	0	2
Unrealized Losses	(122)	(5)
Fair Value	587	709
Held-to-maturity securities, allowance for credit losses	$ 5	$ 6

Investment Securities - Allowan

Investment Securities - Allowance for Credit Losses for HTM Securities (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Jun. 30, 2021	Dec. 31, 2020
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]
Held-to-maturity securities, allowance for credit losses	$ 6	$ 6	$ 6	$ 7	$ 5	$ 1
Held-to-maturity securities, (reduction of) provision for credit losses,	$ 1	(1)	$ 6
Held-to-maturity, accrued interest receivable		294		171
Accrued interest receivable and other assets \| Held-to-maturity Securities
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]
Held-to-maturity, accrued interest receivable		205		225
Municipal bonds and notes
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]
Held-to-maturity securities, allowance for credit losses		1		1
Corporate bonds
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]
Held-to-maturity securities, allowance for credit losses		$ 5		$ 6

Investment Securities - Credit

Investment Securities - Credit Quality Indicators (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	$ 93,292	$ 98,202
Municipal bonds and notes
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	7,429	7,157
Municipal bonds and notes \| Aaa
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	4,270	3,774
Municipal bonds and notes \| Aa1
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	1,880	2,031
Municipal bonds and notes \| Aa2
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	1,081	1,154
Municipal bonds and notes \| Aa3
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	171	172
Municipal bonds and notes \| A1
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	27	26
Corporate bonds
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	709	712
Corporate bonds \| Aaa
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	39	39
Corporate bonds \| Aa2
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	42	42
Corporate bonds \| Aa3
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	105	105
Corporate bonds \| A1
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	282	251
Corporate bonds \| A2
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	230	264
Corporate bonds \| A3
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	$ 11	$ 11

Investment Securities - Summa_3

Investment Securities - Summary of Remaining Contractual Principal Maturities for Held-to-Maturity Securities (Details) - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Schedule of Held-to-maturity Securities [Line Items]
Net Carry Value	$ 93,286
Fair Value	77,370	$ 97,227
One Year or Less, Net Carry Value	72
One Year or Less, Fair Value	71
After One Year to Five Years, Net Carry Value	716
After One Year to Five Years, Fair Value	666
After Five Years to Ten Years, Net Carry Value	4,491
After Five Years to Ten Years, Fair Value	3,931
After Ten Years, Net Carry Value	88,007
After Ten Years, Fair Value	72,702
U.S. agency debentures
Schedule of Held-to-maturity Securities [Line Items]
Net Carry Value	486
Fair Value	433	615
One Year or Less, Net Carry Value	1
One Year or Less, Fair Value	1
After One Year to Five Years, Net Carry Value	118
After One Year to Five Years, Fair Value	111
After Five Years to Ten Years, Net Carry Value	367
After Five Years to Ten Years, Fair Value	321
After Ten Years, Net Carry Value	0
After Ten Years, Fair Value	0
Agency-issued MBS
Schedule of Held-to-maturity Securities [Line Items]
Net Carry Value	59,200
Fair Value	49,183	63,676
One Year or Less, Net Carry Value	1
One Year or Less, Fair Value	1
After One Year to Five Years, Net Carry Value	2
After One Year to Five Years, Fair Value	2
After Five Years to Ten Years, Net Carry Value	1,148
After Five Years to Ten Years, Fair Value	1,063
After Ten Years, Net Carry Value	58,049
After Ten Years, Fair Value	48,117
Agency-issued CMO \| Fixed rate
Schedule of Held-to-maturity Securities [Line Items]
Net Carry Value	10,741
Fair Value	8,928	10,090
One Year or Less, Net Carry Value	0
One Year or Less, Fair Value	0
After One Year to Five Years, Net Carry Value	87
After One Year to Five Years, Fair Value	83
After Five Years to Ten Years, Net Carry Value	154
After Five Years to Ten Years, Fair Value	146
After Ten Years, Net Carry Value	10,500
After Ten Years, Fair Value	8,699
Agency-issued CMO \| Variable rate
Schedule of Held-to-maturity Securities [Line Items]
Net Carry Value	83
Fair Value	82	101
One Year or Less, Net Carry Value	0
One Year or Less, Fair Value	0
After One Year to Five Years, Net Carry Value	0
After One Year to Five Years, Fair Value	0
After Five Years to Ten Years, Net Carry Value	0
After Five Years to Ten Years, Fair Value	0
After Ten Years, Net Carry Value	83
After Ten Years, Fair Value	82
Agency-issued CMBS
Schedule of Held-to-maturity Securities [Line Items]
Net Carry Value	14,644
Fair Value	12,340	14,721
One Year or Less, Net Carry Value	45
One Year or Less, Fair Value	44
After One Year to Five Years, Net Carry Value	159
After One Year to Five Years, Fair Value	146
After Five Years to Ten Years, Net Carry Value	968
After Five Years to Ten Years, Fair Value	802
After Ten Years, Net Carry Value	13,472
After Ten Years, Fair Value	11,348
Municipal bonds and notes
Schedule of Held-to-maturity Securities [Line Items]
Net Carry Value	7,428
Fair Value	5,817	7,315
One Year or Less, Net Carry Value	25
One Year or Less, Fair Value	25
After One Year to Five Years, Net Carry Value	235
After One Year to Five Years, Fair Value	222
After Five Years to Ten Years, Net Carry Value	1,265
After Five Years to Ten Years, Fair Value	1,114
After Ten Years, Net Carry Value	5,903
After Ten Years, Fair Value	4,456
Corporate bonds
Schedule of Held-to-maturity Securities [Line Items]
Net Carry Value	704
Fair Value	587	$ 709
One Year or Less, Net Carry Value	0
One Year or Less, Fair Value	0
After One Year to Five Years, Net Carry Value	115
After One Year to Five Years, Fair Value	102
After Five Years to Ten Years, Net Carry Value	589
After Five Years to Ten Years, Fair Value	485
After Ten Years, Net Carry Value	0
After Ten Years, Fair Value	$ 0
Held-to-maturity Securities \| Lower Limit
Schedule of Held-to-maturity Securities [Line Items]
Mortgage-backed securities contractual maturities (in years)	10 years
Held-to-maturity Securities \| Upper Limit
Schedule of Held-to-maturity Securities [Line Items]
Mortgage-backed securities contractual maturities (in years)	30 years

Investment Securities - Compo_3

Investment Securities - Components of Non-marketable and Other Equity Securities (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Investment Holdings [Line Items]
Investments in qualified affordable housing projects, net	$ 1,205	$ 954
Non-marketable and other equity securities	2,595	2,543
Fair value accounting \| Consolidated venture capital and private equity fund investments
Investment Holdings [Line Items]
Nonmarketable securities	147	130
Fair value accounting \| Unconsolidated venture capital and private equity fund investments
Investment Holdings [Line Items]
Nonmarketable securities	123	208
Fair value accounting \| Equity securities
Investment Holdings [Line Items]
Other equity securities in public companies (fair value accounting)	29	117
Fair value accounting \| Other investments
Investment Holdings [Line Items]
Nonmarketable securities	176	164
Equity method accounting
Investment Holdings [Line Items]
Nonmarketable securities	639	671
Equity method accounting \| Consolidated venture capital and private equity fund investments
Investment Holdings [Line Items]
Nonmarketable securities	639	671
Equity method accounting \| Debt funds
Investment Holdings [Line Items]
Nonmarketable securities	4	5
Equity method accounting \| Other investments
Investment Holdings [Line Items]
Nonmarketable securities	$ 272	$ 294

Investment Securities - Summa_4

Investment Securities - Summary of Venture Capital and Private Equity Fund Investments Held by Consolidated Funds and Percentage Ownership (Details) - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Upper Limit
Investment Holdings [Line Items]
Percentage of ownership	5%
Fair value accounting \| Consolidated venture capital and private equity fund investments
Investment Holdings [Line Items]
Nonmarketable securities	$ 147		$ 130
Fair value accounting \| Consolidated venture capital and private equity fund investments \| Strategic Investors Fund, LP
Investment Holdings [Line Items]
Nonmarketable securities	2		2
Fair value accounting \| Consolidated venture capital and private equity fund investments \| Capital Preferred Return Fund, LP
Investment Holdings [Line Items]
Nonmarketable securities	30		61
Fair value accounting \| Consolidated venture capital and private equity fund investments \| Growth Partners, LP
Investment Holdings [Line Items]
Nonmarketable securities	25		67
Fair value accounting \| Consolidated venture capital and private equity fund investments \| Redwood Evergreen Fund, LP
Investment Holdings [Line Items]
Nonmarketable securities	$ 90		$ 0
Non-marketable securities \| Fair value accounting \| Consolidated venture capital and private equity fund investments \| Strategic Investors Fund, LP
Investment Holdings [Line Items]
Percentage of ownership	12.60%	12.60%
Non-marketable securities \| Fair value accounting \| Consolidated venture capital and private equity fund investments \| Capital Preferred Return Fund, LP
Investment Holdings [Line Items]
Percentage of ownership	20%	20%
Non-marketable securities \| Fair value accounting \| Consolidated venture capital and private equity fund investments \| Growth Partners, LP
Investment Holdings [Line Items]
Percentage of ownership	33%	33%
Non-marketable securities \| Fair value accounting \| Consolidated venture capital and private equity fund investments \| Redwood Evergreen Fund, LP
Investment Holdings [Line Items]
Percentage of ownership	100%	0%

Investment Securities - Non-mar

Investment Securities - Non-marketable and Other Securities Additional Information (Details) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022 USD ($) Investment	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) Investment	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($) Investment
Investment Holdings [Line Items]
Investments in qualified affordable housing projects, net	$ 1,205		$ 1,205		$ 954
Other liabilities	672		672		482
Tax credits and other tax benefits recognized	30	$ 9	80	$ 63
Amortization expense included in provision for income taxes	17	$ 17	52	$ 48
Fair value accounting \| Unconsolidated venture capital and private equity fund investments
Investment Holdings [Line Items]
Nonmarketable securities	123		123		208
Fair value accounting \| Consolidated venture capital and private equity fund investments
Investment Holdings [Line Items]
Nonmarketable securities	147		147		130
Equity method accounting
Investment Holdings [Line Items]
Nonmarketable securities	639		639		671
Equity method accounting \| Consolidated venture capital and private equity fund investments
Investment Holdings [Line Items]
Nonmarketable securities	639		639		671
Equity method accounting \| Consolidated venture capital and private equity fund investments \| CP II, LP
Investment Holdings [Line Items]
Nonmarketable securities	$ 2		$ 2		$ 2
Upper Limit
Investment Holdings [Line Items]
Percentage of ownership	5%
Non-marketable securities \| Fair value accounting \| Unconsolidated venture capital and private equity fund investments
Investment Holdings [Line Items]
Number of investments \| Investment	141		141		150
Non-marketable securities \| Equity method accounting \| Consolidated venture capital and private equity fund investments \| CP II, LP
Investment Holdings [Line Items]
Percentage of ownership	5.10%	5.10%
Non-marketable securities \| Equity method accounting \| Consolidated venture capital and private equity fund investments \| CP II, LP \| Direct ownership interest
Investment Holdings [Line Items]
Percentage of ownership	1.30%

Investment Securities - Changes

Investment Securities - Changes to Carrying Amount of Other Investments without Readily Determinable Fair Value (Details) $ in Millions	9 Months Ended
	Sep. 30, 2022 USD ($)
Investments, Debt and Equity Securities [Abstract]
Carrying value	$ 176
Carrying value adjustments:
Impairment	0
Upward changes for observable prices	0
Downward changes for observable prices	(6)
Cumulative Adjustments
Impairment	(1)
Upward changes for observable prices	52
Downward changes for observable prices	$ (11)

Investment Securities - Carryin

Investment Securities - Carrying Value and Ownership Percentage of Investments (Details) - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Equity method accounting
Investment Holdings [Line Items]
Nonmarketable securities	$ 639		$ 671
Consolidated venture capital and private equity fund investments \| Fair value accounting
Investment Holdings [Line Items]
Nonmarketable securities	147		130
Consolidated venture capital and private equity fund investments \| Equity method accounting
Investment Holdings [Line Items]
Nonmarketable securities	639		671
Consolidated venture capital and private equity fund investments \| Equity method accounting \| Strategic Investors Fund II, LP
Investment Holdings [Line Items]
Nonmarketable securities	2		3
Consolidated venture capital and private equity fund investments \| Equity method accounting \| Strategic Investors Fund III, LP
Investment Holdings [Line Items]
Nonmarketable securities	13		25
Consolidated venture capital and private equity fund investments \| Equity method accounting \| Strategic Investors Fund IV, LP
Investment Holdings [Line Items]
Nonmarketable securities	23		36
Consolidated venture capital and private equity fund investments \| Equity method accounting \| Strategic Investors Fund V funds
Investment Holdings [Line Items]
Nonmarketable securities	59		87
Consolidated venture capital and private equity fund investments \| Equity method accounting \| CP II, LP
Investment Holdings [Line Items]
Nonmarketable securities	2		2
Consolidated venture capital and private equity fund investments \| Equity method accounting \| Other venture capital and private equity fund investments
Investment Holdings [Line Items]
Nonmarketable securities	540		518
Debt funds \| Equity method accounting
Investment Holdings [Line Items]
Nonmarketable securities	4		5
Debt funds \| Equity method accounting \| Gold Hill Capital 2008, LP
Investment Holdings [Line Items]
Nonmarketable securities	3		4
Debt funds \| Equity method accounting \| Other debt funds
Investment Holdings [Line Items]
Nonmarketable securities	1		1
Other investments \| Fair value accounting
Investment Holdings [Line Items]
Nonmarketable securities	176		164
Other investments \| Equity method accounting
Investment Holdings [Line Items]
Nonmarketable securities	272		294
Other investments \| Equity method accounting \| SPD Silicon Valley Bank Co., Ltd.
Investment Holdings [Line Items]
Nonmarketable securities	143		154
Other investments \| Equity method accounting \| Other investments
Investment Holdings [Line Items]
Nonmarketable securities	$ 129		$ 140
Non-marketable securities \| Consolidated venture capital and private equity fund investments \| Equity method accounting \| Strategic Investors Fund II, LP
Investment Holdings [Line Items]
Percentage of ownership	8.60%	8.60%
Non-marketable securities \| Consolidated venture capital and private equity fund investments \| Equity method accounting \| Strategic Investors Fund III, LP
Investment Holdings [Line Items]
Percentage of ownership	5.90%	5.90%
Non-marketable securities \| Consolidated venture capital and private equity fund investments \| Equity method accounting \| Strategic Investors Fund IV, LP
Investment Holdings [Line Items]
Percentage of ownership	5%	5%
Non-marketable securities \| Consolidated venture capital and private equity fund investments \| Equity method accounting \| CP II, LP
Investment Holdings [Line Items]
Percentage of ownership	5.10%	5.10%
Non-marketable securities \| Consolidated venture capital and private equity fund investments \| Equity method accounting \| CP II, LP \| Direct ownership interest
Investment Holdings [Line Items]
Percentage of ownership	1.30%
Non-marketable securities \| Consolidated venture capital and private equity fund investments \| Equity method accounting \| CP II, LP \| Indirect ownership interest
Investment Holdings [Line Items]
Percentage of ownership	3.80%
Non-marketable securities \| Debt funds \| Equity method accounting \| Direct ownership interest
Investment Holdings [Line Items]
Percentage of ownership	11.50%
Non-marketable securities \| Debt funds \| Equity method accounting \| Indirect ownership interest
Investment Holdings [Line Items]
Percentage of ownership	4%
Non-marketable securities \| Debt funds \| Equity method accounting \| Gold Hill Capital 2008, LP
Investment Holdings [Line Items]
Percentage of ownership	15.50%	15.50%
Non-marketable securities \| Other investments \| Equity method accounting \| SPD Silicon Valley Bank Co., Ltd.
Investment Holdings [Line Items]
Percentage of ownership	50%	50%

Investment Securities - Net Gai

Investment Securities - Net Gains on Non-marketable and Other Equity Securities (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Gain (Loss) on Securities [Line Items]
Total net gains on non-marketable and other equity securities	$ (127)	$ 189	$ (247)	$ 661
Non-marketable securities
Gain (Loss) on Securities [Line Items]
Less: realized net gains (losses) on sales of non-marketable and other equity securities	13	(17)	(16)	110
Net (losses) gains on non-marketable and other equity securities still held	(140)	206	(231)	551
Non-marketable securities \| Fair value accounting \| Consolidated venture capital and private equity fund investments
Gain (Loss) on Securities [Line Items]
Total net gains on non-marketable and other equity securities	(52)	36	(100)	72
Non-marketable securities \| Fair value accounting \| Unconsolidated venture capital and private equity fund investments
Gain (Loss) on Securities [Line Items]
Total net gains on non-marketable and other equity securities	(61)	47	(80)	79
Non-marketable securities \| Fair value accounting \| Other investments
Gain (Loss) on Securities [Line Items]
Total net gains on non-marketable and other equity securities	0	(2)	(3)	11
Non-marketable securities \| Equity method accounting \| Consolidated venture capital and private equity fund investments
Gain (Loss) on Securities [Line Items]
Total net gains on non-marketable and other equity securities	(12)	144	(20)	438
Non-marketable securities \| Equity method accounting \| Debt funds
Gain (Loss) on Securities [Line Items]
Total net gains on non-marketable and other equity securities	(1)	0	(1)	2
Non-marketable securities \| Equity method accounting \| Other investments
Gain (Loss) on Securities [Line Items]
Total net gains on non-marketable and other equity securities	7	3	9	6
Other equity securities \| Fair value accounting
Gain (Loss) on Securities [Line Items]
Total net gains on non-marketable and other equity securities	$ (8)	$ (39)	$ (52)	$ 53

Loans and Allowance for Credi_3

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Composition of Loans, Net of Unearned Income (Details) - USD ($) $ in Millions	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	$ 72,129		$ 66,276
ACL	(557)	$ (545)	(422)	$ (398)	$ (396)	$ (448)
Net loans	71,572		65,854
Unearned income on loans	244		250
Credit cards
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	582		583
Construction loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	454		367
Global fund banking
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	40,337		37,958
ACL	(91)	(89)	(67)	(59)	(66)	(46)
Investor dependent
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	6,309		5,544
ACL	(234)	(224)	(146)	(138)	(158)	(213)
Investor dependent \| Early stage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	1,911		1,593
Investor dependent \| Growth stage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	4,398		3,951
Cash flow dependent and innovation C&I (Commercial and Industrial)
Accounts, Notes, Loans and Financing Receivable [Line Items]
ACL	(136)	(130)	(118)	(109)	(119)	(125)
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Cash flow dependent - SLBO
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	1,845		1,798
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Innovation C&I
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	8,321		6,673
Private bank
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	10,102		8,743
ACL	(47)	(45)	(33)	(31)	(47)	(53)
CRE
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	2,609		2,670
ACL	(27)	(34)	(36)	(40)	0	0
Other C&I
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	1,087		1,257
ACL	(12)	(12)	(14)	(12)	0	0
Premium wine and other
Accounts, Notes, Loans and Financing Receivable [Line Items]
ACL	(10)	$ (11)	(8)	(9)	$ (6)	(9)
Premium wine and other \| Premium wine
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	1,117		985
PPP Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	$ 28		$ 331
ACL				$ 0		$ (2)

Loans and Allowance for Credi_4

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Credit Quality Indicators, Broken out by Risk-Based Segments and Vintage Year (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	$ 8,623	$ 11,032
Year Two	8,711	5,880
Year Three	4,127	3,045
Year Four	2,154	1,279
Year Five	835	1,006
Prior	2,696	2,462
Revolving Loans	44,967	41,516
Revolving Loans Converted to Term Loans	60	77
Unallocated	(44)	(21)
Loans, amortized cost	72,129	66,276
Global fund banking
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	512	814
Year Two	95	133
Year Three	63	36
Year Four	31	6
Year Five	1	8
Prior	10	5
Revolving Loans	39,625	36,956
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	40,337	37,958
Global fund banking \| Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	0
Year Two	0	0
Year Three	0	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	0	0
Global fund banking \| Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	512	764
Year Two	95	115
Year Three	63	36
Year Four	31	6
Year Five	1	8
Prior	10	4
Revolving Loans	39,616	36,955
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	40,328	37,888
Global fund banking \| Criticized
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	50
Year Two	0	18
Year Three	0	0
Year Four	0	0
Year Five	0	0
Prior	0	1
Revolving Loans	9	1
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	9	70
Investor dependent
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	2,645	3,053
Year Two	2,456	1,374
Year Three	515	448
Year Four	129	117
Year Five	35	23
Prior	9	2
Revolving Loans	515	522
Revolving Loans Converted to Term Loans	5	5
Unallocated	0	0
Loans, amortized cost	6,309	5,544
Investor dependent \| Early stage
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	795	820
Year Two	749	379
Year Three	100	155
Year Four	43	31
Year Five	2	6
Prior	3	1
Revolving Loans	219	201
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	1,911	1,593
Investor dependent \| Early stage \| Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	1	2
Year Two	1	5
Year Three	0	3
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	2	1
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	4	11
Investor dependent \| Early stage \| Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	727	754
Year Two	626	287
Year Three	73	122
Year Four	36	26
Year Five	2	6
Prior	1	1
Revolving Loans	191	171
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	1,656	1,367
Investor dependent \| Early stage \| Criticized
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	67	64
Year Two	122	87
Year Three	27	30
Year Four	7	5
Year Five	0	0
Prior	2	0
Revolving Loans	26	29
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	251	215
Investor dependent \| Growth stage
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	1,850	2,233
Year Two	1,707	995
Year Three	415	293
Year Four	86	86
Year Five	33	17
Prior	6	1
Revolving Loans	296	321
Revolving Loans Converted to Term Loans	5	5
Unallocated	0	0
Loans, amortized cost	4,398	3,951
Investor dependent \| Growth stage \| Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	19	2
Year Two	18	0
Year Three	2	1
Year Four	0	2
Year Five	0	0
Prior	0	0
Revolving Loans	4	1
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	43	6
Investor dependent \| Growth stage \| Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	1,684	2,072
Year Two	1,456	910
Year Three	360	265
Year Four	72	78
Year Five	28	14
Prior	6	1
Revolving Loans	243	286
Revolving Loans Converted to Term Loans	5	5
Unallocated	0	0
Loans, amortized cost	3,854	3,631
Investor dependent \| Growth stage \| Criticized
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	147	159
Year Two	233	85
Year Three	53	27
Year Four	14	6
Year Five	5	3
Prior	0	0
Revolving Loans	49	34
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	501	314
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Cash flow dependent - SLBO
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	698	875
Year Two	609	384
Year Three	215	284
Year Four	205	107
Year Five	20	83
Prior	61	15
Revolving Loans	37	50
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	1,845	1,798
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Cash flow dependent - SLBO \| Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	0
Year Two	0	0
Year Three	0	12
Year Four	0	10
Year Five	5	7
Prior	0	0
Revolving Loans	2	5
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	7	34
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Cash flow dependent - SLBO \| Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	678	875
Year Two	609	384
Year Three	199	252
Year Four	203	72
Year Five	14	76
Prior	39	2
Revolving Loans	30	35
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	1,772	1,696
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Cash flow dependent - SLBO \| Criticized
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	20	0
Year Two	0	0
Year Three	16	20
Year Four	2	25
Year Five	1	0
Prior	22	13
Revolving Loans	5	10
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	66	68
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Innovation C&I
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	1,837	2,294
Year Two	1,882	1,188
Year Three	894	350
Year Four	198	135
Year Five	29	58
Prior	54	0
Revolving Loans	3,427	2,648
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	8,321	6,673
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Innovation C&I \| Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	0
Year Two	0	0
Year Three	0	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	1	1
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	1	1
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Innovation C&I \| Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	1,788	2,230
Year Two	1,734	1,058
Year Three	773	288
Year Four	166	123
Year Five	18	58
Prior	54	0
Revolving Loans	3,102	2,411
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	7,635	6,168
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Innovation C&I \| Criticized
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	49	64
Year Two	148	130
Year Three	121	62
Year Four	32	12
Year Five	11	0
Prior	0	0
Revolving Loans	324	236
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	685	504
Private bank
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	2,210	2,952
Year Two	2,833	2,015
Year Three	1,754	1,126
Year Four	952	529
Year Five	442	434
Prior	1,077	969
Revolving Loans	829	710
Revolving Loans Converted to Term Loans	5	8
Unallocated	0	0
Loans, amortized cost	10,102	8,743
Private bank \| Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	0
Year Two	0	0
Year Three	1	2
Year Four	2	9
Year Five	1	0
Prior	8	8
Revolving Loans	1	2
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	13	21
Private bank \| Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	2,210	2,952
Year Two	2,817	2,015
Year Three	1,753	1,122
Year Four	948	520
Year Five	441	432
Prior	1,054	952
Revolving Loans	818	705
Revolving Loans Converted to Term Loans	5	8
Unallocated	0	0
Loans, amortized cost	10,046	8,706
Private bank \| Criticized
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	0
Year Two	16	0
Year Three	0	2
Year Four	2	0
Year Five	0	2
Prior	15	9
Revolving Loans	10	3
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	43	16
CRE
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	408	329
Year Two	296	254
Year Three	232	463
Year Four	380	192
Year Five	167	283
Prior	1,008	1,007
Revolving Loans	113	128
Revolving Loans Converted to Term Loans	5	14
Unallocated	0	0
Loans, amortized cost	2,609	2,670
CRE \| Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	0
Year Two	0	0
Year Three	0	5
Year Four	5	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	5	5
CRE \| Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	406	326
Year Two	292	215
Year Three	181	344
Year Four	240	155
Year Five	143	236
Prior	894	868
Revolving Loans	96	110
Revolving Loans Converted to Term Loans	5	2
Unallocated	0	0
Loans, amortized cost	2,257	2,256
CRE \| Criticized
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	2	3
Year Two	4	39
Year Three	51	114
Year Four	135	37
Year Five	24	47
Prior	114	139
Revolving Loans	17	18
Revolving Loans Converted to Term Loans	0	12
Unallocated	0	0
Loans, amortized cost	347	409
Premium wine and other \| Premium wine
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	256	218
Year Two	218	119
Year Three	91	167
Year Four	144	78
Year Five	56	71
Prior	153	162
Revolving Loans	165	136
Revolving Loans Converted to Term Loans	34	34
Unallocated	0	0
Loans, amortized cost	1,117	985
Premium wine and other \| Premium wine \| Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	0
Year Two	0	0
Year Three	0	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	0	0
Premium wine and other \| Premium wine \| Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	255	217
Year Two	213	112
Year Three	91	156
Year Four	137	69
Year Five	47	71
Prior	144	162
Revolving Loans	156	125
Revolving Loans Converted to Term Loans	34	34
Unallocated	0	0
Loans, amortized cost	1,077	946
Premium wine and other \| Premium wine \| Criticized
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	1	1
Year Two	5	7
Year Three	0	11
Year Four	7	9
Year Five	9	0
Prior	9	0
Revolving Loans	9	11
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	40	39
Premium wine and other \| Other
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	25	61
Year Two	154	151
Year Three	189	83
Year Four	39	20
Year Five	0	16
Prior	0	0
Revolving Loans	11	7
Revolving Loans Converted to Term Loans	0	0
Unallocated	(44)	(21)
Loans, amortized cost	374	317
Premium wine and other \| Other \| Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	0
Year Two	0	0
Year Three	0	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	0	0
Premium wine and other \| Other \| Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	25	61
Year Two	151	144
Year Three	172	82
Year Four	30	20
Year Five	0	14
Prior	0	0
Revolving Loans	11	7
Revolving Loans Converted to Term Loans	0	0
Unallocated	(44)	(21)
Loans, amortized cost	345	307
Premium wine and other \| Other \| Criticized
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	0
Year Two	3	7
Year Three	17	1
Year Four	9	0
Year Five	0	2
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	29	10
Other C&I
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	32	186
Year Two	149	181
Year Three	165	88
Year Four	76	95
Year Five	85	30
Prior	324	302
Revolving Loans	245	359
Revolving Loans Converted to Term Loans	11	16
Unallocated	0	0
Loans, amortized cost	1,087	1,257
Other C&I \| Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	0
Year Two	0	0
Year Three	1	0
Year Four	0	2
Year Five	1	0
Prior	1	1
Revolving Loans	0	1
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	3	4
Other C&I \| Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	31	181
Year Two	149	175
Year Three	161	82
Year Four	70	86
Year Five	81	28
Prior	304	301
Revolving Loans	234	350
Revolving Loans Converted to Term Loans	10	11
Unallocated	0	0
Loans, amortized cost	1,040	1,214
Other C&I \| Criticized
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	1	5
Year Two	0	6
Year Three	3	6
Year Four	6	7
Year Five	3	2
Prior	19	0
Revolving Loans	11	8
Revolving Loans Converted to Term Loans	1	5
Unallocated	0	0
Loans, amortized cost	44	39
PPP Loans
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	250
Year Two	19	81
Year Three	9	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	28	331
PPP Loans \| Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	2
Year Two	0	0
Year Three	0	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	0	2
PPP Loans \| Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	226
Year Two	16	72
Year Three	3	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	19	298
PPP Loans \| Criticized
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	22
Year Two	3	9
Year Three	6	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	$ 9	$ 31

Loans and Allowance for Credi_5

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Activity Relating to our Allowance for Credit Losses for Loans (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Jun. 30, 2021	Dec. 31, 2020
Financing Receivable, Allowance for Credit Loss [Line Items]
Change in allowance for credit loss	$ 12
Held-to-maturity, accrued interest receivable	294		$ 294		$ 171
Allowance for credit loss, beginning balance	545	$ 396	422	$ 448
Initial Allowance on PCD Loans						$ 22	$ 22
Charge-offs	(26)	(19)	(66)	(129)
Recoveries	11	8	23	16
Provision (Reduction) for Credit Loss for Loans	30	(9)	184	41
Foreign Currency Translation Adjustments	(3)		(6)
Allowance for credit loss, ending balance	557	398	557	398
Global fund banking
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit loss, beginning balance	89	66	67	46
Initial Allowance on PCD Loans						0	0
Charge-offs	0	0	0	(80)
Recoveries	6	0	6	0
Provision (Reduction) for Credit Loss for Loans	(4)	(7)	18	93
Foreign Currency Translation Adjustments	0		0
Allowance for credit loss, ending balance	91	59	91	59
Investor dependent
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit loss, beginning balance	224	158	146	213
Initial Allowance on PCD Loans						0	0
Charge-offs	(20)	(17)	(53)	(37)
Recoveries	4	5	13	13
Provision (Reduction) for Credit Loss for Loans	25	(8)	126	(51)
Foreign Currency Translation Adjustments	1		2
Allowance for credit loss, ending balance	234	138	234	138
Cash flow dependent and innovation C&I (Commercial and Industrial)
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit loss, beginning balance	130	119	118	125
Initial Allowance on PCD Loans						0	0
Charge-offs	(5)	(1)	(9)	(8)
Recoveries	0	3	0	3
Provision (Reduction) for Credit Loss for Loans	11	(12)	27	(11)
Foreign Currency Translation Adjustments	0		0
Allowance for credit loss, ending balance	136	109	136	109
Private bank
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit loss, beginning balance	45	47	33	53
Initial Allowance on PCD Loans						1	1
Charge-offs	0	(1)	0	(3)
Recoveries	0	0	2	0
Provision (Reduction) for Credit Loss for Loans	2	(16)	12	(20)
Foreign Currency Translation Adjustments	0		0
Allowance for credit loss, ending balance	47	31	47	31
CRE
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit loss, beginning balance	34	0	36	0
Initial Allowance on PCD Loans						17	17
Charge-offs	0	0	0
Recoveries	0	0	0
Provision (Reduction) for Credit Loss for Loans	(7)	23	(9)
Foreign Currency Translation Adjustments	0		0
Allowance for credit loss, ending balance	27	40	27	40
Other C&I
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit loss, beginning balance	12	0	14	0
Initial Allowance on PCD Loans						4	4
Charge-offs	(1)	0	(3)
Recoveries	1	0	1
Provision (Reduction) for Credit Loss for Loans	0	8	0
Foreign Currency Translation Adjustments	0		0
Allowance for credit loss, ending balance	12	12	12	12
Premium wine and other
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit loss, beginning balance	11	6	8	9
Initial Allowance on PCD Loans						$ 0	0
Charge-offs	0	0	(1)	(1)
Recoveries	0	0	1	0
Provision (Reduction) for Credit Loss for Loans	3	3	10	1
Foreign Currency Translation Adjustments	(4)		(8)
Allowance for credit loss, ending balance	$ 10	9	$ 10	9
PPP Loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit loss, beginning balance				2
Initial Allowance on PCD Loans							$ 0
Charge-offs				0
Recoveries				0
Provision (Reduction) for Credit Loss for Loans				(2)
Allowance for credit loss, ending balance		$ 0		$ 0

Loans and Allowance for Credi_6

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Summary of the Aging of Loans Broken out by Risk-based Segments (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	$ 72,129	$ 66,276
Loans Past Due 90 Days or More Still Accruing Interest	6	7
30 - 59 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	43	63
60 - 89 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	40	8
Equal to or Greater Than 90 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	19	20
Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	102	91
Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	72,027	66,185
Global fund banking
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	40,337	37,958
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Global fund banking \| 30 - 59 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Global fund banking \| 60 - 89 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Global fund banking \| Equal to or Greater Than 90 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Global fund banking \| Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Global fund banking \| Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	40,337	37,958
Investor dependent
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	6,309	5,544
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Investor dependent \| 30 - 59 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	28	22
Investor dependent \| 60 - 89 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	15	5
Investor dependent \| Equal to or Greater Than 90 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	3	0
Investor dependent \| Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	46	27
Investor dependent \| Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	6,263	5,517
Investor dependent \| Early stage
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	1,911	1,593
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Investor dependent \| Early stage \| 30 - 59 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	2	6
Investor dependent \| Early stage \| 60 - 89 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	2	5
Investor dependent \| Early stage \| Equal to or Greater Than 90 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	1	0
Investor dependent \| Early stage \| Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	5	11
Investor dependent \| Early stage \| Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	1,906	1,582
Investor dependent \| Growth stage
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	4,398	3,951
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Investor dependent \| Growth stage \| 30 - 59 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	26	16
Investor dependent \| Growth stage \| 60 - 89 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	13	0
Investor dependent \| Growth stage \| Equal to or Greater Than 90 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	2	0
Investor dependent \| Growth stage \| Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	41	16
Investor dependent \| Growth stage \| Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	4,357	3,935
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Cash flow dependent - SLBO
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	1,845	1,798
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Cash flow dependent - SLBO \| 30 - 59 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	4	0
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Cash flow dependent - SLBO \| 60 - 89 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Cash flow dependent - SLBO \| Equal to or Greater Than 90 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Cash flow dependent - SLBO \| Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	4	0
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Cash flow dependent - SLBO \| Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	1,841	1,798
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Innovation C&I
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	8,321	6,673
Loans Past Due 90 Days or More Still Accruing Interest	0	7
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Innovation C&I \| 30 - 59 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	6	7
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Innovation C&I \| 60 - 89 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	3	0
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Innovation C&I \| Equal to or Greater Than 90 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	7
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Innovation C&I \| Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	9	14
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Innovation C&I \| Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	8,312	6,659
Private bank
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	10,102	8,743
Loans Past Due 90 Days or More Still Accruing Interest	1	0
Private bank \| 30 - 59 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	1	28
Private bank \| 60 - 89 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	12	1
Private bank \| Equal to or Greater Than 90 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	5	12
Private bank \| Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	18	41
Private bank \| Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	10,084	8,702
CRE
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	2,609	2,670
Loans Past Due 90 Days or More Still Accruing Interest	0	0
CRE \| 30 - 59 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	1	1
CRE \| 60 - 89 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	7	0
CRE \| Equal to or Greater Than 90 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	5	0
CRE \| Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	13	1
CRE \| Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	2,596	2,669
Other C&I
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	1,087	1,257
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Other C&I \| 30 - 59 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	1
Other C&I \| 60 - 89 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	3	2
Other C&I \| Equal to or Greater Than 90 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	1
Other C&I \| Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	3	4
Other C&I \| Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	1,084	1,253
Premium wine and other \| Premium wine
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	1,117	985
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Premium wine and other \| Premium wine \| 30 - 59 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	3	3
Premium wine and other \| Premium wine \| 60 - 89 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Premium wine and other \| Premium wine \| Equal to or Greater Than 90 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Premium wine and other \| Premium wine \| Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	3	3
Premium wine and other \| Premium wine \| Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	1,114	982
Premium wine and other \| Other
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	374	317
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Premium wine and other \| Other \| 30 - 59 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Premium wine and other \| Other \| 60 - 89 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Premium wine and other \| Other \| Equal to or Greater Than 90 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Premium wine and other \| Other \| Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Premium wine and other \| Other \| Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	374	317
PPP Loans
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	28	331
Loans Past Due 90 Days or More Still Accruing Interest	5	0
PPP Loans \| 30 - 59 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	1
PPP Loans \| 60 - 89 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
PPP Loans \| Equal to or Greater Than 90 Days Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	6	0
PPP Loans \| Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	6	1
PPP Loans \| Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	$ 22	$ 330

Loans and Allowance for Credi_7

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Nonaccrual Loans with No Allowance for Credit Loss (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Financing Receivable, Nonaccrual [Line Items]
Nonaccrual Loans	$ 76	$ 84
Nonaccrual Loans with no Allowance for Credit Loss	7	9
Investor dependent
Financing Receivable, Nonaccrual [Line Items]
Nonaccrual Loans	47	17
Nonaccrual Loans with no Allowance for Credit Loss	1	0
Investor dependent \| Early stage
Financing Receivable, Nonaccrual [Line Items]
Nonaccrual Loans	4	11
Nonaccrual Loans with no Allowance for Credit Loss	0	0
Investor dependent \| Growth stage
Financing Receivable, Nonaccrual [Line Items]
Nonaccrual Loans	43	6
Nonaccrual Loans with no Allowance for Credit Loss	1	0
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Cash flow dependent - SLBO
Financing Receivable, Nonaccrual [Line Items]
Nonaccrual Loans	7	34
Nonaccrual Loans with no Allowance for Credit Loss	0	0
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Innovation C&I
Financing Receivable, Nonaccrual [Line Items]
Nonaccrual Loans	1	1
Nonaccrual Loans with no Allowance for Credit Loss	0	1
Private bank
Financing Receivable, Nonaccrual [Line Items]
Nonaccrual Loans	13	21
Nonaccrual Loans with no Allowance for Credit Loss	6	8
CRE
Financing Receivable, Nonaccrual [Line Items]
Nonaccrual Loans	5	5
Nonaccrual Loans with no Allowance for Credit Loss	0	0
Other C&I
Financing Receivable, Nonaccrual [Line Items]
Nonaccrual Loans	3	4
Nonaccrual Loans with no Allowance for Credit Loss	0	0
PPP Loans
Financing Receivable, Nonaccrual [Line Items]
Nonaccrual Loans	0	2
Nonaccrual Loans with no Allowance for Credit Loss	$ 0	$ 0

Loans and Allowance for Credi_8

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Summary of Loans Modified in Troubled Debt Restructurings (TDRs) (Details) $ in Millions	9 Months Ended
	Sep. 30, 2022 USD ($) troubled_debt_restructuring	Dec. 31, 2021 USD ($)
Financing Receivable, Troubled Debt Restructuring [Line Items]
Number of TDRs \| troubled_debt_restructuring	39
Loans modified in TDRs	$ 85	$ 96
Unfunded commitments available for funding associated with TDRs	0
Investor dependent
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	33	15
Investor dependent \| Early stage
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	1	12
Investor dependent \| Growth stage
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	32	3
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Cash flow dependent - SLBO
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	8	34
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Innovation C&I
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	1	0
Private bank
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	8	12
CRE
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	33	33
Other C&I
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	$ 2	$ 2

Loans and Allowance for Credi_9

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Recorded Investment in Loans Modified in TDRs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	$ 19,000	$ 53,000	$ 40,000	$ 66,000
Partial charge-offs on loans classified as TDRs	4,000		9,000	7,000
Payment deferrals
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	19,000	17,000	38,000	30,000
Extended Maturity
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period		14,000		14,000
Interest Rate Below Market Reduction
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period			1,000
Payment Deferral and Extended Maturity
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period		22,000		22,000
Modified Through Settlement
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period			1,000
Investor dependent
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	13,000	8,000	33,000	9,000
Investor dependent \| Early stage
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	1,000	0	1,000	1,000
Recorded investment in loans modified in TDRs			1,000
Investor dependent \| Growth stage
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	12,000	8,000	32,000	8,000
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Cash flow dependent - SLBO
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	0	0	0	12,000
Cash flow dependent and innovation C&I (Commercial and Industrial) \| Innovation C&I
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	1,000	0	1,000	0
Private bank
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	0	2,000	1,000	2,000
CRE
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	$ 5,000	$ 43,000	$ 5,000	$ 43,000

Loans and Allowance for Cred_10

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Allowance for Credit Losses: Unfunded Credit Commitments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Financing Receivable, Allowance for Credit Loss [Line Items]
Change in allowance for credit loss	$ 12
Allowance for credit loss, beginning balance	545	$ 396	$ 422	$ 448
Provision for (reduction in) credit losses	30	(9)	184	41
Foreign currency translation adjustments	(3)		(6)
Allowance for credit loss, ending balance	557	398	557	398
Unfunded Credit Commitments
Financing Receivable, Allowance for Credit Loss [Line Items]
Change in allowance for credit loss	41
Allowance for credit loss, beginning balance	224	120	171	121
Provision for (reduction in) credit losses	42	29	96	28
Foreign currency translation adjustments	(1)	0	(2)	0
Allowance for credit loss, ending balance	$ 265	$ 149	$ 265	$ 149

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Narrative (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 375	$ 375
Amortization expense	$ 18

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets - Other Intangible Assets (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Other intangible assets:
Estimated Fair Value	$ 192	$ 192
Accumulated Amortization	50	32
Net Carrying Amount	142	160
Customer relationships
Other intangible assets:
Estimated Fair Value	135	135
Accumulated Amortization	27	16
Net Carrying Amount	108	119
Other
Other intangible assets:
Estimated Fair Value	57	57
Accumulated Amortization	23	16
Net Carrying Amount	$ 34	$ 41

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets - Future Amortization Expense (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
2022 (excluding the nine months ended September 30, 2022)	$ 6
2023	22
2024	20
2025	17
2026	15
2027 and thereafter	62
Net Carrying Amount	$ 142	$ 160

Derivative Financial Instrume_3

Derivative Financial Instruments - Fair Value Hedges (Details) - Interest rate swaps - Other assets - Derivatives designated as hedging instruments - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Derivative [Line Items]
Amortized Cost Basis of the Hedged Assets	$ 8,773	$ 15,260
Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Assets, Active	0	(131)
Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Assets, Terminated	$ (301)	6
Amortized cost of hedged items where the hedged item is the last layer expected to be remaining at the end of the hedging relationship		11,200
Amount of hedged items where the hedged item is the last layer expected to be remaining at the end of the hedging relationship		6,700
Cumulative adjustments of hedged items where the hedged item is the last layer expected to be remaining at the end of the hedging relationship		$ 83

Derivative Financial Instrume_4

Derivative Financial Instruments - Cash Flow Hedges (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Mar. 31, 2020
Derivative [Line Items]
Unrealized gain on terminated cash flow hedge remaining in AOCI, before tax	$ 73
Unrealized gain on terminated cash flow hedge remaining in AOCI, net of tax	$ 52
Term unrealized gains reclassified into earnings	3 years
Derivatives designated as hedging instruments \| Interest rate swaps
Derivative [Line Items]
Derivative notional amount		$ 5,000
Derivatives net asset fair value		$ 228

Derivative Financial Instrume_5

Derivative Financial Instruments - Currency Exchange Risk (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Net investment pretax gains (losses) recognized in AOCI	$ 94	$ 94

Derivative Financial Instrume_6

Derivative Financial Instruments - Total Notional or Contractual Amounts, Fair Value, Collateral and Net Exposure of Derivative Financial Instruments (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Derivative [Line Items]
Derivative Assets, Fair Value	$ 597	$ 165
Derivative Liabilities, Fair Value	256	148
Derivative Assets, Total Gross Derivatives	1,161	565
Derivative Liabilities, Total Gross Derivatives	758	238
Less: netting adjustment (Derivative Assets)	(495)	(137)
Less: netting adjustment (Derivative Liabilities)	(234)	(120)
Derivative Assets, Total derivatives	666	428
Derivative Liabilities, Total derivatives	524	118
Approximate reduction amounts of derivative assets reflecting variation margin treated as settlement of the related derivative fair values	117	112
Cash collateral in excess of net derivative receivables	6
Cash collateral in excess of net derivative payables		1
Derivatives designated as hedging instruments
Derivative [Line Items]
Derivative Assets, Fair Value	94	18
Derivatives designated as hedging instruments \| Interest rate swaps \| Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	0	10,700
Derivative Assets, Fair Value	0	18
Derivatives designated as hedging instruments \| Foreign exchange contracts \| Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	1,546
Derivative Assets, Fair Value	94	0
Derivatives not designated as hedging instruments
Derivative [Line Items]
Derivative Assets, Fair Value	1,067	547
Derivative Liabilities, Fair Value	758	238
Derivatives not designated as hedging instruments \| Foreign exchange contracts \| Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	2,860	701
Derivative Assets, Fair Value	46	16
Derivatives not designated as hedging instruments \| Foreign exchange contracts \| Other liabilities
Derivative [Line Items]
Derivative Liabilities, Notional or Contractual Amount	308	62
Derivative Liabilities, Fair Value	13	2
Derivatives not designated as hedging instruments \| Equity warrant assets \| Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	353	322
Derivative Assets, Fair Value	351	277
Derivatives not designated as hedging instruments \| Contingent conversion rights \| Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	52
Derivative Assets, Fair Value	6
Derivatives not designated as hedging instruments \| Client foreign exchange contracts \| Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	10,658	8,245
Derivative Assets, Fair Value	500	146
Derivatives not designated as hedging instruments \| Client foreign exchange contracts \| Other liabilities
Derivative [Line Items]
Derivative Liabilities, Notional or Contractual Amount	10,615	7,764
Derivative Liabilities, Fair Value	499	126
Derivatives not designated as hedging instruments \| Total return swaps \| Other assets
Derivative [Line Items]
Derivative Assets, Fair Value	25	0
Derivatives not designated as hedging instruments \| Total return swaps \| Other liabilities
Derivative [Line Items]
Derivative Liabilities, Notional or Contractual Amount	110	0
Derivatives not designated as hedging instruments \| Client foreign currency options \| Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	266	688
Derivative Assets, Fair Value	11	9
Derivatives not designated as hedging instruments \| Client foreign currency options \| Other liabilities
Derivative [Line Items]
Derivative Liabilities, Notional or Contractual Amount	266	688
Derivative Liabilities, Fair Value	11	9
Derivatives not designated as hedging instruments \| Client interest rate derivatives \| Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	2,248	2,178
Derivative Assets, Fair Value	128	99
Derivatives not designated as hedging instruments \| Client interest rate derivatives \| Other liabilities
Derivative [Line Items]
Derivative Liabilities, Notional or Contractual Amount	2,447	2,315
Derivative Liabilities, Fair Value	$ 235	$ 101

Derivative Financial Instrume_7

Derivative Financial Instruments - Summary of Derivative Activity and Related Impact on Consolidated Statements of Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives			$ (345)	$ (18)
Interest rate risks \| Derivatives designated as hedging instruments
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	$ 13	$ 15	42	46
Interest rate risks \| Derivatives designated as hedging instruments \| Reclassification out of Accumulated Other Comprehensive Income \| Interest income - loans
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	14	16	43	47
Interest rate risks \| Derivatives designated as hedging instruments \| Change In Fair Value Of Interest Rate Swaps Hedging Investment Securities \| Interest income - loans
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	(2)	5	384	18
Interest rate risks \| Derivatives designated as hedging instruments \| Change In Fair Value Of Hedged Investment Securities \| Interest income - loans
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	1	(6)	(385)	(19)
Currency exchange risk \| Derivatives not designated as hedging instruments
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	(4)	0	(5)	0
Currency exchange risk \| Derivatives not designated as hedging instruments \| Revaluations of internal foreign currency instruments, net \| Other noninterest income
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	47	(14)	26	(35)
Currency exchange risk \| Derivatives not designated as hedging instruments \| Foreign exchange forward contracts, net \| Other noninterest income
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	(51)	14	(31)	35
Other derivative instruments \| Derivatives not designated as hedging instruments
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	10	(4)	12	1
Other derivative instruments \| Derivatives not designated as hedging instruments \| Other noninterest income
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	2	2	8	4
Other derivative instruments \| Derivatives not designated as hedging instruments \| Revaluations of internal foreign currency instruments, net \| Other noninterest income
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	12	1	7	16
Other derivative instruments \| Derivatives not designated as hedging instruments \| Foreign exchange forward contracts, net \| Other noninterest income
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	(2)	(5)	5	(15)
Total return swaps \| Derivatives not designated as hedging instruments \| Other noninterest income
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	(2)	0	25	0
Equity warrant assets \| Derivatives not designated as hedging instruments \| Gains on equity warrant assets, net
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	$ 40	$ 147	$ 120	$ 491

Derivative Financial Instrume_8

Derivative Financial Instruments - Balance Sheet Offsetting, Assets (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Derivative Assets
Gross Amounts of Recognized Assets	$ 597	$ 165
Gross Amounts Offset in the Statement of Financial Position, Financial Instruments	(229)	(87)
Gross Amounts Offset in the Statement of Financial Position, Cash Collateral Received	(266)	(50)
Net Amounts of Assets Presented in the Statement of Financial Position	102	28
Net Amount	102	28
Reverse repurchase, securities borrowing, and similar arrangements
Gross Amounts of Recognized Assets	397	607
Gross Amounts Offset in the Statement of Financial Position, Financial Instruments	0	0
Net Amounts of Assets Presented in the Statement of Financial Position	397	607
Gross Amounts Not Offset in the Statement of Financial Position	(397)	(607)
Net Amount	0	0
Total
Gross Amounts of Recognized Assets	994	772
Gross Amounts Offset in the Statement of Financial Position, Financial Instruments	(229)	(87)
Net Amounts of Assets Presented in the Statement of Financial Position	499	635
Cash Collateral Received	(397)	(607)
Net Amount	$ 102	$ 28

Derivative Financial Instrume_9

Derivative Financial Instruments - Balance Sheet Offsetting, Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Derivative Liabilities
Gross Amounts of Recognized Liabilities	$ 256	$ 148
Gross Amounts Offset in the Statement of Financial Position, Financial Instruments	(229)	(87)
Gross Amounts Offset in the Statement of Financial Position, Cash Collateral Pledged	(5)	(33)
Net Amounts of Liabilities Presented in the Statement of Financial Position	22	28
Net Amount	22	28
Repurchase, securities lending, and similar arrangements
Gross Amounts of Recognized Liabilities	36	61
Gross Amounts Offset in the Statement of Financial Position, Financial Instruments	0	0
Net Amounts of Liabilities Presented in the Statement of Financial Position	36	61
Gross Amounts Not Offset in the Statement of Financial Position	0	0
Net Amount	36	61
Total
Gross Amounts of Recognized Liabilities	292	209
Gross Amounts Offset in the Statement of Financial Position, Financial Instruments	(229)	(87)
Net Amounts of Liabilities Presented in the Statement of Financial Position	58	89
Gross Amounts Not Offset in the Statement of Financial Position	0	0
Net Amount	$ 58	$ 89

Noninterest Income - Summary of

Noninterest Income - Summary of Noninterest Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Other Income and Expenses [Abstract]
Gains (losses) on investment securities, net	$ (127)	$ 189	$ (199)	$ 661
Gains on equity warrant assets, net	40	147	120	491
Client investment fees	119	20	237	55
Wealth management and trust fees	19	22	63	22
Foreign exchange fees	74	65	216	189
Credit card fees	37	34	114	93
Deposit service charges	32	29	94	82
Lending related fees	20	21	65	55
Letters of credit and standby letters of credit fees	15	13	43	39
Investment banking revenue	75	90	293	335
Commissions	24	17	73	58
Other	31	25	119	97
Total noninterest income	$ 359	$ 672	$ 1,238	$ 2,177

Noninterest Income - Gains and

Noninterest Income - Gains and Losses on Investments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Other Income and Expenses [Abstract]
Total net gains on non-marketable and other equity securities	$ (127)	$ 189	$ (247)	$ 661
Gains (losses) on sales of AFS securities, net	0	0	48	0
Gains on investment securities, net	$ (127)	$ 189	$ (199)	$ 661

Noninterest Income - Gains an_2

Noninterest Income - Gains and Losses on Derivatives (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Other Income and Expenses [Abstract]
Gains on exercises, net	$ 9	$ 91	$ 44	$ 381
Terminations	(1)	(1)	(3)	(2)
Changes in fair value, net	32	57	79	112
Gains on equity warrant assets, net	$ 40	$ 147	$ 120	$ 491

Noninterest Income - Client Inv

Noninterest Income - Client Investment Fees (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	$ 350	$ 315	$ 1,070	$ 948
Sweep money market fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	64	12	144	31
Asset management fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	16	7	41	22
Repurchase agreement fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	39	1	52	2
Client investment fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	$ 119	$ 20	$ 237	$ 55

Noninterest Income - Wealth Man

Noninterest Income - Wealth Management and Trust Fees (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Other Income and Expenses [Abstract]
Wealth management fees	$ 17	$ 20	$ 58	$ 20
Trust fees	2	2	5	2
Wealth management and trust fees	$ 19	$ 22	$ 63	$ 22

Noninterest Income - Foreign Ex

Noninterest Income - Foreign Exchange Fees (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	$ 350	$ 315	$ 1,070	$ 948
Revenue not from contract with customer	9	357	168	1,229
Foreign exchange fees	74	65	216	189
Spot contract commissions
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	74	65	215	188
Option premium fees
Disaggregation of Revenue [Line Items]
Revenue not from contract with customer	$ 0	$ 0	$ 1	$ 1

Noninterest Income - Credit Car

Noninterest Income - Credit Card Fees (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Card interchange fees, net	$ 29	$ 29	$ 91	$ 78
Revenue from contracts with customers	350	315	1,070	948
Revenue not from contract with customer	9	357	168	1,229
Total credit card fees	37	34	114	93
Merchant service fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	6	4	18	12
Card service fees
Disaggregation of Revenue [Line Items]
Revenue not from contract with customer	$ 2	$ 1	$ 5	$ 3

Noninterest Income - Lending Re

Noninterest Income - Lending Related Fees (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Lending related fees	$ 20	$ 21	$ 65	$ 55
Unused commitment fees
Accounts, Notes, Loans and Financing Receivable [Line Items]
Lending related fees	14	14	49	42
Other
Accounts, Notes, Loans and Financing Receivable [Line Items]
Lending related fees	$ 6	$ 7	$ 16	$ 13

Noninterest Income - Investment

Noninterest Income - Investment Banking Revenue (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Investment banking revenue:
Underwriting fees	$ 24	$ 39	$ 97	$ 248
Advisory fees	40	26	163	39
Private placements and other	11	25	33	48
Total investment banking revenue	$ 75	$ 90	$ 293	$ 335

Noninterest Income - Summary _2

Noninterest Income - Summary of Other Noninterest Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Trading Activity, Gains and Losses, Net [Line Items]
Revenue from contracts with customers	$ 350	$ 315	$ 1,070	$ 948
Net losses on revaluation of foreign currency instruments, net of foreign exchange forward contracts	6	(4)	7	1
Gains on total return swaps	(3)	0	25	0
Other service revenue	12	14	44	45
Other	31	25	119	97
Fund management fees
Trading Activity, Gains and Losses, Net [Line Items]
Revenue from contracts with customers	$ 16	$ 15	$ 43	$ 51

Noninterest Income - Disaggrega

Noninterest Income - Disaggregation of Revenue (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	$ 350	$ 315	$ 1,070	$ 948
Revenues outside the scope of ASC 606	9	357	168	1,229
Noninterest income (loss)	359	672	1,238	2,177
Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	1	4	3
Revenues outside the scope of ASC 606	(17)	188	107	793
Noninterest income (loss)	(17)	189	111	796
Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	214	165	586	463
Revenues outside the scope of ASC 606	94	17	195	51
Noninterest income (loss)	308	182	781	514
SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	20	23	66	26
Revenues outside the scope of ASC 606	2	2	6	2
Noninterest income (loss)	22	25	72	28
SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	15	18	43	59
Revenues outside the scope of ASC 606	(69)	127	(121)	330
Noninterest income (loss)	(54)	145	(78)	389
SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	101	108	371	397
Revenues outside the scope of ASC 606	(1)	23	(19)	53
Noninterest income (loss)	100	131	352	450
Investment banking revenue
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	119	20	237	55
Investment banking revenue \| Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	1	0
Investment banking revenue \| Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	119	20	236	53
Investment banking revenue \| SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	2
Investment banking revenue \| SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Investment banking revenue \| SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Wealth management and trust fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	19	22	63	22
Wealth management and trust fees \| Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0		0	0
Wealth management and trust fees \| Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Wealth management and trust fees \| SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	19	22	63	22
Wealth management and trust fees \| SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0		0	0
Wealth management and trust fees \| SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0		0	0
Spot contract commissions
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	74	65	215	188
Card interchange fees, gross
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	55	52	173	142
Card interchange fees, gross \| Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	2	1
Card interchange fees, gross \| Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	54	52	170	140
Card interchange fees, gross \| SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	1	0	1	1
Card interchange fees, gross \| SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Card interchange fees, gross \| SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Merchant service fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	7	4	18	12
Merchant service fees \| Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Merchant service fees \| Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	7	4	18	12
Merchant service fees \| SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Merchant service fees \| SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Merchant service fees \| SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Deposit service charges
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	32	29	94	82
Deposit service charges \| Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	1	1	2
Deposit service charges \| Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	32	28	92	80
Deposit service charges \| SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	1	0
Deposit service charges \| SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Deposit service charges \| SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Investment banking revenue
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	75	90	293	335
Investment banking revenue \| Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Investment banking revenue \| Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Investment banking revenue \| SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Investment banking revenue \| SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Investment banking revenue \| SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	75	90	293	335
Commissions
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	24	17	73	58
Commissions \| Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Commissions \| Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Commissions \| SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Commissions \| SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Commissions \| SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	24	17	73	58
Fund management fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	16	15	43	51
Fund management fees \| Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Fund management fees \| Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	1	0	1	0
Fund management fees \| SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Fund management fees \| SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	13	14	37	47
Fund management fees \| SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	2	1	5	4
Other
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	3	66	76	191
Other \| Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Other \| Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	1	61	69	178
Other \| SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	1	1	1
Other \| SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	2	4	6	12
Other \| SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	$ 0	$ 0	$ 0	$ 0

Segment Reporting - Narrative (

Segment Reporting - Narrative (Details)	3 Months Ended
Segment Reporting - Narrative (Details)	Sep. 30, 2022 Segment
Segment Reporting [Abstract]
Number of reportable segments	4

Segment Reporting - Segment Inf

Segment Reporting - Segment Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Segment Reporting Information [Line Items]
Net interest income	$ 1,198	$ 852	$ 3,447	$ 2,240
(Provision for) reduction of credit losses	(72)	(21)	(279)	(75)
Noninterest income (loss)	359	672	1,238	2,177
Noninterest expense	(892)	(879)	(2,613)	(2,168)
Income before income tax expense	593	624	1,793	2,174
Total average loans, amortized cost	71,098	59,291	69,158	51,843
Total average assets	215,740	182,690	216,652	152,952
Total average deposits	185,556	163,392	189,428	136,113
Goodwill	375		375		$ 375
Silicon Valley Bank
Segment Reporting Information [Line Items]
Noninterest income (loss)	308	182	781	514
SVB Private
Segment Reporting Information [Line Items]
Noninterest income (loss)	22	25	72	28
SVB Capital
Segment Reporting Information [Line Items]
Noninterest income (loss)	(54)	145	(78)	389
SVB Securities
Segment Reporting Information [Line Items]
Noninterest income (loss)	100	131	352	450
Operating segments \| Silicon Valley Bank
Segment Reporting Information [Line Items]
Net interest income	1,107	766	2,993	2,084
(Provision for) reduction of credit losses	(32)	29	(174)	(27)
Noninterest income (loss)	308	182	781	514
Noninterest expense	(381)	(336)	(1,148)	(911)
Income before income tax expense	1,002	641	2,452	1,660
Total average loans, amortized cost	55,177	44,789	53,855	41,591
Total average assets	175,620	151,352	178,209	130,177
Total average deposits	172,427	148,879	175,370	128,006
Operating segments \| SVB Private
Segment Reporting Information [Line Items]
Net interest income	111	74	296	146
(Provision for) reduction of credit losses	3	(20)	(9)	(16)
Noninterest income (loss)	22	25	72	28
Noninterest expense	(85)	(93)	(267)	(126)
Income before income tax expense	51	(14)	92	32
Total average loans, amortized cost	15,181	13,515	14,711	8,610
Total average assets	17,032	15,930	16,456	9,459
Total average deposits	12,436	13,431	13,327	7,108
Operating segments \| SVB Capital
Segment Reporting Information [Line Items]
Net interest income	0	0	0	0
(Provision for) reduction of credit losses	0	0	0	0
Noninterest income (loss)	(54)	145	(78)	389
Noninterest expense	(17)	(15)	(53)	(48)
Income before income tax expense	(71)	130	(131)	341
Total average loans, amortized cost	0	0	0	0
Total average assets	883	730	956	641
Total average deposits	0	0	0	0
Operating segments \| SVB Securities
Segment Reporting Information [Line Items]
Net interest income	1	0	1	0
(Provision for) reduction of credit losses	0	0	0	0
Noninterest income (loss)	100	131	352	450
Noninterest expense	(131)	(142)	(406)	(376)
Income before income tax expense	(30)	(11)	(53)	74
Total average loans, amortized cost	0	0	0	0
Total average assets	898	837	912	778
Total average deposits	0	0	0	0
Goodwill	174	138	174	138
Operating segments \| Private bank
Segment Reporting Information [Line Items]
Goodwill	201	201	201	201
Other Items
Segment Reporting Information [Line Items]
Net interest income	(21)	12	157	10
(Provision for) reduction of credit losses	(43)	(30)	(96)	(32)
Noninterest income (loss)	(17)	189	111	796
Noninterest expense	(278)	(293)	(739)	(707)
Income before income tax expense	(359)	(122)	(567)	67
Total average loans, amortized cost	740	987	592	1,642
Total average assets	21,307	13,841	20,119	11,897
Total average deposits	$ 693	$ 1,082	$ 731	$ 999

Segment Reporting - Segment I_2

Segment Reporting - Segment Information (Additional Information) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Segment Reporting Information [Line Items]
Goodwill	$ 375		$ 375		$ 375
Operating segments \| Silicon Valley Bank
Segment Reporting Information [Line Items]
Depreciation and amortization	13	$ 10	34	$ 25
Operating segments \| SVB Securities
Segment Reporting Information [Line Items]
Goodwill	174	138	174	138
Operating segments \| Private bank
Segment Reporting Information [Line Items]
Goodwill	$ 201	$ 201	$ 201	$ 201

Off-Balance Sheet Arrangement_3

Off-Balance Sheet Arrangements, Guarantees and Other Commitments - Commitments to Extend Credit (Details) - USD ($) $ in Millions	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020
Financing Receivable, Allowance for Credit Loss [Line Items]
Total unfunded credit commitments	$ 55,698		$ 44,016
Allowance for credit losses: loans	557	$ 545	422	$ 398	$ 396	$ 448
Loan commitments
Financing Receivable, Allowance for Credit Loss [Line Items]
Total unfunded credit commitments	51,769		40,327
Standby letters of credit
Financing Receivable, Allowance for Credit Loss [Line Items]
Total unfunded credit commitments	3,824		3,612
Commercial letters of credit
Financing Receivable, Allowance for Credit Loss [Line Items]
Total unfunded credit commitments	105		77
Unfunded Credit Commitments
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit losses: loans	$ 265	$ 224	$ 171	$ 149	$ 120	$ 121

Off-Balance Sheet Arrangement_4

Off-Balance Sheet Arrangements, Guarantees and Other Commitments - Standby Letters of Credit (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Guarantor Obligations [Line Items]
Expires in One Year or Less	$ 3,689
Expires After One Year	135
Total Amount Outstanding	3,824
Maximum Amount of Future Payments	3,824
Financial standby letters of credit
Guarantor Obligations [Line Items]
Expires in One Year or Less	3,617
Expires After One Year	126
Total Amount Outstanding	3,743
Maximum Amount of Future Payments	3,743
Performance standby letters of credit
Guarantor Obligations [Line Items]
Expires in One Year or Less	72
Expires After One Year	9
Total Amount Outstanding	81
Maximum Amount of Future Payments	81
Standby letters of credit
Guarantor Obligations [Line Items]
Deferred fees	$ 20	$ 20

Off-Balance Sheet Arrangement_5

Off-Balance Sheet Arrangements, Guarantees and Other Commitments - Commitments to Invest in Venture Capital and Private Equity Funds (Details) - Parent Company $ in Millions	3 Months Ended
	Sep. 30, 2022 USD ($)
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	$ 672
SVBFG Unfunded Commitments	142
Redwood Evergreen Fund, LP
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	250
SVBFG Unfunded Commitments	$ 119
SVBFG Ownership of each Fund	100%
Capital Preferred Return Fund, LP
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	$ 13
SVBFG Unfunded Commitments	$ 0
SVBFG Ownership of each Fund	20%
Growth Partners, LP
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	$ 25
SVBFG Unfunded Commitments	$ 1
SVBFG Ownership of each Fund	33%
Strategic Investors Fund, LP
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	$ 15
SVBFG Unfunded Commitments	$ 1
SVBFG Ownership of each Fund	12.60%
CP II, LP
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	$ 1
SVBFG Unfunded Commitments	$ 0
SVBFG Ownership of each Fund	5.10%
Strategic Investors Fund II, LP
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	$ 15
SVBFG Unfunded Commitments	$ 1
SVBFG Ownership of each Fund	8.60%
Strategic Investors Fund III, LP
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	$ 15
SVBFG Unfunded Commitments	$ 1
SVBFG Ownership of each Fund	5.90%
Strategic Investors Fund IV, LP
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	$ 12
SVBFG Unfunded Commitments	$ 2
SVBFG Ownership of each Fund	5%
Strategic Investors Fund V funds
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	$ 1
SVBFG Unfunded Commitments	0
Other venture capital and private equity fund investments
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	18
SVBFG Unfunded Commitments	5
Debt funds (equity method accounting)
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	59
SVBFG Unfunded Commitments	0
Other fund investments
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	248
SVBFG Unfunded Commitments	$ 12
SVBFG Ownership of each Fund	5%

Off-Balance Sheet Arrangement_6

Off-Balance Sheet Arrangements, Guarantees and Other Commitments - Commitments to Invest in Venture Capital and Private Equity Funds (Additional Information) (Details) $ in Millions	3 Months Ended
	Sep. 30, 2022 USD ($) Investment	Sep. 30, 2021
Parent Company
Venture Capital and Private Equity Fund Investments [Line Items]
Unfunded commitments	$ 142
Parent Company \| Redwood Evergreen Fund, LP
Venture Capital and Private Equity Fund Investments [Line Items]
Percentage of ownership	100%
Unfunded commitments	$ 119
Upper Limit
Venture Capital and Private Equity Fund Investments [Line Items]
Percentage of ownership	5%
CP II, LP \| Parent Company
Venture Capital and Private Equity Fund Investments [Line Items]
Percentage of ownership	5.10%
Unfunded commitments	$ 0
Other fund investments \| Parent Company
Venture Capital and Private Equity Fund Investments [Line Items]
Percentage of ownership	5%
Unfunded commitments	$ 12
Strategic Investors Fund IV, LP \| Parent Company
Venture Capital and Private Equity Fund Investments [Line Items]
Percentage of ownership	5%
Unfunded commitments	$ 2
Consolidated venture capital and private equity fund investments
Venture Capital and Private Equity Fund Investments [Line Items]
Commitments to invest, period from the inception of the fund	10 years
Call unrestricted, percentage of committed capital	100%
Unfunded commitments	$ 3
Consolidated venture capital and private equity fund investments \| Lower Limit
Venture Capital and Private Equity Fund Investments [Line Items]
Expected commitment period to invest in venture capital and private equity funds (in years)	5 years
Consolidated venture capital and private equity fund investments \| Upper Limit
Venture Capital and Private Equity Fund Investments [Line Items]
Expected commitment period to invest in venture capital and private equity funds (in years)	7 years
Consolidated venture capital and private equity fund investments \| Non-marketable securities \| Equity method accounting \| CP II, LP
Venture Capital and Private Equity Fund Investments [Line Items]
Percentage of ownership	5.10%	5.10%
Consolidated venture capital and private equity fund investments \| Non-marketable securities \| Equity method accounting \| Other fund investments
Venture Capital and Private Equity Fund Investments [Line Items]
Number of other funds with investment commitments \| Investment	147
Consolidated venture capital and private equity fund investments \| Non-marketable securities \| Equity method accounting \| Strategic Investors Fund IV, LP
Venture Capital and Private Equity Fund Investments [Line Items]
Percentage of ownership	5%	5%
Consolidated venture capital and private equity fund investments \| Non-marketable securities \| Direct ownership interest \| Equity method accounting \| CP II, LP
Venture Capital and Private Equity Fund Investments [Line Items]
Percentage of ownership	1.30%
Consolidated venture capital and private equity fund investments \| Non-marketable securities \| Indirect ownership interest \| Equity method accounting \| CP II, LP
Venture Capital and Private Equity Fund Investments [Line Items]
Percentage of ownership	3.80%

Income Taxes (Details)

Income Taxes (Details) $ in Millions	Sep. 30, 2022 USD ($)
Income Tax Disclosure [Abstract]
Unrecognized tax benefits	$ 42
Income tax reduction from recognized tax benefit	$ 34

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2022 USD ($)	Sep. 30, 2022 USD ($)	Dec. 31, 2021 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	$ 26,711	$ 26,711	$ 27,221
Derivative Assets, Fair Value	597	597	165
Derivative Liabilities, Fair Value	256	256	148
Less: netting adjustment (Derivative Assets)	(495)	(495)	(137)
Less: netting adjustment	(234)	(234)	(120)
Derivatives not designated as hedging instruments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	1,067	1,067	547
Derivative Liabilities, Fair Value	758	758	238
Total return swaps \| Other assets \| Derivatives not designated as hedging instruments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	25	25	0
Equity warrant assets \| Other assets \| Derivatives not designated as hedging instruments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	351	351	277
Contingent conversion rights \| Other assets \| Derivatives not designated as hedging instruments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	6	6
Client interest rate derivatives \| Other assets \| Derivatives not designated as hedging instruments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	128	128	99
Client interest rate derivatives \| Other liabilities \| Derivatives not designated as hedging instruments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities, Fair Value	235	235	101
U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	16,845	16,845	15,850
U.S. agency debentures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	100	100	196
Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	913	913	61
Agency-issued MBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	6,683	6,683	8,589
Agency-issued CMO
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	714	714	982
Agency-issued CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	1,456	1,456	1,543
Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	26,711	26,711	27,221
Total assets	27,680	27,680	28,112
Total liabilities	528	528	126
Recurring \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other assets			8
Recurring \| Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other liabilities			8
Recurring \| Foreign exchange contract \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	309	309	151
Recurring \| Foreign exchange contract \| Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities, Fair Value	524	524	118
Recurring \| Equity warrant assets \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	351	351	277
Recurring \| Contingent conversion rights \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	6	6
Recurring \| Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-marketable securities	299	299	455
Recurring \| U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	16,845	16,845	15,850
Recurring \| U.S. agency debentures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	100	100	196
Recurring \| Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	913	913	61
Recurring \| Agency-issued MBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	6,683	6,683	8,589
Recurring \| Agency-issued CMO
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	714	714	982
Recurring \| Agency-issued CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	1,456	1,456	1,543
Recurring \| Other equity securities in public companies \| Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-marketable securities	29	29	117
Recurring \| Other assets \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other assets	4	4
Recurring \| Other liabilities \| Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other liabilities	4	4
Recurring \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	17,758	17,758	15,911
Total assets	17,789	17,789	15,962
Total liabilities	4	4	8
Recurring \| Level 1 \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other assets			8
Recurring \| Level 1 \| Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other liabilities			8
Recurring \| Level 1 \| Foreign exchange contract \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	0	0	0
Recurring \| Level 1 \| Foreign exchange contract \| Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities, Fair Value	0	0	0
Recurring \| Level 1 \| Equity warrant assets \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	0	0	0
Recurring \| Level 1 \| Contingent conversion rights \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	0	0
Recurring \| Level 1 \| Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-marketable securities	27	27	43
Recurring \| Level 1 \| U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	16,845	16,845	15,850
Recurring \| Level 1 \| U.S. agency debentures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring \| Level 1 \| Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	913	913	61
Recurring \| Level 1 \| Agency-issued MBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring \| Level 1 \| Agency-issued CMO
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring \| Level 1 \| Agency-issued CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring \| Level 1 \| Other equity securities in public companies \| Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-marketable securities	27	27	43
Recurring \| Level 1 \| Other assets \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other assets	4	4
Recurring \| Level 1 \| Other liabilities \| Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other liabilities	4	4
Recurring \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	8,953	8,953	11,310
Total assets	9,765	9,765	11,680
Total liabilities	758	758	238
Recurring \| Level 2 \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other assets			0
Recurring \| Level 2 \| Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other liabilities			0
Recurring \| Level 2 \| Foreign exchange contract \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	804	804	288
Recurring \| Level 2 \| Foreign exchange contract \| Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities, Fair Value	758	758	238
Recurring \| Level 2 \| Equity warrant assets \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	6	6	8
Recurring \| Level 2 \| Contingent conversion rights \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	0	0
Recurring \| Level 2 \| Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-marketable securities	2	2	74
Recurring \| Level 2 \| U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring \| Level 2 \| U.S. agency debentures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	100	100	196
Recurring \| Level 2 \| Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring \| Level 2 \| Agency-issued MBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	6,683	6,683	8,589
Recurring \| Level 2 \| Agency-issued CMO
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	714	714	982
Recurring \| Level 2 \| Agency-issued CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	1,456	1,456	1,543
Recurring \| Level 2 \| Other equity securities in public companies \| Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-marketable securities	2	2	74
Recurring \| Level 2 \| Other assets \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other assets	0	0
Recurring \| Level 2 \| Other liabilities \| Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other liabilities	0	0
Recurring \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Total assets	351	351	269
Total liabilities	0	0	0
Recurring \| Level 3 \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other assets			0
Recurring \| Level 3 \| Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other liabilities			0
Recurring \| Level 3 \| Foreign exchange contract \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	0	0	0
Recurring \| Level 3 \| Foreign exchange contract \| Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities, Fair Value	0	0	0
Recurring \| Level 3 \| Equity warrant assets \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	345	345	269
Recurring \| Level 3 \| Contingent conversion rights \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	6	6
Recurring \| Level 3 \| Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-marketable securities	0	0	0
Recurring \| Level 3 \| U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring \| Level 3 \| U.S. agency debentures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring \| Level 3 \| Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring \| Level 3 \| Agency-issued MBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring \| Level 3 \| Agency-issued CMO
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring \| Level 3 \| Agency-issued CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring \| Level 3 \| Other equity securities in public companies \| Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-marketable securities	0	0	0
Recurring \| Level 3 \| Other assets \| Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other assets	0	0
Recurring \| Level 3 \| Other liabilities \| Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other liabilities	0	0
Recurring \| Measured at net asset value \| Venture capital and private equity fund investments \| Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-marketable securities	$ 270	$ 270	$ 338
Lower Limit \| Other equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, sales restriction, period	3 years
Upper Limit \| Other equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, sales restriction, period		6 months
Sales restrictions discount \| Lower Limit \| Other equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.10	0.10
Sales restrictions discount \| Upper Limit \| Other equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.20	0.20

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Additional Information about Level 3 Assets Measured at Fair Value on a Recurring Basis (Details) - Recurring - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Equity warrant assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	$ 318	$ 257	$ 269	$ 192
Total Net Gains Included in Net Income	39	149	124	490
Sales/Exits	(21)	(146)	(67)	(431)
Issuances	9	6	21	18
Transfers Into Level 3	0	(1)	(2)	(4)
Ending Balance	345	$ 265	345	$ 265
Contingent conversion rights
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	6		0
Total Net Gains Included in Net Income	0		(1)
Sales/Exits	0		0
Issuances	0		7
Transfers Into Level 3	0		0
Ending Balance	$ 6		$ 6

Fair Value of Financial Instr_5

Fair Value of Financial Instruments - Unrealized Gains Included in Earnings Attributable to Level 3 Assets Held (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Unrealized Gains (Losses) [Line Items]
Unrealized gains included in earnings attributable to Level 3 assets still held	$ 26	$ 21	$ 83	$ 113
Equity warrant assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Unrealized Gains (Losses) [Line Items]
Unrealized gains included in earnings attributable to Level 3 assets still held	26	21	84	113
Contingent conversion rights
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Unrealized Gains (Losses) [Line Items]
Unrealized gains included in earnings attributable to Level 3 assets still held	$ 0	$ 0	$ (1)	$ 0

Fair Value of Financial Instr_6

Fair Value of Financial Instruments - Quantitative Information About Significant Unobservable Inputs (Details) - Level 3 $ in Millions	Sep. 30, 2022 USD ($)	Dec. 31, 2021 USD ($)
Equity warrant assets \| Public Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Fair value		$ 2
Equity warrant assets \| Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Fair value	$ 345	$ 267
Contingent conversion rights \| Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Fair value	$ 6
Volatility \| Equity warrant assets \| Lower Limit \| Public Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input		0.278
Volatility \| Equity warrant assets \| Lower Limit \| Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.238	0.247
Volatility \| Equity warrant assets \| Upper Limit \| Public Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input		0.550
Volatility \| Equity warrant assets \| Upper Limit \| Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.513	0.550
Volatility \| Equity warrant assets \| Weighted Average \| Public Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input		0.011
Volatility \| Equity warrant assets \| Weighted Average \| Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.423	0.430
Risk-Free interest rate \| Equity warrant assets \| Lower Limit \| Public Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input		0.006
Risk-Free interest rate \| Equity warrant assets \| Lower Limit \| Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.033	0.0006
Risk-Free interest rate \| Equity warrant assets \| Upper Limit \| Public Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input		0.015
Risk-Free interest rate \| Equity warrant assets \| Upper Limit \| Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.044	0.0140
Risk-Free interest rate \| Equity warrant assets \| Weighted Average \| Public Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input		0.107
Risk-Free interest rate \| Equity warrant assets \| Weighted Average \| Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.042	0.008
Sales restrictions discount \| Equity warrant assets \| Lower Limit \| Public Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input		0.100
Sales restrictions discount \| Equity warrant assets \| Upper Limit \| Public Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input		0.200
Sales restrictions discount \| Equity warrant assets \| Weighted Average \| Public Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input		0.437
Marketability discount \| Equity warrant assets \| Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.171	0.201
Marketability discount \| Equity warrant assets \| Weighted Average \| Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.171	0.201
Remaining life assumption \| Equity warrant assets \| Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.400	0.400
Remaining life assumption \| Equity warrant assets \| Weighted Average \| Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.400	0.400

Fair Value of Financial Instr_7

Fair Value of Financial Instruments - Quantitative Information About Significant Unobservable Inputs (Additional Information) (Details)	3 Months Ended
	Sep. 30, 2022
Equity warrant assets, private portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Weighted average remaining life	6 years 2 months 12 days
Weighted average remaining life	2 years 6 months
Sales restrictions discount \| Upper Limit \| Equity warrant asset, public portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.20
Level 3 \| Lower Limit \| Equity warrant asset, public portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Fair value inputs, sales restriction, period	3 months
Level 3 \| Upper Limit \| Equity warrant asset, public portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Fair value inputs, sales restriction, period	6 months
Level 3 \| Sales restrictions discount \| Lower Limit \| Equity warrant asset, public portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.10
Level 3 \| Sales restrictions discount \| Upper Limit \| Equity warrant asset, public portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.20

Fair Value of Financial Instr_8

Fair Value of Financial Instruments - Summary of Estimated Fair Values of Financial Instruments not Carried at Fair Value (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
HTM securities	$ 77,370	$ 97,227
Net loans	71,572	65,854
Carrying Amount
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	13,968	14,586
HTM securities	93,286	98,195
Non-marketable securities not measured at net asset value	431	424
Non-marketable securities measured at net asset value	660	710
Net loans	71,572	65,854
FHLB and Federal Reserve Bank stock	665	107
Non-maturity deposits	171,545	187,464
Time deposits	5,274	1,739
Junior subordinated debentures	91	90
Commitments to extend credit	0	0
Carrying Amount \| Short-term borrowings
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term borrowings	13,552	71
Carrying Amount \| 3.50% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	349	349
Carrying Amount \| 3.125% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	496	496
Carrying Amount \| 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	495	494
Carrying Amount \| 2.100% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	496	496
Carrying Amount \| 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	646	645
Carrying Amount \| 4.345% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	348
Carrying Amount \| 4.570% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	447
Estimate of Fair Value Measurement
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	13,968	14,586
HTM securities	77,370	97,227
Non-marketable securities not measured at net asset value	431	424
Non-marketable securities measured at net asset value	660	710
Net loans	72,489	67,335
FHLB and Federal Reserve Bank stock	665	107
Non-maturity deposits	171,545	187,464
Time deposits	4,916	1,728
Junior subordinated debentures	91	92
Commitments to extend credit	49	47
Estimate of Fair Value Measurement \| Short-term borrowings
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term borrowings	13,552	71
Estimate of Fair Value Measurement \| 3.50% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	336	370
Estimate of Fair Value Measurement \| 3.125% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	407	526
Estimate of Fair Value Measurement \| 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	358	474
Estimate of Fair Value Measurement \| 2.100% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	408	501
Estimate of Fair Value Measurement \| 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	559	649
Estimate of Fair Value Measurement \| 4.345% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	327
Estimate of Fair Value Measurement \| 4.570% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	396
Estimate of Fair Value Measurement \| Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	13,968	14,586
HTM securities	0	0
Non-marketable securities not measured at net asset value	0	0
Non-marketable securities measured at net asset value	0	0
Net loans	0	0
FHLB and Federal Reserve Bank stock	0	0
Non-maturity deposits	171,545	187,464
Time deposits	0	0
Junior subordinated debentures	0	0
Commitments to extend credit	0	0
Estimate of Fair Value Measurement \| Level 1 \| Short-term borrowings
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term borrowings	0	0
Estimate of Fair Value Measurement \| Level 1 \| 3.50% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0	0
Estimate of Fair Value Measurement \| Level 1 \| 3.125% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0	0
Estimate of Fair Value Measurement \| Level 1 \| 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0	0
Estimate of Fair Value Measurement \| Level 1 \| 2.100% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0	0
Estimate of Fair Value Measurement \| Level 1 \| 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0	0
Estimate of Fair Value Measurement \| Level 1 \| 4.345% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0
Estimate of Fair Value Measurement \| Level 1 \| 4.570% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0
Estimate of Fair Value Measurement \| Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	0	0
HTM securities	77,370	97,227
Non-marketable securities not measured at net asset value	0	0
Non-marketable securities measured at net asset value	0	0
Net loans	0	0
FHLB and Federal Reserve Bank stock	0	0
Non-maturity deposits	0	0
Time deposits	4,916	1,728
Junior subordinated debentures	91	92
Commitments to extend credit	0	0
Estimate of Fair Value Measurement \| Level 2 \| Short-term borrowings
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term borrowings	13,552	71
Estimate of Fair Value Measurement \| Level 2 \| 3.50% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	336	370
Estimate of Fair Value Measurement \| Level 2 \| 3.125% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	407	526
Estimate of Fair Value Measurement \| Level 2 \| 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	358	474
Estimate of Fair Value Measurement \| Level 2 \| 2.100% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	408	501
Estimate of Fair Value Measurement \| Level 2 \| 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	559	649
Estimate of Fair Value Measurement \| Level 2 \| 4.345% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	327
Estimate of Fair Value Measurement \| Level 2 \| 4.570% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	396
Estimate of Fair Value Measurement \| Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	0	0
HTM securities	0	0
Non-marketable securities not measured at net asset value	431	424
Non-marketable securities measured at net asset value	0	0
Net loans	72,489	67,335
FHLB and Federal Reserve Bank stock	665	107
Non-maturity deposits	0	0
Time deposits	0	0
Junior subordinated debentures	0	0
Commitments to extend credit	49	47
Estimate of Fair Value Measurement \| Level 3 \| Short-term borrowings
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term borrowings	0	0
Estimate of Fair Value Measurement \| Level 3 \| 3.50% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0	0
Estimate of Fair Value Measurement \| Level 3 \| 3.125% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0	0
Estimate of Fair Value Measurement \| Level 3 \| 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0	0
Estimate of Fair Value Measurement \| Level 3 \| 2.100% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0	0
Estimate of Fair Value Measurement \| Level 3 \| 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0	$ 0
Estimate of Fair Value Measurement \| Level 3 \| 4.345% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0
Estimate of Fair Value Measurement \| Level 3 \| 4.570% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	$ 0

Fair Value of Financial Instr_9

Fair Value of Financial Instruments - Summary of Estimated Fair Values of Investments and Remaining Unfunded Commitments for Each Major Category of Investments (Details) $ in Millions	Sep. 30, 2022 USD ($)
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Carrying Amount	$ 930
Fair Value	930
Unfunded Commitments	25
Non-marketable securities \| Venture capital and private equity fund investments \| Fair value accounting
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Carrying Amount	270
Fair Value	270
Unfunded Commitments	13
Non-marketable securities \| Venture capital and private equity fund investments \| Equity method accounting
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Carrying Amount	639
Fair Value	639
Unfunded Commitments	11
Non-marketable securities \| Debt funds \| Equity method accounting
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Carrying Amount	4
Fair Value	4
Unfunded Commitments	0
Non-marketable securities \| Other investments \| Equity method accounting
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Carrying Amount	17
Fair Value	17
Unfunded Commitments	$ 1

Fair Value of Financial Inst_10

Fair Value of Financial Instruments - Summary of Estimated Fair Values of Investments and Remaining Unfunded Commitments for Each Major Category of Investments (Textual) (Details) $ in Millions	3 Months Ended
	Sep. 30, 2022 USD ($)
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Fair value	$ 930
Unfunded commitments	25
Non-marketable securities \| Venture capital and private equity fund investments \| Fair value accounting
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Fair value	270
Unfunded commitments	$ 13
Non-marketable securities \| Venture capital and private equity fund investments \| Fair value accounting \| Lower Limit
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Period distributions from fund investments to be received	10 years
Non-marketable securities \| Venture capital and private equity fund investments \| Fair value accounting \| Upper Limit
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Period distributions from fund investments to be received	13 years
Non-marketable securities \| Venture capital and private equity fund investments \| Equity method accounting
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Fair value	$ 639
Unfunded commitments	11
Non-marketable securities \| Venture capital and private equity fund investments \| Noncontrolling Interests \| Fair value accounting
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Fair value	42
Unfunded commitments	2
Non-marketable securities \| Other investments \| Equity method accounting
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Fair value	17
Unfunded commitments	$ 1
Non-marketable securities \| Other investments \| Equity method accounting \| Lower Limit
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Period distributions from fund investments to be received	5 years
Non-marketable securities \| Other investments \| Equity method accounting \| Upper Limit
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Period distributions from fund investments to be received	8 years